KR20160025475A - Liquid crystal compound, liquid crystal composition and polymer thereof - Google Patents
Liquid crystal compound, liquid crystal composition and polymer thereof Download PDFInfo
- Publication number
- KR20160025475A KR20160025475A KR1020150119701A KR20150119701A KR20160025475A KR 20160025475 A KR20160025475 A KR 20160025475A KR 1020150119701 A KR1020150119701 A KR 1020150119701A KR 20150119701 A KR20150119701 A KR 20150119701A KR 20160025475 A KR20160025475 A KR 20160025475A
- Authority
- KR
- South Korea
- Prior art keywords
- carbon atoms
- compound
- liquid crystal
- alkyl
- coo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 318
- 239000004973 liquid crystal related substance Substances 0.000 title claims abstract description 215
- 239000000203 mixture Substances 0.000 title claims abstract description 194
- 229920000642 polymer Polymers 0.000 title claims description 25
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 54
- 125000004955 1,4-cyclohexylene group Chemical group [H]C1([H])C([H])([H])C([H])([*:1])C([H])([H])C([H])([H])C1([H])[*:2] 0.000 claims abstract description 23
- 125000001140 1,4-phenylene group Chemical group [H]C1=C([H])C([*:2])=C([H])C([H])=C1[*:1] 0.000 claims abstract description 16
- 125000003118 aryl group Chemical group 0.000 claims abstract description 15
- 125000004432 carbon atom Chemical group C* 0.000 claims description 148
- -1 pyridine-2,5-diyl Chemical group 0.000 claims description 71
- 229910052739 hydrogen Inorganic materials 0.000 claims description 63
- 239000001257 hydrogen Substances 0.000 claims description 63
- 230000003287 optical effect Effects 0.000 claims description 41
- 229910052731 fluorine Inorganic materials 0.000 claims description 39
- 239000011737 fluorine Substances 0.000 claims description 39
- 238000000034 method Methods 0.000 claims description 37
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 36
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 34
- 125000003545 alkoxy group Chemical group 0.000 claims description 34
- 239000000460 chlorine Substances 0.000 claims description 34
- 229910052801 chlorine Inorganic materials 0.000 claims description 34
- 239000000126 substance Substances 0.000 claims description 33
- 125000005907 alkyl ester group Chemical group 0.000 claims description 28
- 150000002431 hydrogen Chemical class 0.000 claims description 27
- 125000001589 carboacyl group Chemical group 0.000 claims description 26
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 24
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 21
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 18
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 16
- 125000002947 alkylene group Chemical group 0.000 claims description 15
- 125000004044 trifluoroacetyl group Chemical group FC(C(=O)*)(F)F 0.000 claims description 15
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims description 14
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 claims description 12
- 229910052736 halogen Inorganic materials 0.000 claims description 12
- 150000002367 halogens Chemical class 0.000 claims description 12
- 125000003342 alkenyl group Chemical group 0.000 claims description 10
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 5
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 4
- 125000001153 fluoro group Chemical group F* 0.000 claims description 3
- 125000000962 organic group Chemical group 0.000 claims description 3
- 125000004001 thioalkyl group Chemical group 0.000 claims description 3
- 230000001678 irradiating effect Effects 0.000 claims description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims 10
- 125000002252 acyl group Chemical group 0.000 claims 1
- 229910052698 phosphorus Inorganic materials 0.000 claims 1
- 239000011574 phosphorus Substances 0.000 claims 1
- 239000006185 dispersion Substances 0.000 abstract description 30
- 230000002441 reversible effect Effects 0.000 abstract description 8
- 230000001747 exhibiting effect Effects 0.000 abstract description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 141
- 239000010408 film Substances 0.000 description 136
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 135
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 84
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 65
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 63
- 239000002904 solvent Substances 0.000 description 53
- 239000012044 organic layer Substances 0.000 description 47
- 239000000758 substrate Substances 0.000 description 44
- 230000002829 reductive effect Effects 0.000 description 41
- 239000012299 nitrogen atmosphere Substances 0.000 description 40
- 239000000243 solution Substances 0.000 description 33
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 32
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 31
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 29
- 230000007704 transition Effects 0.000 description 28
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 26
- 238000000576 coating method Methods 0.000 description 25
- 239000007788 liquid Substances 0.000 description 24
- 239000011248 coating agent Substances 0.000 description 22
- 239000010410 layer Substances 0.000 description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 21
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 20
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 19
- 239000002244 precipitate Substances 0.000 description 19
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 18
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 18
- 238000006116 polymerization reaction Methods 0.000 description 18
- 239000000047 product Substances 0.000 description 18
- 238000004440 column chromatography Methods 0.000 description 17
- 239000003960 organic solvent Substances 0.000 description 17
- 229910002027 silica gel Inorganic materials 0.000 description 17
- 239000000741 silica gel Substances 0.000 description 17
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 16
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 15
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 15
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 15
- 238000010438 heat treatment Methods 0.000 description 15
- 238000001816 cooling Methods 0.000 description 13
- 239000013078 crystal Substances 0.000 description 13
- OAMZXMDZZWGPMH-UHFFFAOYSA-N ethyl acetate;toluene Chemical compound CCOC(C)=O.CC1=CC=CC=C1 OAMZXMDZZWGPMH-UHFFFAOYSA-N 0.000 description 13
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 12
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 12
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 12
- 238000005160 1H NMR spectroscopy Methods 0.000 description 11
- 238000005481 NMR spectroscopy Methods 0.000 description 11
- 239000003480 eluent Substances 0.000 description 11
- 239000011259 mixed solution Substances 0.000 description 11
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 10
- 239000002736 nonionic surfactant Substances 0.000 description 10
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 10
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 10
- 0 *C1CC2(*)OC2(*)CC1 Chemical compound *C1CC2(*)OC2(*)CC1 0.000 description 9
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 9
- 239000011521 glass Substances 0.000 description 9
- 238000004519 manufacturing process Methods 0.000 description 9
- 239000003963 antioxidant agent Substances 0.000 description 8
- 229920006395 saturated elastomer Polymers 0.000 description 8
- 239000004094 surface-active agent Substances 0.000 description 8
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 7
- 239000012298 atmosphere Substances 0.000 description 7
- 239000000178 monomer Substances 0.000 description 7
- 239000002985 plastic film Substances 0.000 description 7
- 229920006255 plastic film Polymers 0.000 description 7
- 239000003505 polymerization initiator Substances 0.000 description 7
- FCEHBMOGCRZNNI-UHFFFAOYSA-N 1-benzothiophene Chemical compound C1=CC=C2SC=CC2=C1 FCEHBMOGCRZNNI-UHFFFAOYSA-N 0.000 description 6
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 6
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical class CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 6
- 239000006087 Silane Coupling Agent Substances 0.000 description 6
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 6
- IISBACLAFKSPIT-UHFFFAOYSA-N bisphenol A Chemical compound C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 IISBACLAFKSPIT-UHFFFAOYSA-N 0.000 description 6
- 239000012986 chain transfer agent Substances 0.000 description 6
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 6
- 239000000975 dye Substances 0.000 description 6
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 6
- 229910052753 mercury Inorganic materials 0.000 description 6
- 230000010287 polarization Effects 0.000 description 6
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 6
- 235000017557 sodium bicarbonate Nutrition 0.000 description 6
- 238000004381 surface treatment Methods 0.000 description 6
- TXBCBTDQIULDIA-UHFFFAOYSA-N 2-[[3-hydroxy-2,2-bis(hydroxymethyl)propoxy]methyl]-2-(hydroxymethyl)propane-1,3-diol Chemical class OCC(CO)(CO)COCC(CO)(CO)CO TXBCBTDQIULDIA-UHFFFAOYSA-N 0.000 description 5
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 5
- 229920001577 copolymer Polymers 0.000 description 5
- 230000007547 defect Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000004611 light stabiliser Substances 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- JFNLZVQOOSMTJK-KNVOCYPGSA-N norbornene Chemical compound C1[C@@H]2CC[C@H]1C=C2 JFNLZVQOOSMTJK-KNVOCYPGSA-N 0.000 description 5
- 229920003023 plastic Polymers 0.000 description 5
- 239000004033 plastic Substances 0.000 description 5
- 229920000728 polyester Polymers 0.000 description 5
- 229920006254 polymer film Polymers 0.000 description 5
- 229910000027 potassium carbonate Inorganic materials 0.000 description 5
- 239000012279 sodium borohydride Substances 0.000 description 5
- 229910000033 sodium borohydride Inorganic materials 0.000 description 5
- 238000002834 transmittance Methods 0.000 description 5
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 5
- IANQTJSKSUMEQM-UHFFFAOYSA-N 1-benzofuran Chemical compound C1=CC=C2OC=CC2=C1 IANQTJSKSUMEQM-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 4
- 239000004215 Carbon black (E152) Substances 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 4
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 4
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- BGTOWKSIORTVQH-UHFFFAOYSA-N cyclopentanone Chemical compound O=C1CCCC1 BGTOWKSIORTVQH-UHFFFAOYSA-N 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 229930195733 hydrocarbon Natural products 0.000 description 4
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 4
- 239000003112 inhibitor Substances 0.000 description 4
- 239000003999 initiator Substances 0.000 description 4
- 238000009832 plasma treatment Methods 0.000 description 4
- 230000000379 polymerizing effect Effects 0.000 description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 4
- 239000007870 radical polymerization initiator Substances 0.000 description 4
- 239000011347 resin Substances 0.000 description 4
- 229920005989 resin Polymers 0.000 description 4
- 238000004528 spin coating Methods 0.000 description 4
- 150000003440 styrenes Chemical class 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
- HZQLUIZFUXNFHK-UHFFFAOYSA-N 1-(bromomethyl)-4-phenylbenzene Chemical group C1=CC(CBr)=CC=C1C1=CC=CC=C1 HZQLUIZFUXNFHK-UHFFFAOYSA-N 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- LWRBVKNFOYUCNP-UHFFFAOYSA-N 2-methyl-1-(4-methylsulfanylphenyl)-2-morpholin-4-ylpropan-1-one Chemical compound C1=CC(SC)=CC=C1C(=O)C(C)(C)N1CCOCC1 LWRBVKNFOYUCNP-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- 239000004642 Polyimide Substances 0.000 description 3
- 239000004990 Smectic liquid crystal Substances 0.000 description 3
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 3
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 3
- 239000006096 absorbing agent Substances 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 150000001408 amides Chemical class 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 150000001925 cycloalkenes Chemical class 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000004210 ether based solvent Substances 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 125000000524 functional group Chemical group 0.000 description 3
- 125000000623 heterocyclic group Chemical group 0.000 description 3
- DKAGJZJALZXOOV-UHFFFAOYSA-N hydrate;hydrochloride Chemical compound O.Cl DKAGJZJALZXOOV-UHFFFAOYSA-N 0.000 description 3
- 125000001041 indolyl group Chemical group 0.000 description 3
- 150000002576 ketones Chemical class 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 229920001721 polyimide Polymers 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- LLHKCFNBLRBOGN-UHFFFAOYSA-N propylene glycol methyl ether acetate Chemical compound COCC(C)OC(C)=O LLHKCFNBLRBOGN-UHFFFAOYSA-N 0.000 description 3
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 3
- 150000003573 thiols Chemical group 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical group C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- KVNYFPKFSJIPBJ-UHFFFAOYSA-N 1,2-diethylbenzene Chemical compound CCC1=CC=CC=C1CC KVNYFPKFSJIPBJ-UHFFFAOYSA-N 0.000 description 2
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 2
- LIPRQQHINVWJCH-UHFFFAOYSA-N 1-ethoxypropan-2-yl acetate Chemical compound CCOCC(C)OC(C)=O LIPRQQHINVWJCH-UHFFFAOYSA-N 0.000 description 2
- 239000012956 1-hydroxycyclohexylphenyl-ketone Substances 0.000 description 2
- ARXJGSRGQADJSQ-UHFFFAOYSA-N 1-methoxypropan-2-ol Chemical compound COCC(C)O ARXJGSRGQADJSQ-UHFFFAOYSA-N 0.000 description 2
- PWSZACWUDDFZMQ-UHFFFAOYSA-N 2,4-Diphenyl-1-butene Chemical compound C=1C=CC=CC=1C(=C)CCC1=CC=CC=C1 PWSZACWUDDFZMQ-UHFFFAOYSA-N 0.000 description 2
- FIOCEWASVZHBTK-UHFFFAOYSA-N 2-[2-(2-oxo-2-phenylacetyl)oxyethoxy]ethyl 2-oxo-2-phenylacetate Chemical compound C=1C=CC=CC=1C(=O)C(=O)OCCOCCOC(=O)C(=O)C1=CC=CC=C1 FIOCEWASVZHBTK-UHFFFAOYSA-N 0.000 description 2
- HCLJOFJIQIJXHS-UHFFFAOYSA-N 2-[2-[2-(2-prop-2-enoyloxyethoxy)ethoxy]ethoxy]ethyl prop-2-enoate Chemical compound C=CC(=O)OCCOCCOCCOCCOC(=O)C=C HCLJOFJIQIJXHS-UHFFFAOYSA-N 0.000 description 2
- XMLYCEVDHLAQEL-UHFFFAOYSA-N 2-hydroxy-2-methyl-1-phenylpropan-1-one Chemical compound CC(C)(O)C(=O)C1=CC=CC=C1 XMLYCEVDHLAQEL-UHFFFAOYSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- RVLAXPQGTRTHEV-UHFFFAOYSA-N 4-pentylcyclohexane-1-carboxylic acid Chemical compound CCCCCC1CCC(C(O)=O)CC1 RVLAXPQGTRTHEV-UHFFFAOYSA-N 0.000 description 2
- LPEKGGXMPWTOCB-UHFFFAOYSA-N 8beta-(2,3-epoxy-2-methylbutyryloxy)-14-acetoxytithifolin Natural products COC(=O)C(C)O LPEKGGXMPWTOCB-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 2
- XJUZRXYOEPSWMB-UHFFFAOYSA-N Chloromethyl methyl ether Chemical compound COCCl XJUZRXYOEPSWMB-UHFFFAOYSA-N 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- YNQLUTRBYVCPMQ-UHFFFAOYSA-N Ethylbenzene Chemical compound CCC1=CC=CC=C1 YNQLUTRBYVCPMQ-UHFFFAOYSA-N 0.000 description 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 239000004988 Nematic liquid crystal Substances 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000004952 Polyamide Substances 0.000 description 2
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 229920000297 Rayon Polymers 0.000 description 2
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- BGYHLZZASRKEJE-UHFFFAOYSA-N [3-[3-(3,5-ditert-butyl-4-hydroxyphenyl)propanoyloxy]-2,2-bis[3-(3,5-ditert-butyl-4-hydroxyphenyl)propanoyloxymethyl]propyl] 3-(3,5-ditert-butyl-4-hydroxyphenyl)propanoate Chemical compound CC(C)(C)C1=C(O)C(C(C)(C)C)=CC(CCC(=O)OCC(COC(=O)CCC=2C=C(C(O)=C(C=2)C(C)(C)C)C(C)(C)C)(COC(=O)CCC=2C=C(C(O)=C(C=2)C(C)(C)C)C(C)(C)C)COC(=O)CCC=2C=C(C(O)=C(C=2)C(C)(C)C)C(C)(C)C)=C1 BGYHLZZASRKEJE-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- HFBMWMNUJJDEQZ-UHFFFAOYSA-N acryloyl chloride Chemical compound ClC(=O)C=C HFBMWMNUJJDEQZ-UHFFFAOYSA-N 0.000 description 2
- 239000005456 alcohol based solvent Substances 0.000 description 2
- JTSVYBPWSSQBEB-UHFFFAOYSA-N azanium;hexanoate Chemical compound [NH4+].CCCCCC([O-])=O JTSVYBPWSSQBEB-UHFFFAOYSA-N 0.000 description 2
- 238000007611 bar coating method Methods 0.000 description 2
- WARCRYXKINZHGQ-UHFFFAOYSA-N benzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1 WARCRYXKINZHGQ-UHFFFAOYSA-N 0.000 description 2
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 2
- 239000012965 benzophenone Substances 0.000 description 2
- UENWRTRMUIOCKN-UHFFFAOYSA-N benzyl thiol Chemical compound SCC1=CC=CC=C1 UENWRTRMUIOCKN-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- MQDJYUACMFCOFT-UHFFFAOYSA-N bis[2-(1-hydroxycyclohexyl)phenyl]methanone Chemical compound C=1C=CC=C(C(=O)C=2C(=CC=CC=2)C2(O)CCCCC2)C=1C1(O)CCCCC1 MQDJYUACMFCOFT-UHFFFAOYSA-N 0.000 description 2
- ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 description 2
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 2
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 2
- XUPYJHCZDLZNFP-UHFFFAOYSA-N butyl butanoate Chemical compound CCCCOC(=O)CCC XUPYJHCZDLZNFP-UHFFFAOYSA-N 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- 229940061627 chloromethyl methyl ether Drugs 0.000 description 2
- 230000003098 cholesteric effect Effects 0.000 description 2
- 239000011247 coating layer Substances 0.000 description 2
- 238000003851 corona treatment Methods 0.000 description 2
- 210000002858 crystal cell Anatomy 0.000 description 2
- RWGFKTVRMDUZSP-UHFFFAOYSA-N cumene Chemical compound CC(C)C1=CC=CC=C1 RWGFKTVRMDUZSP-UHFFFAOYSA-N 0.000 description 2
- LPIQUOYDBNQMRZ-UHFFFAOYSA-N cyclopentene Chemical compound C1CC=CC1 LPIQUOYDBNQMRZ-UHFFFAOYSA-N 0.000 description 2
- NNBZCPXTIHJBJL-UHFFFAOYSA-N decalin Chemical compound C1CCCC2CCCCC21 NNBZCPXTIHJBJL-UHFFFAOYSA-N 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 125000004386 diacrylate group Chemical group 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- ODQWQRRAPPTVAG-GZTJUZNOSA-N doxepin Chemical compound C1OC2=CC=CC=C2C(=C/CCN(C)C)/C2=CC=CC=C21 ODQWQRRAPPTVAG-GZTJUZNOSA-N 0.000 description 2
- LZCLXQDLBQLTDK-UHFFFAOYSA-N ethyl 2-hydroxypropanoate Chemical compound CCOC(=O)C(C)O LZCLXQDLBQLTDK-UHFFFAOYSA-N 0.000 description 2
- JBTWLSYIZRCDFO-UHFFFAOYSA-N ethyl methyl carbonate Chemical compound CCOC(=O)OC JBTWLSYIZRCDFO-UHFFFAOYSA-N 0.000 description 2
- FKRCODPIKNYEAC-UHFFFAOYSA-N ethyl propionate Chemical compound CCOC(=O)CC FKRCODPIKNYEAC-UHFFFAOYSA-N 0.000 description 2
- XLLIQLLCWZCATF-UHFFFAOYSA-N ethylene glycol monomethyl ether acetate Natural products COCCOC(C)=O XLLIQLLCWZCATF-UHFFFAOYSA-N 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 238000010304 firing Methods 0.000 description 2
- 125000003983 fluorenyl group Chemical class C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 2
- 239000007850 fluorescent dye Substances 0.000 description 2
- 238000007756 gravure coating Methods 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 239000011261 inert gas Substances 0.000 description 2
- MLFHJEHSLIIPHL-UHFFFAOYSA-N isoamyl acetate Chemical compound CC(C)CCOC(C)=O MLFHJEHSLIIPHL-UHFFFAOYSA-N 0.000 description 2
- RGFNRWTWDWVHDD-UHFFFAOYSA-N isobutyl butyrate Chemical compound CCCC(=O)OCC(C)C RGFNRWTWDWVHDD-UHFFFAOYSA-N 0.000 description 2
- LVHBHZANLOWSRM-UHFFFAOYSA-N itaconic acid Chemical class OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 description 2
- 125000005647 linker group Chemical group 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 229910001507 metal halide Inorganic materials 0.000 description 2
- 150000005309 metal halides Chemical class 0.000 description 2
- 229940057867 methyl lactate Drugs 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- XNLICIUVMPYHGG-UHFFFAOYSA-N pentan-2-one Chemical compound CCCC(C)=O XNLICIUVMPYHGG-UHFFFAOYSA-N 0.000 description 2
- PGMYKACGEOXYJE-UHFFFAOYSA-N pentyl acetate Chemical compound CCCCCOC(C)=O PGMYKACGEOXYJE-UHFFFAOYSA-N 0.000 description 2
- 229920001515 polyalkylene glycol Polymers 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- ODLMAHJVESYWTB-UHFFFAOYSA-N propylbenzene Chemical compound CCCC1=CC=CC=C1 ODLMAHJVESYWTB-UHFFFAOYSA-N 0.000 description 2
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 2
- 239000002516 radical scavenger Substances 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 239000002964 rayon Substances 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- YTZKOQUCBOVLHL-UHFFFAOYSA-N tert-butylbenzene Chemical compound CC(C)(C)C1=CC=CC=C1 YTZKOQUCBOVLHL-UHFFFAOYSA-N 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 2
- 229910052724 xenon Inorganic materials 0.000 description 2
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 description 2
- QNODIIQQMGDSEF-UHFFFAOYSA-N (1-hydroxycyclohexyl)-phenylmethanone Chemical compound C=1C=CC=CC=1C(=O)C1(O)CCCCC1 QNODIIQQMGDSEF-UHFFFAOYSA-N 0.000 description 1
- BZNWHCKKWLBKFW-UHFFFAOYSA-N (2,4,6-trinitro-3,5-diphenylphenyl)hydrazine Chemical compound [O-][N+](=O)C=1C(C=2C=CC=CC=2)=C([N+]([O-])=O)C(NN)=C([N+]([O-])=O)C=1C1=CC=CC=C1 BZNWHCKKWLBKFW-UHFFFAOYSA-N 0.000 description 1
- HJIAMFHSAAEUKR-UHFFFAOYSA-N (2-hydroxyphenyl)-phenylmethanone Chemical compound OC1=CC=CC=C1C(=O)C1=CC=CC=C1 HJIAMFHSAAEUKR-UHFFFAOYSA-N 0.000 description 1
- ZOKCNEIWFQCSCM-UHFFFAOYSA-N (2-methyl-4-phenylpent-4-en-2-yl)benzene Chemical compound C=1C=CC=CC=1C(C)(C)CC(=C)C1=CC=CC=C1 ZOKCNEIWFQCSCM-UHFFFAOYSA-N 0.000 description 1
- GKQXPTHQTXCXEV-UHFFFAOYSA-N (4-chlorophenyl)methanethiol Chemical compound SCC1=CC=C(Cl)C=C1 GKQXPTHQTXCXEV-UHFFFAOYSA-N 0.000 description 1
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
- FBZVZUSVGKOWHG-UHFFFAOYSA-N 1,1-dimethoxy-n,n-dimethylethanamine Chemical compound COC(C)(OC)N(C)C FBZVZUSVGKOWHG-UHFFFAOYSA-N 0.000 description 1
- GJZFGDYLJLCGHT-UHFFFAOYSA-N 1,2-diethylthioxanthen-9-one Chemical compound C1=CC=C2C(=O)C3=C(CC)C(CC)=CC=C3SC2=C1 GJZFGDYLJLCGHT-UHFFFAOYSA-N 0.000 description 1
- VNQNXQYZMPJLQX-UHFFFAOYSA-N 1,3,5-tris[(3,5-ditert-butyl-4-hydroxyphenyl)methyl]-1,3,5-triazinane-2,4,6-trione Chemical compound CC(C)(C)C1=C(O)C(C(C)(C)C)=CC(CN2C(N(CC=3C=C(C(O)=C(C=3)C(C)(C)C)C(C)(C)C)C(=O)N(CC=3C=C(C(O)=C(C=3)C(C)(C)C)C(C)(C)C)C2=O)=O)=C1 VNQNXQYZMPJLQX-UHFFFAOYSA-N 0.000 description 1
- CYSGHNMQYZDMIA-UHFFFAOYSA-N 1,3-Dimethyl-2-imidazolidinon Chemical compound CN1CCN(C)C1=O CYSGHNMQYZDMIA-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- NQUXRXBRYDZZDL-UHFFFAOYSA-N 1-(2-prop-2-enoyloxyethyl)cyclohexane-1,2-dicarboxylic acid Chemical compound OC(=O)C1CCCCC1(CCOC(=O)C=C)C(O)=O NQUXRXBRYDZZDL-UHFFFAOYSA-N 0.000 description 1
- IKSNDOVDVVPSMA-UHFFFAOYSA-N 1-(bromomethyl)-4-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=CC=C(CBr)C=C1 IKSNDOVDVVPSMA-UHFFFAOYSA-N 0.000 description 1
- WKBPZYKAUNRMKP-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)pentyl]1,2,4-triazole Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(CCC)CN1C=NC=N1 WKBPZYKAUNRMKP-UHFFFAOYSA-N 0.000 description 1
- ZDQNWDNMNKSMHI-UHFFFAOYSA-N 1-[2-(2-prop-2-enoyloxypropoxy)propoxy]propan-2-yl prop-2-enoate Chemical compound C=CC(=O)OC(C)COC(C)COCC(C)OC(=O)C=C ZDQNWDNMNKSMHI-UHFFFAOYSA-N 0.000 description 1
- RWNUSVWFHDHRCJ-UHFFFAOYSA-N 1-butoxypropan-2-ol Chemical compound CCCCOCC(C)O RWNUSVWFHDHRCJ-UHFFFAOYSA-N 0.000 description 1
- FUWDFGKRNIDKAE-UHFFFAOYSA-N 1-butoxypropan-2-yl acetate Chemical compound CCCCOCC(C)OC(C)=O FUWDFGKRNIDKAE-UHFFFAOYSA-N 0.000 description 1
- CNJRPYFBORAQAU-UHFFFAOYSA-N 1-ethoxy-2-(2-methoxyethoxy)ethane Chemical compound CCOCCOCCOC CNJRPYFBORAQAU-UHFFFAOYSA-N 0.000 description 1
- YIKSHDNOAYSSPX-UHFFFAOYSA-N 1-propan-2-ylthioxanthen-9-one Chemical compound S1C2=CC=CC=C2C(=O)C2=C1C=CC=C2C(C)C YIKSHDNOAYSSPX-UHFFFAOYSA-N 0.000 description 1
- HFZLSTDPRQSZCQ-UHFFFAOYSA-N 1-pyrrolidin-3-ylpyrrolidine Chemical compound C1CCCN1C1CNCC1 HFZLSTDPRQSZCQ-UHFFFAOYSA-N 0.000 description 1
- WJFKNYWRSNBZNX-UHFFFAOYSA-N 10H-phenothiazine Chemical compound C1=CC=C2NC3=CC=CC=C3SC2=C1 WJFKNYWRSNBZNX-UHFFFAOYSA-N 0.000 description 1
- HECLRDQVFMWTQS-RGOKHQFPSA-N 1755-01-7 Chemical compound C1[C@H]2[C@@H]3CC=C[C@@H]3[C@@H]1C=C2 HECLRDQVFMWTQS-RGOKHQFPSA-N 0.000 description 1
- CNYSMFWGLSIKQG-UHFFFAOYSA-N 2,2,3-trimethylpent-4-enoic acid Chemical compound C=CC(C)C(C)(C)C(O)=O CNYSMFWGLSIKQG-UHFFFAOYSA-N 0.000 description 1
- IMQFZQVZKBIPCQ-UHFFFAOYSA-N 2,2-bis(3-sulfanylpropanoyloxymethyl)butyl 3-sulfanylpropanoate Chemical compound SCCC(=O)OCC(CC)(COC(=O)CCS)COC(=O)CCS IMQFZQVZKBIPCQ-UHFFFAOYSA-N 0.000 description 1
- LTMRRSWNXVJMBA-UHFFFAOYSA-L 2,2-diethylpropanedioate Chemical compound CCC(CC)(C([O-])=O)C([O-])=O LTMRRSWNXVJMBA-UHFFFAOYSA-L 0.000 description 1
- KWVGIHKZDCUPEU-UHFFFAOYSA-N 2,2-dimethoxy-2-phenylacetophenone Chemical compound C=1C=CC=CC=1C(OC)(OC)C(=O)C1=CC=CC=C1 KWVGIHKZDCUPEU-UHFFFAOYSA-N 0.000 description 1
- KMZHZAAOEWVPSE-UHFFFAOYSA-N 2,3-dihydroxypropyl acetate Chemical compound CC(=O)OCC(O)CO KMZHZAAOEWVPSE-UHFFFAOYSA-N 0.000 description 1
- FPZWZCWUIYYYBU-UHFFFAOYSA-N 2-(2-ethoxyethoxy)ethyl acetate Chemical compound CCOCCOCCOC(C)=O FPZWZCWUIYYYBU-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- DRLRGHZJOQGQEC-UHFFFAOYSA-N 2-(2-methoxypropoxy)propyl acetate Chemical compound COC(C)COC(C)COC(C)=O DRLRGHZJOQGQEC-UHFFFAOYSA-N 0.000 description 1
- IEQWWMKDFZUMMU-UHFFFAOYSA-N 2-(2-prop-2-enoyloxyethyl)butanedioic acid Chemical compound OC(=O)CC(C(O)=O)CCOC(=O)C=C IEQWWMKDFZUMMU-UHFFFAOYSA-N 0.000 description 1
- UHOPWFKONJYLCF-UHFFFAOYSA-N 2-(2-sulfanylethyl)isoindole-1,3-dione Chemical compound C1=CC=C2C(=O)N(CCS)C(=O)C2=C1 UHOPWFKONJYLCF-UHFFFAOYSA-N 0.000 description 1
- JAHNSTQSQJOJLO-UHFFFAOYSA-N 2-(3-fluorophenyl)-1h-imidazole Chemical compound FC1=CC=CC(C=2NC=CN=2)=C1 JAHNSTQSQJOJLO-UHFFFAOYSA-N 0.000 description 1
- OEPOKWHJYJXUGD-UHFFFAOYSA-N 2-(3-phenylmethoxyphenyl)-1,3-thiazole-4-carbaldehyde Chemical class O=CC1=CSC(C=2C=C(OCC=3C=CC=CC=3)C=CC=2)=N1 OEPOKWHJYJXUGD-UHFFFAOYSA-N 0.000 description 1
- CSRNEJUWFJUPPI-UHFFFAOYSA-N 2-(4-propan-2-ylphenoxy)pyridine Chemical compound C1=CC(C(C)C)=CC=C1OC1=CC=CC=N1 CSRNEJUWFJUPPI-UHFFFAOYSA-N 0.000 description 1
- OLFNXLXEGXRUOI-UHFFFAOYSA-N 2-(benzotriazol-2-yl)-4,6-bis(2-phenylpropan-2-yl)phenol Chemical compound C=1C(N2N=C3C=CC=CC3=N2)=C(O)C(C(C)(C)C=2C=CC=CC=2)=CC=1C(C)(C)C1=CC=CC=C1 OLFNXLXEGXRUOI-UHFFFAOYSA-N 0.000 description 1
- IYAZLDLPUNDVAG-UHFFFAOYSA-N 2-(benzotriazol-2-yl)-4-(2,4,4-trimethylpentan-2-yl)phenol Chemical compound CC(C)(C)CC(C)(C)C1=CC=C(O)C(N2N=C3C=CC=CC3=N2)=C1 IYAZLDLPUNDVAG-UHFFFAOYSA-N 0.000 description 1
- UZUNCLSDTUBVCN-UHFFFAOYSA-N 2-(benzotriazol-2-yl)-6-(2-phenylpropan-2-yl)-4-(2,4,4-trimethylpentan-2-yl)phenol Chemical compound C=1C(C(C)(C)CC(C)(C)C)=CC(N2N=C3C=CC=CC3=N2)=C(O)C=1C(C)(C)C1=CC=CC=C1 UZUNCLSDTUBVCN-UHFFFAOYSA-N 0.000 description 1
- GJKGAPPUXSSCFI-UHFFFAOYSA-N 2-Hydroxy-4'-(2-hydroxyethoxy)-2-methylpropiophenone Chemical compound CC(C)(O)C(=O)C1=CC=C(OCCO)C=C1 GJKGAPPUXSSCFI-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- WMYINDVYGQKYMI-UHFFFAOYSA-N 2-[2,2-bis(hydroxymethyl)butoxymethyl]-2-ethylpropane-1,3-diol Chemical compound CCC(CO)(CO)COCC(CC)(CO)CO WMYINDVYGQKYMI-UHFFFAOYSA-N 0.000 description 1
- LCZVSXRMYJUNFX-UHFFFAOYSA-N 2-[2-(2-hydroxypropoxy)propoxy]propan-1-ol Chemical compound CC(O)COC(C)COC(C)CO LCZVSXRMYJUNFX-UHFFFAOYSA-N 0.000 description 1
- SMEYUYOKJMUICN-UHFFFAOYSA-N 2-[2-(2-methyl-2-prop-2-enoyloxypropoxy)ethoxy]ethyl prop-2-enoate Chemical compound C(C=C)(=O)OC(COCCOCCOC(C=C)=O)(C)C SMEYUYOKJMUICN-UHFFFAOYSA-N 0.000 description 1
- QSRJVOOOWGXUDY-UHFFFAOYSA-N 2-[2-[2-[3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propanoyloxy]ethoxy]ethoxy]ethyl 3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propanoate Chemical compound CC(C)(C)C1=C(O)C(C)=CC(CCC(=O)OCCOCCOCCOC(=O)CCC=2C=C(C(O)=C(C)C=2)C(C)(C)C)=C1 QSRJVOOOWGXUDY-UHFFFAOYSA-N 0.000 description 1
- SITYOOWCYAYOKL-UHFFFAOYSA-N 2-[4,6-bis(2,4-dimethylphenyl)-1,3,5-triazin-2-yl]-5-(3-dodecoxy-2-hydroxypropoxy)phenol Chemical compound OC1=CC(OCC(O)COCCCCCCCCCCCC)=CC=C1C1=NC(C=2C(=CC(C)=CC=2)C)=NC(C=2C(=CC(C)=CC=2)C)=N1 SITYOOWCYAYOKL-UHFFFAOYSA-N 0.000 description 1
- DNDBXYWKDTXSPJ-UHFFFAOYSA-N 2-[bis(2-hydroxyethyl)amino]propan-1-ol Chemical compound OCC(C)N(CCO)CCO DNDBXYWKDTXSPJ-UHFFFAOYSA-N 0.000 description 1
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 description 1
- VRVRGVPWCUEOGV-UHFFFAOYSA-N 2-aminothiophenol Chemical compound NC1=CC=CC=C1S VRVRGVPWCUEOGV-UHFFFAOYSA-N 0.000 description 1
- UHFFVFAKEGKNAQ-UHFFFAOYSA-N 2-benzyl-2-(dimethylamino)-1-(4-morpholin-4-ylphenyl)butan-1-one Chemical compound C=1C=C(N2CCOCC2)C=CC=1C(=O)C(CC)(N(C)C)CC1=CC=CC=C1 UHFFVFAKEGKNAQ-UHFFFAOYSA-N 0.000 description 1
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 description 1
- NQBXSWAWVZHKBZ-UHFFFAOYSA-N 2-butoxyethyl acetate Chemical compound CCCCOCCOC(C)=O NQBXSWAWVZHKBZ-UHFFFAOYSA-N 0.000 description 1
- SUODCTNNAKSRHB-UHFFFAOYSA-N 2-ethylhexyl 3-sulfanylpropanoate Chemical compound CCCCC(CC)COC(=O)CCS SUODCTNNAKSRHB-UHFFFAOYSA-N 0.000 description 1
- PCKZAVNWRLEHIP-UHFFFAOYSA-N 2-hydroxy-1-[4-[[4-(2-hydroxy-2-methylpropanoyl)phenyl]methyl]phenyl]-2-methylpropan-1-one Chemical compound C1=CC(C(=O)C(C)(O)C)=CC=C1CC1=CC=C(C(=O)C(C)(C)O)C=C1 PCKZAVNWRLEHIP-UHFFFAOYSA-N 0.000 description 1
- KXGFMDJXCMQABM-UHFFFAOYSA-N 2-methoxy-6-methylphenol Chemical compound [CH]OC1=CC=CC([CH])=C1O KXGFMDJXCMQABM-UHFFFAOYSA-N 0.000 description 1
- RYDOQJPDRXMRRP-UHFFFAOYSA-N 2-methylpropan-1-one Chemical compound CC(C)[C]=O RYDOQJPDRXMRRP-UHFFFAOYSA-N 0.000 description 1
- SEILKFZTLVMHRR-UHFFFAOYSA-N 2-phosphonooxyethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOP(O)(O)=O SEILKFZTLVMHRR-UHFFFAOYSA-N 0.000 description 1
- KGIGUEBEKRSTEW-UHFFFAOYSA-N 2-vinylpyridine Chemical class C=CC1=CC=CC=N1 KGIGUEBEKRSTEW-UHFFFAOYSA-N 0.000 description 1
- UJVBZCCNLAAMOV-UHFFFAOYSA-N 2h-1,2-benzothiazine Chemical class C1=CC=C2C=CNSC2=C1 UJVBZCCNLAAMOV-UHFFFAOYSA-N 0.000 description 1
- RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical compound C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 description 1
- QISZCVLALJOROC-UHFFFAOYSA-N 3-(2-hydroxyethyl)-4-(2-prop-2-enoyloxyethyl)phthalic acid Chemical compound OCCC1=C(CCOC(=O)C=C)C=CC(C(O)=O)=C1C(O)=O QISZCVLALJOROC-UHFFFAOYSA-N 0.000 description 1
- UXTGJIIBLZIQPK-UHFFFAOYSA-N 3-(2-prop-2-enoyloxyethyl)phthalic acid Chemical compound OC(=O)C1=CC=CC(CCOC(=O)C=C)=C1C(O)=O UXTGJIIBLZIQPK-UHFFFAOYSA-N 0.000 description 1
- QCAHUFWKIQLBNB-UHFFFAOYSA-N 3-(3-methoxypropoxy)propan-1-ol Chemical compound COCCCOCCCO QCAHUFWKIQLBNB-UHFFFAOYSA-N 0.000 description 1
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 1
- MFKRHJVUCZRDTF-UHFFFAOYSA-N 3-methoxy-3-methylbutan-1-ol Chemical compound COC(C)(C)CCO MFKRHJVUCZRDTF-UHFFFAOYSA-N 0.000 description 1
- QMYGFTJCQFEDST-UHFFFAOYSA-N 3-methoxybutyl acetate Chemical compound COC(C)CCOC(C)=O QMYGFTJCQFEDST-UHFFFAOYSA-N 0.000 description 1
- KBQVDAIIQCXKPI-UHFFFAOYSA-N 3-trimethoxysilylpropyl prop-2-enoate Chemical compound CO[Si](OC)(OC)CCCOC(=O)C=C KBQVDAIIQCXKPI-UHFFFAOYSA-N 0.000 description 1
- LABQKWYHWCYABU-UHFFFAOYSA-N 4-(3-sulfanylbutanoyloxy)butyl 3-sulfanylbutanoate Chemical compound CC(S)CC(=O)OCCCCOC(=O)CC(C)S LABQKWYHWCYABU-UHFFFAOYSA-N 0.000 description 1
- UMLFTCYAQPPZER-UHFFFAOYSA-N 4-(bromomethyl)benzonitrile Chemical compound BrCC1=CC=C(C#N)C=C1 UMLFTCYAQPPZER-UHFFFAOYSA-N 0.000 description 1
- YDIYEOMDOWUDTJ-UHFFFAOYSA-N 4-(dimethylamino)benzoic acid Chemical compound CN(C)C1=CC=C(C(O)=O)C=C1 YDIYEOMDOWUDTJ-UHFFFAOYSA-N 0.000 description 1
- HCFRWBBJISAZNK-UHFFFAOYSA-N 4-Hydroxycyclohexylcarboxylic acid Chemical compound OC1CCC(C(O)=O)CC1 HCFRWBBJISAZNK-UHFFFAOYSA-N 0.000 description 1
- SWZOQAGVRGQLDV-UHFFFAOYSA-N 4-[2-(4-hydroxy-2,2,6,6-tetramethylpiperidin-1-yl)ethoxy]-4-oxobutanoic acid Chemical compound CC1(C)CC(O)CC(C)(C)N1CCOC(=O)CCC(O)=O SWZOQAGVRGQLDV-UHFFFAOYSA-N 0.000 description 1
- NDWUBGAGUCISDV-UHFFFAOYSA-N 4-hydroxybutyl prop-2-enoate Chemical compound OCCCCOC(=O)C=C NDWUBGAGUCISDV-UHFFFAOYSA-N 0.000 description 1
- 125000004861 4-isopropyl phenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- YVYFTQAVOXKAEM-UHFFFAOYSA-N 4-methoxy-5-phenyl-2,4-bis(trichloromethyl)-1,3-dihydrotriazine Chemical compound COC1(C(Cl)(Cl)Cl)NN(C(Cl)(Cl)Cl)NC=C1C1=CC=CC=C1 YVYFTQAVOXKAEM-UHFFFAOYSA-N 0.000 description 1
- MQWCXKGKQLNYQG-UHFFFAOYSA-N 4-methylcyclohexan-1-ol Chemical compound CC1CCC(O)CC1 MQWCXKGKQLNYQG-UHFFFAOYSA-N 0.000 description 1
- JHWGFJBTMHEZME-UHFFFAOYSA-N 4-prop-2-enoyloxybutyl prop-2-enoate Chemical compound C=CC(=O)OCCCCOC(=O)C=C JHWGFJBTMHEZME-UHFFFAOYSA-N 0.000 description 1
- JNTPTNNCGDAGEJ-UHFFFAOYSA-N 6-chlorohexan-1-ol Chemical compound OCCCCCCCl JNTPTNNCGDAGEJ-UHFFFAOYSA-N 0.000 description 1
- FIHBHSQYSYVZQE-UHFFFAOYSA-N 6-prop-2-enoyloxyhexyl prop-2-enoate Chemical compound C=CC(=O)OCCCCCCOC(=O)C=C FIHBHSQYSYVZQE-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- PGDIJTMOHORACQ-UHFFFAOYSA-N 9-prop-2-enoyloxynonyl prop-2-enoate Chemical compound C=CC(=O)OCCCCCCCCCOC(=O)C=C PGDIJTMOHORACQ-UHFFFAOYSA-N 0.000 description 1
- 229920000178 Acrylic resin Polymers 0.000 description 1
- 239000004925 Acrylic resin Substances 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical class C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 1
- YCNPNYBJNLCMKI-UHFFFAOYSA-N COc(cc1)c(cc(C(N)=O)[s]2)c2c1OC Chemical compound COc(cc1)c(cc(C(N)=O)[s]2)c2c1OC YCNPNYBJNLCMKI-UHFFFAOYSA-N 0.000 description 1
- QPTAXKZWXWDWDI-UHFFFAOYSA-N COc(cc1)c(cc(C(O)=O)[s]2)c2c1OC Chemical compound COc(cc1)c(cc(C(O)=O)[s]2)c2c1OC QPTAXKZWXWDWDI-UHFFFAOYSA-N 0.000 description 1
- UGPHCSMCOIOJNB-UHFFFAOYSA-N COc(cc1)c(cc(C(OC(c2ccccc2)=N)=N)[s]2)c2c1OC Chemical compound COc(cc1)c(cc(C(OC(c2ccccc2)=N)=N)[s]2)c2c1OC UGPHCSMCOIOJNB-UHFFFAOYSA-N 0.000 description 1
- 101100026251 Caenorhabditis elegans atf-2 gene Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920002284 Cellulose triacetate Polymers 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- JGFBQFKZKSSODQ-UHFFFAOYSA-N Isothiocyanatocyclopropane Chemical compound S=C=NC1CC1 JGFBQFKZKSSODQ-UHFFFAOYSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 1
- RJUFJBKOKNCXHH-UHFFFAOYSA-N Methyl propionate Chemical compound CCC(=O)OC RJUFJBKOKNCXHH-UHFFFAOYSA-N 0.000 description 1
- WRQNANDWMGAFTP-UHFFFAOYSA-N Methylacetoacetic acid Chemical compound COC(=O)CC(C)=O WRQNANDWMGAFTP-UHFFFAOYSA-N 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- CMEWLCATCRTSGF-UHFFFAOYSA-N N,N-dimethyl-4-nitrosoaniline Chemical compound CN(C)C1=CC=C(N=O)C=C1 CMEWLCATCRTSGF-UHFFFAOYSA-N 0.000 description 1
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 1
- SUAKHGWARZSWIH-UHFFFAOYSA-N N,N‐diethylformamide Chemical compound CCN(CC)C=O SUAKHGWARZSWIH-UHFFFAOYSA-N 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical class C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- ZWXPDGCFMMFNRW-UHFFFAOYSA-N N-methylcaprolactam Chemical compound CN1CCCCCC1=O ZWXPDGCFMMFNRW-UHFFFAOYSA-N 0.000 description 1
- ORWAAXIOEHCRCP-UHFFFAOYSA-N N=C(c([s]c1c(cc2)O)cc1c2O)OC(c1ccccc1)=N Chemical compound N=C(c([s]c1c(cc2)O)cc1c2O)OC(c1ccccc1)=N ORWAAXIOEHCRCP-UHFFFAOYSA-N 0.000 description 1
- 229930192627 Naphthoquinone Natural products 0.000 description 1
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Nc1ccccc1 Chemical compound Nc1ccccc1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- BFJLGHJGJYFISZ-UHFFFAOYSA-N OC(C1)C11CCCCC1 Chemical compound OC(C1)C11CCCCC1 BFJLGHJGJYFISZ-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- WYWZRNAHINYAEF-UHFFFAOYSA-N Padimate O Chemical compound CCCCC(CC)COC(=O)C1=CC=C(N(C)C)C=C1 WYWZRNAHINYAEF-UHFFFAOYSA-N 0.000 description 1
- CYTYCFOTNPOANT-UHFFFAOYSA-N Perchloroethylene Chemical group ClC(Cl)=C(Cl)Cl CYTYCFOTNPOANT-UHFFFAOYSA-N 0.000 description 1
- 239000004696 Poly ether ether ketone Substances 0.000 description 1
- 229930182556 Polyacetal Natural products 0.000 description 1
- 239000004962 Polyamide-imide Substances 0.000 description 1
- 239000004695 Polyether sulfone Substances 0.000 description 1
- 239000004697 Polyetherimide Substances 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 239000004734 Polyphenylene sulfide Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
- STSCVKRWJPWALQ-UHFFFAOYSA-N TRIFLUOROACETIC ACID ETHYL ESTER Chemical compound CCOC(=O)C(F)(F)F STSCVKRWJPWALQ-UHFFFAOYSA-N 0.000 description 1
- UWHCKJMYHZGTIT-UHFFFAOYSA-N Tetraethylene glycol, Natural products OCCOCCOCCOCCO UWHCKJMYHZGTIT-UHFFFAOYSA-N 0.000 description 1
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical group ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical class ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
- 101100184148 Xenopus laevis mix-a gene Proteins 0.000 description 1
- LFOXEOLGJPJZAA-UHFFFAOYSA-N [(2,6-dimethoxybenzoyl)-(2,4,4-trimethylpentyl)phosphoryl]-(2,6-dimethoxyphenyl)methanone Chemical compound COC1=CC=CC(OC)=C1C(=O)P(=O)(CC(C)CC(C)(C)C)C(=O)C1=C(OC)C=CC=C1OC LFOXEOLGJPJZAA-UHFFFAOYSA-N 0.000 description 1
- NNLVGZFZQQXQNW-ADJNRHBOSA-N [(2r,3r,4s,5r,6s)-4,5-diacetyloxy-3-[(2s,3r,4s,5r,6r)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6s)-4,5,6-triacetyloxy-2-(acetyloxymethyl)oxan-3-yl]oxyoxan-2-yl]methyl acetate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](OC(C)=O)[C@H]1OC(C)=O)O[C@H]1[C@@H]([C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](COC(C)=O)O1)OC(C)=O)COC(=O)C)[C@@H]1[C@@H](COC(C)=O)O[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O NNLVGZFZQQXQNW-ADJNRHBOSA-N 0.000 description 1
- VTLHIRNKQSFSJS-UHFFFAOYSA-N [3-(3-sulfanylbutanoyloxy)-2,2-bis(3-sulfanylbutanoyloxymethyl)propyl] 3-sulfanylbutanoate Chemical compound CC(S)CC(=O)OCC(COC(=O)CC(C)S)(COC(=O)CC(C)S)COC(=O)CC(C)S VTLHIRNKQSFSJS-UHFFFAOYSA-N 0.000 description 1
- JOBBTVPTPXRUBP-UHFFFAOYSA-N [3-(3-sulfanylpropanoyloxy)-2,2-bis(3-sulfanylpropanoyloxymethyl)propyl] 3-sulfanylpropanoate Chemical compound SCCC(=O)OCC(COC(=O)CCS)(COC(=O)CCS)COC(=O)CCS JOBBTVPTPXRUBP-UHFFFAOYSA-N 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 125000005396 acrylic acid ester group Chemical group 0.000 description 1
- 125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000002723 alicyclic group Chemical group 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 150000001346 alkyl aryl ethers Chemical class 0.000 description 1
- 125000005233 alkylalcohol group Chemical group 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 125000004103 aminoalkyl group Chemical group 0.000 description 1
- 230000002547 anomalous effect Effects 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 101150059062 apln gene Proteins 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- DMLAVOWQYNRWNQ-UHFFFAOYSA-N azobenzene Chemical compound C1=CC=CC=C1N=NC1=CC=CC=C1 DMLAVOWQYNRWNQ-UHFFFAOYSA-N 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- RFRXIWQYSOIBDI-UHFFFAOYSA-N benzarone Chemical compound CCC=1OC2=CC=CC=C2C=1C(=O)C1=CC=C(O)C=C1 RFRXIWQYSOIBDI-UHFFFAOYSA-N 0.000 description 1
- 125000005605 benzo group Chemical group 0.000 description 1
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 1
- KCXMKQUNVWSEMD-UHFFFAOYSA-N benzyl chloride Chemical compound ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 description 1
- 229940073608 benzyl chloride Drugs 0.000 description 1
- 230000001588 bifunctional effect Effects 0.000 description 1
- FLPKSBDJMLUTEX-UHFFFAOYSA-N bis(1,2,2,6,6-pentamethylpiperidin-4-yl) 2-butyl-2-[(3,5-ditert-butyl-4-hydroxyphenyl)methyl]propanedioate Chemical compound C1C(C)(C)N(C)C(C)(C)CC1OC(=O)C(C(=O)OC1CC(C)(C)N(C)C(C)(C)C1)(CCCC)CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 FLPKSBDJMLUTEX-UHFFFAOYSA-N 0.000 description 1
- RSOILICUEWXSLA-UHFFFAOYSA-N bis(1,2,2,6,6-pentamethylpiperidin-4-yl) decanedioate Chemical compound C1C(C)(C)N(C)C(C)(C)CC1OC(=O)CCCCCCCCC(=O)OC1CC(C)(C)N(C)C(C)(C)C1 RSOILICUEWXSLA-UHFFFAOYSA-N 0.000 description 1
- XITRBUPOXXBIJN-UHFFFAOYSA-N bis(2,2,6,6-tetramethylpiperidin-4-yl) decanedioate Chemical compound C1C(C)(C)NC(C)(C)CC1OC(=O)CCCCCCCCC(=O)OC1CC(C)(C)NC(C)(C)C1 XITRBUPOXXBIJN-UHFFFAOYSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 239000005388 borosilicate glass Substances 0.000 description 1
- OCWYEMOEOGEQAN-UHFFFAOYSA-N bumetrizole Chemical compound CC(C)(C)C1=CC(C)=CC(N2N=C3C=C(Cl)C=CC3=N2)=C1O OCWYEMOEOGEQAN-UHFFFAOYSA-N 0.000 description 1
- OWBTYPJTUOEWEK-UHFFFAOYSA-N butane-2,3-diol Chemical compound CC(O)C(C)O OWBTYPJTUOEWEK-UHFFFAOYSA-N 0.000 description 1
- 229940043232 butyl acetate Drugs 0.000 description 1
- PWLNAUNEAKQYLH-UHFFFAOYSA-N butyric acid octyl ester Natural products CCCCCCCCOC(=O)CCC PWLNAUNEAKQYLH-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- LQCIDLXXSFUYSA-UHFFFAOYSA-N cerium(4+);tetranitrate Chemical compound [Ce+4].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O LQCIDLXXSFUYSA-UHFFFAOYSA-N 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000002178 crystalline material Substances 0.000 description 1
- 238000001723 curing Methods 0.000 description 1
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 description 1
- URYYVOIYTNXXBN-UPHRSURJSA-N cyclooctene Chemical compound C1CCC\C=C/CC1 URYYVOIYTNXXBN-UPHRSURJSA-N 0.000 description 1
- 239000004913 cyclooctene Substances 0.000 description 1
- MWPIIMNHWGOFBL-UHFFFAOYSA-N dichloromethane;toluene Chemical compound ClCCl.CC1=CC=CC=C1 MWPIIMNHWGOFBL-UHFFFAOYSA-N 0.000 description 1
- 238000007607 die coating method Methods 0.000 description 1
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 1
- 229940075557 diethylene glycol monoethyl ether Drugs 0.000 description 1
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 1
- HANKSFAYJLDDKP-UHFFFAOYSA-N dihydrodicyclopentadiene Chemical compound C12CC=CC2C2CCC1C2 HANKSFAYJLDDKP-UHFFFAOYSA-N 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- WNAHIZMDSQCWRP-UHFFFAOYSA-N dodecane-1-thiol Chemical compound CCCCCCCCCCCCS WNAHIZMDSQCWRP-UHFFFAOYSA-N 0.000 description 1
- MCPKSFINULVDNX-UHFFFAOYSA-N drometrizole Chemical compound CC1=CC=C(O)C(N2N=C3C=CC=CC3=N2)=C1 MCPKSFINULVDNX-UHFFFAOYSA-N 0.000 description 1
- 238000010891 electric arc Methods 0.000 description 1
- 238000010894 electron beam technology Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000003822 epoxy resin Substances 0.000 description 1
- 239000005007 epoxy-phenolic resin Substances 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 239000003759 ester based solvent Substances 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- SSXOSWWUPHFFGN-UHFFFAOYSA-N ethenyl 2,2-dimethylpentanoate Chemical compound CCCC(C)(C)C(=O)OC=C SSXOSWWUPHFFGN-UHFFFAOYSA-N 0.000 description 1
- YCUBDDIKWLELPD-UHFFFAOYSA-N ethenyl 2,2-dimethylpropanoate Chemical compound CC(C)(C)C(=O)OC=C YCUBDDIKWLELPD-UHFFFAOYSA-N 0.000 description 1
- KVMGZRHAVFZQQJ-UHFFFAOYSA-N ethenyl 2-methylhexanoate Chemical compound CCCCC(C)C(=O)OC=C KVMGZRHAVFZQQJ-UHFFFAOYSA-N 0.000 description 1
- UIWXSTHGICQLQT-UHFFFAOYSA-N ethenyl propanoate Chemical compound CCC(=O)OC=C UIWXSTHGICQLQT-UHFFFAOYSA-N 0.000 description 1
- ZANNOFHADGWOLI-UHFFFAOYSA-N ethyl 2-hydroxyacetate Chemical compound CCOC(=O)CO ZANNOFHADGWOLI-UHFFFAOYSA-N 0.000 description 1
- 229940093499 ethyl acetate Drugs 0.000 description 1
- 229940116333 ethyl lactate Drugs 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 150000002237 fumaric acid derivatives Chemical class 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- OHMBHFSEKCCCBW-UHFFFAOYSA-N hexane-2,5-diol Chemical compound CC(O)CCC(C)O OHMBHFSEKCCCBW-UHFFFAOYSA-N 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- GJRQTCIYDGXPES-UHFFFAOYSA-N iso-butyl acetate Natural products CC(C)COC(C)=O GJRQTCIYDGXPES-UHFFFAOYSA-N 0.000 description 1
- JSLCOZYBKYHZNL-UHFFFAOYSA-N isobutyric acid butyl ester Natural products CCCCOC(=O)C(C)C JSLCOZYBKYHZNL-UHFFFAOYSA-N 0.000 description 1
- FGKJLKRYENPLQH-UHFFFAOYSA-M isocaproate Chemical compound CC(C)CCC([O-])=O FGKJLKRYENPLQH-UHFFFAOYSA-M 0.000 description 1
- JMMWKPVZQRWMSS-UHFFFAOYSA-N isopropanol acetate Natural products CC(C)OC(C)=O JMMWKPVZQRWMSS-UHFFFAOYSA-N 0.000 description 1
- 229940011051 isopropyl acetate Drugs 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-N isovaleric acid Chemical compound CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 1
- OQAGVSWESNCJJT-UHFFFAOYSA-N isovaleric acid methyl ester Natural products COC(=O)CC(C)C OQAGVSWESNCJJT-UHFFFAOYSA-N 0.000 description 1
- 239000005453 ketone based solvent Substances 0.000 description 1
- 238000003475 lamination Methods 0.000 description 1
- 239000005355 lead glass Substances 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000005499 meniscus Effects 0.000 description 1
- VSQYNPJPULBZKU-UHFFFAOYSA-N mercury xenon Chemical compound [Xe].[Hg] VSQYNPJPULBZKU-UHFFFAOYSA-N 0.000 description 1
- AUHZEENZYGFFBQ-UHFFFAOYSA-N mesitylene Substances CC1=CC(C)=CC(C)=C1 AUHZEENZYGFFBQ-UHFFFAOYSA-N 0.000 description 1
- 125000001827 mesitylenyl group Chemical group [H]C1=C(C(*)=C(C([H])=C1C([H])([H])[H])C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 150000002734 metacrylic acid derivatives Chemical class 0.000 description 1
- 125000005641 methacryl group Chemical group 0.000 description 1
- YDKNBNOOCSNPNS-UHFFFAOYSA-N methyl 1,3-benzoxazole-2-carboxylate Chemical compound C1=CC=C2OC(C(=O)OC)=NC2=C1 YDKNBNOOCSNPNS-UHFFFAOYSA-N 0.000 description 1
- UJRDRFZCRQNLJM-UHFFFAOYSA-N methyl 3-[3-(benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl]propanoate Chemical compound CC(C)(C)C1=CC(CCC(=O)OC)=CC(N2N=C3C=CC=CC3=N2)=C1O UJRDRFZCRQNLJM-UHFFFAOYSA-N 0.000 description 1
- BDJSOPWXYLFTNW-UHFFFAOYSA-N methyl 3-methoxypropanoate Chemical compound COCCC(=O)OC BDJSOPWXYLFTNW-UHFFFAOYSA-N 0.000 description 1
- 229940017219 methyl propionate Drugs 0.000 description 1
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 description 1
- 229960000907 methylthioninium chloride Drugs 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- AJFDBNQQDYLMJN-UHFFFAOYSA-N n,n-diethylacetamide Chemical compound CCN(CC)C(C)=O AJFDBNQQDYLMJN-UHFFFAOYSA-N 0.000 description 1
- YKYONYBAUNKHLG-UHFFFAOYSA-N n-Propyl acetate Natural products CCCOC(C)=O YKYONYBAUNKHLG-UHFFFAOYSA-N 0.000 description 1
- UUIQMZJEGPQKFD-UHFFFAOYSA-N n-butyric acid methyl ester Natural products CCCC(=O)OC UUIQMZJEGPQKFD-UHFFFAOYSA-N 0.000 description 1
- RQAKESSLMFZVMC-UHFFFAOYSA-N n-ethenylacetamide Chemical compound CC(=O)NC=C RQAKESSLMFZVMC-UHFFFAOYSA-N 0.000 description 1
- 150000002791 naphthoquinones Chemical class 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 238000006053 organic reaction Methods 0.000 description 1
- 150000002921 oxetanes Chemical class 0.000 description 1
- 125000003566 oxetanyl group Chemical group 0.000 description 1
- 150000002924 oxiranes Chemical class 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- FZUGPQWGEGAKET-UHFFFAOYSA-N parbenate Chemical compound CCOC(=O)C1=CC=C(N(C)C)C=C1 FZUGPQWGEGAKET-UHFFFAOYSA-N 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- RGSFGYAAUTVSQA-UHFFFAOYSA-N pentamethylene Natural products C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 1
- 229920001568 phenolic resin Polymers 0.000 description 1
- 229950000688 phenothiazine Drugs 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 238000000016 photochemical curing Methods 0.000 description 1
- 239000003504 photosensitizing agent Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- FSDNTQSJGHSJBG-UHFFFAOYSA-N piperidine-4-carbonitrile Chemical compound N#CC1CCNCC1 FSDNTQSJGHSJBG-UHFFFAOYSA-N 0.000 description 1
- 229920005575 poly(amic acid) Polymers 0.000 description 1
- 229920001643 poly(ether ketone) Polymers 0.000 description 1
- 229920003207 poly(ethylene-2,6-naphthalate) Polymers 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920002312 polyamide-imide Polymers 0.000 description 1
- 229920001230 polyarylate Polymers 0.000 description 1
- 229920001707 polybutylene terephthalate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 229920006393 polyether sulfone Polymers 0.000 description 1
- 229920002530 polyetherether ketone Polymers 0.000 description 1
- 229920001601 polyetherimide Polymers 0.000 description 1
- 239000011112 polyethylene naphthalate Substances 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920001470 polyketone Polymers 0.000 description 1
- 229920006324 polyoxymethylene Polymers 0.000 description 1
- 229920006380 polyphenylene oxide Polymers 0.000 description 1
- 229920000069 polyphenylene sulfide Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920005606 polypropylene copolymer Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- KIWATKANDHUUOB-UHFFFAOYSA-N propan-2-yl 2-hydroxypropanoate Chemical compound CC(C)OC(=O)C(C)O KIWATKANDHUUOB-UHFFFAOYSA-N 0.000 description 1
- ILVGAIQLOCKNQA-UHFFFAOYSA-N propyl 2-hydroxypropanoate Chemical compound CCCOC(=O)C(C)O ILVGAIQLOCKNQA-UHFFFAOYSA-N 0.000 description 1
- 229940090181 propyl acetate Drugs 0.000 description 1
- KOUKXHPPRFNWPP-UHFFFAOYSA-N pyrazine-2,5-dicarboxylic acid;hydrate Chemical compound O.OC(=O)C1=CN=C(C(O)=O)C=N1 KOUKXHPPRFNWPP-UHFFFAOYSA-N 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000007142 ring opening reaction Methods 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching effect Effects 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 229910000077 silane Inorganic materials 0.000 description 1
- 229910052814 silicon oxide Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 150000003397 sorbic acid derivatives Chemical class 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 229950011008 tetrachloroethylene Drugs 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 125000005369 trialkoxysilyl group Chemical group 0.000 description 1
- FRGPKMWIYVTFIQ-UHFFFAOYSA-N triethoxy(3-isocyanatopropyl)silane Chemical compound CCO[Si](OCC)(OCC)CCCN=C=O FRGPKMWIYVTFIQ-UHFFFAOYSA-N 0.000 description 1
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 1
- PXXNTAGJWPJAGM-UHFFFAOYSA-N vertaline Natural products C1C2C=3C=C(OC)C(OC)=CC=3OC(C=C3)=CC=C3CCC(=O)OC1CC1N2CCCC1 PXXNTAGJWPJAGM-UHFFFAOYSA-N 0.000 description 1
- KOZCZZVUFDCZGG-UHFFFAOYSA-N vinyl benzoate Chemical compound C=COC(=O)C1=CC=CC=C1 KOZCZZVUFDCZGG-UHFFFAOYSA-N 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- NLVXSWCKKBEXTG-UHFFFAOYSA-N vinylsulfonic acid Chemical class OS(=O)(=O)C=C NLVXSWCKKBEXTG-UHFFFAOYSA-N 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D333/70—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D333/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/10—Esters
- C08F220/26—Esters containing oxygen in addition to the carboxy oxygen
- C08F220/30—Esters containing oxygen in addition to the carboxy oxygen containing aromatic rings in the alcohol moiety
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F222/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical and containing at least one other carboxyl radical in the molecule; Salts, anhydrides, esters, amides, imides, or nitriles thereof
- C08F222/10—Esters
- C08F222/12—Esters of phenols or saturated alcohols
- C08F222/20—Esters containing oxygen in addition to the carboxy oxygen
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K19/00—Liquid crystal materials
- C09K19/04—Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
- C09K19/06—Non-steroidal liquid crystal compounds
- C09K19/34—Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
- C09K19/3402—Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom
- C09K19/3405—Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom the heterocyclic ring being a five-membered ring
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K19/00—Liquid crystal materials
- C09K19/04—Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
- C09K19/06—Non-steroidal liquid crystal compounds
- C09K19/34—Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
- C09K19/3441—Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having nitrogen as hetero atom
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K19/00—Liquid crystal materials
- C09K19/04—Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
- C09K19/06—Non-steroidal liquid crystal compounds
- C09K19/34—Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
- C09K19/3491—Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having sulfur as hetero atom
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K19/00—Liquid crystal materials
- C09K19/04—Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
- C09K19/06—Non-steroidal liquid crystal compounds
- C09K19/34—Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
- C09K19/3491—Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having sulfur as hetero atom
- C09K19/3497—Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having sulfur as hetero atom the heterocyclic ring containing sulfur and nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K19/00—Liquid crystal materials
- C09K19/04—Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
- C09K19/42—Mixtures of liquid crystal compounds covered by two or more of the preceding groups C09K19/06 - C09K19/40
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K19/00—Liquid crystal materials
- C09K19/04—Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
- C09K19/42—Mixtures of liquid crystal compounds covered by two or more of the preceding groups C09K19/06 - C09K19/40
- C09K19/46—Mixtures of liquid crystal compounds covered by two or more of the preceding groups C09K19/06 - C09K19/40 containing esters
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B5/00—Optical elements other than lenses
- G02B5/30—Polarising elements
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/10—Esters
- C08F220/26—Esters containing oxygen in addition to the carboxy oxygen
- C08F220/30—Esters containing oxygen in addition to the carboxy oxygen containing aromatic rings in the alcohol moiety
- C08F220/305—Esters containing oxygen in addition to the carboxy oxygen containing aromatic rings in the alcohol moiety and containing a polyether chain in the alcohol moiety
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F222/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical and containing at least one other carboxyl radical in the molecule; Salts, anhydrides, esters, amides, imides, or nitriles thereof
- C08F222/10—Esters
- C08F222/12—Esters of phenols or saturated alcohols
- C08F222/20—Esters containing oxygen in addition to the carboxy oxygen
- C08F222/205—Esters containing oxygen in addition to the carboxy oxygen the ester chains containing seven or more carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Polarising Elements (AREA)
- Liquid Crystal (AREA)
- Liquid Crystal Substances (AREA)
- Plural Heterocyclic Compounds (AREA)
- Polymerisation Methods In General (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
본 발명은, 파장에 의한 굴절율 이방성을 제어할 수 있는 저파장 분산 특성, 및 역파장 분산성을 나타내는 화합물, 및 이 화합물을 함유하고 양호한 도포성 등을 가지는 액정 조성물을 제공하는 것을 과제로 한다.
본 발명은 하기 식(1)으로 표시되는 화합물 및 상기 화합물을 포함하는 액정 조성물을 제공한다.
상기 식(1) 중에서, A1 및 A2는 각각 독립적으로 1,4-페닐렌 또는 1,4-시클로헥실렌이며; Z1 및 Z2는 각각 독립적으로 단결합, -OCH2-, -CH2O-, -COO-, -OCO-, -CH=CHCOO-, -OCOCH=CH-, -CH2CH2COO-, -OCOCH2CH2-, -CH2CH2OCO- 또는 -COOCH2CH2-이며; m 및 n은 각각 0∼3의 정수이며; X1은 -S-이며; Q1은 방향환이며; R1 및 R2는 알킬이나 중합성 기를 가지는 기 등이다.Disclosure of the Invention An object of the present invention is to provide a liquid crystal composition having a low wavelength dispersion property capable of controlling refractive index anisotropy due to a wavelength and a compound exhibiting reverse wavelength dispersion property, and a liquid crystal composition containing the compound and having good applicability.
The present invention provides a compound represented by the following formula (1) and a liquid crystal composition comprising the compound.
In the formula (1), A 1 and A 2 are each independently 1,4-phenylene or 1,4-cyclohexylene; Z 1 and Z 2 are each independently a single bond, -OCH 2 -, -CH 2 O-, -COO-, -OCO-, -CH═CHCOO-, -OCOCH═CH-, -CH 2 CH 2 COO- , -OCOCH 2 CH 2 -, -CH 2 CH 2 OCO- or -COOCH 2 CH 2 -, and; m and n are each an integer of 0 to 3; X 1 is -S-; Q 1 is an aromatic ring; R 1 and R 2 are alkyl or a group having a polymerizable group.
Description
본 발명은, 벤조티오펜류, 벤조퓨란류 또는 인돌류 구조를 가지는 액정성 화합물, 상기 화합물을 포함하는 액정 조성물, 및 이 액정 조성물로부터 얻어지는 중합체, 광학 이방성 필름 및 이들의 용도에 관한 것이다.The present invention relates to a liquid crystal compound having a benzothiophene, a benzofuran or an indole structure, a liquid crystal composition containing the compound, a polymer obtained from the liquid crystal composition, an optically anisotropic film, and uses thereof.
최근, 중합성 기를 가지는 액정 화합물이, 반사형 편광판, 위상차판 등의 복굴절성(광학 이방성)을 나타내는 광학 이방성 필름에 활용되고 있다. 이 화합물은 액정 상태로 복굴절을 나타내고, 중합함으로써 그 배향이 고정된다. 이 중합체의 고정된 배향 상태로서는, 호모지니어스(수평 배향), 틸트(경사 배향), 호메오트로픽(수직 배향) 및 트위스트(비틀림 배향) 등을 예로 들수 있다.In recent years, a liquid crystal compound having a polymerizable group has been utilized for an optically anisotropic film exhibiting birefringence (optical anisotropy) such as a reflection type polarizing plate and a retardation plate. This compound exhibits birefringence in a liquid crystal state, and its orientation is fixed by polymerization. Examples of the fixed orientation state of the polymer include homogeneous (horizontal orientation), tilt (oblique orientation), homeotropic (vertical orientation), and twist (torsional orientation).
호모지니어스 배향을 가지는 광학 이방성 필름은, 예를 들면, 1/2 파장판, 1/4 파장판, 또는 다른 광학 기능을 가지는 필름과 조합함으로써, 복합 위상차판, 원편광판으로서 사용할 수 있다(특허 문헌 1 참조).An optically anisotropic film having a homogeneous orientation can be used as a composite retardation plate or a circular polarizer plate by combining with, for example, a half-wave plate, a quarter-wave plate, or a film having another optical function 1).
호메오트로픽 배향을 가지는 광학 이방성 필름은, 광축의 방향이 nz 방향이며, 광축 방향의 굴절율이 그 직교하는 방향의 굴절율보다 큰므로, 굴절율 타원체에서는, 포지티브 C-플레이트로 분류된다. 이 포지티브 C-플레이트는, 다른 광학 기능을 가지는 필름과 조합함으로써, 수평 배향한 액정 모드 이른바 IPS(In-Plane Switching) 모드 등의 광학 보상, 예를 들면, 편광판의 시야각 특성의 개선에 응용할 수 있다(비특허 문헌 1∼3, 특허 문헌 2 및 3).No. optically anisotropic film having a homeotropic orientation, and the orientation of the optical axis, n z direction, since the refractive index in the optical axis direction is larger than the refractive index in a direction perpendicular to that, the refractive index ellipsoid, it is classified as positive C- plate. This positive C-plate can be applied to optical compensation such as a so-called IPS (In-Plane Switching) mode in which the liquid crystal mode is horizontally aligned, for example, by improving the viewing angle characteristic of a polarizing plate by combining with a film having another optical function (Non-Patent Documents 1 to 3, Patent Documents 2 and 3).
광학 이방성 필름에 필요한 광학적 특성은, 용도나 목적에 따라 상이하므로, 사용되는 화합물로서 다양한 액정 화합물이 개발되어 있다. 또한, 단독으로는 전술한 이방성을 제어하는 것이 곤란한 경우가 많기 때문에, 각종 화합물과 조합하여, 액정 조성물로서 이용된다.The optical properties required for the optically anisotropic film vary depending on the purpose and purpose, and various liquid crystal compounds have been developed as the compounds to be used. In addition, since it is often difficult to control the above-described anisotropy alone, it is used as a liquid crystal composition in combination with various compounds.
이와 같은 액정 조성물은 도포성을 조절할 목적 등으로 유기용제에 용해시켜 잉크로서 사용한다. 액정 조성물을 사용하여 광학 이방성을 가지는 필름을 제조하기 위해서는, 액정 화합물, 광중합 개시제, 계면활성제 등을 유기용제에 용해시켜 용액 점도, 레벨링성 등을 조정한 잉크를 조제한다. 이 잉크를 배향 처리한 기판에 도포하고, 용제를 건조시켜, 액정 조성물을 기판 상에 배향시킨다. 다음으로, 자외선을 조사(照射)하여 중합시켜, 배향 상태를 고정화한다. 통상, 유기용제를 건조 제거하고나서 중합할 때까지 실온 하에서 행해지며, 이 동안에는 결정 등이 석출하지 않고 균일한 액정 상태를 유지하지 않으면 안된다. 그러므로, 액정 조성물에 사용하는 중합성 화합물은, 다른 액정성 화합물과의 양호한 상용성(相溶性)이나 유기용제에 대한 높은 용해성 나아가서는 실온 부근에서 장시간 액정성을 유지하지 않으면 안된다. 또한, 유기용제는 환경 부하나 인체에 대한 영향을 고려하여, 안정성이 높은 유기용제에 대하여 높은 용해성을 가지는 것이 요구된다.Such a liquid crystal composition is used as an ink by dissolving it in an organic solvent for the purpose of controlling the coating property. In order to produce a film having optical anisotropy using a liquid crystal composition, an ink is prepared by dissolving a liquid crystal compound, a photopolymerization initiator, a surfactant, and the like in an organic solvent to adjust solution viscosity, leveling property, and the like. This ink is applied to a substrate subjected to alignment treatment, and the solvent is dried to align the liquid crystal composition on the substrate. Next, ultraviolet rays are irradiated and polymerized to fix the alignment state. Normally, the organic solvent is dried and removed, and the polymerization is carried out at room temperature until polymerization. During this time, crystals and the like must not be precipitated and a uniform liquid crystal state must be maintained. Therefore, the polymerizable compound used in the liquid crystal composition must maintain good compatibility with other liquid crystalline compounds, high solubility in an organic solvent, and furthermore, maintain liquidity for a long time at around room temperature. Further, the organic solvent is required to have high solubility in an organic solvent having high stability in consideration of the influence on the environment or human body.
또한, 상기 액정 조성물로부터 얻어지는 중합체는 광학 이방성의 특성 이외에 높은 투명성, 기계적 강도의 강함, 기판에 대한 높은 밀착성, 수축성이 낮은 것, 높은 내열성, 높은 내약품성 등의 특성도 요구된다.In addition to the properties of optical anisotropy, the polymer obtained from the liquid crystal composition is also required to have high transparency, strong mechanical strength, high adhesion to substrates, low shrinkability, high heat resistance, and high chemical resistance.
봉형(棒形) 분자에 의해 형성된 광학 이방성 층에 있어서, 통상, 이방성 분자의 2개의 굴절율 ne(분자 장축에 대하여 평행한 방향에서의 이상(異常) 굴절율)와 no(분자 장축에 대하여 수직인 방향에서의 통상 굴절율)는 파장이 커짐에 따라, 작아진다. 이 때, no보다 ne가 파장에 대한 굴절율 변화율이 크므로, 굴절율 이방성(Δn=ne-no)은 적용 파장이 커짐에 따라 작아진다. 한편 액정 디스플레이(LCD) 등의 표시 디바이스에 있어서는, 광원은 380∼800 ㎚ 정도의 파장의 광으로 이루어지는 백색광이지만, 통상의 광학 이방층을 사용하여 1/2λ나 1/4λ 판 등을 설계하여 적용하는 경우, 상기한 파장 분산성에 의해, 파장에 의해 편광 상태의 변화가 생기고, 광이 유색이 되는 등의 문제가 생긴다. 이 문제를 방지하기 위해서는, 각 파장에 있어서 설계한 위상차가 되도록, 파장 분산성을 제어할 필요가 있으며, 파장에 의한 굴절율 이방성의 의존성의 낮은(저파장 분산 특성) 재료나, 또한 파장이 커짐에 따라 굴절율 이방성이 커지는(역파장 분산 특성) 재료가 요구되고 있다.In an optically anisotropic layer formed by rod-shaped molecules, usually, two refractive indices ne (anomalous refractive index in a direction parallel to the molecular long axis) and no (refractive index in a direction perpendicular to the molecular long axis) of an anisotropic molecule ) Becomes smaller as the wavelength becomes larger. In this case, the refractive index anisotropy (? N = ne-no) becomes smaller as the applied wavelength increases, since the refractive index change ratio with respect to the wavelength is greater than no. On the other hand, in the case of a display device such as a liquid crystal display (LCD), the light source is white light composed of light having a wavelength of about 380 to 800 nm, but a 1/2 λ or 1/4 λ plate is designed and applied using a normal optical anisotropic layer , There arises a problem that the wavelength dispersion causes the change of the polarization state due to the wavelength and causes the light to become colored. In order to prevent this problem, it is necessary to control the wavelength dispersion so as to have a designed retardation at each wavelength, and it is necessary to use a material having a low dependence of the refractive index anisotropy due to the wavelength (low wavelength dispersion property) (Reverse wavelength dispersion characteristic) in which the refractive index anisotropy is increased.
역파장 분산 특성을 가지는 광학 이방성 층을 얻기 위해서는, 2장의 위상차층을, 굴절율 이방성의 방향으로 각각 각도를 형성하여 적층하는 방법이 제안되어 있다(특허 문헌 4 및 5). 그러나, 이와 같은 적층체에서는, 2장의 위상차층이 필요하게 되며, 또한 2장의 위상차층의 이방성의 각도를 조절할 필요가 있는 등, 적층체를 형성하기 위한 제조 상의 번잡함이나, 광학 이방성 층의 막 두께가 두꺼워지는 점 등이 과제였다.In order to obtain an optically anisotropic layer having an inverse wavelength dispersion characteristic, a method has been proposed in which two retardation layers are formed by forming an angle in the direction of refractive index anisotropy, respectively (Patent Documents 4 and 5). However, such a laminate requires two retardation layers, and it is necessary to adjust the anisotropy angles of the two retardation layers, and the manufacturing complexity for forming a laminate, and the film thickness of the optically anisotropic layer And the problem of thickening.
최근, 이와 같은 과제를 해결하기 위해 적층하지 않고 역파장 분산을 가지는 광학 이방성 층이 요구되고 있고, 역파장 분산 특성을 가지는 액정성 화합물이 제안되어 있다(특허 문헌 6∼10).In recent years, in order to solve such a problem, there has been proposed an optically anisotropic layer having an inverse wavelength dispersion without lamination, and liquid crystal compounds having reverse wavelength dispersion characteristics have been proposed (Patent Documents 6 to 10).
그러나, 특허 문헌 6에 기재된 화합물은 굴절율 이방성이 낮기 때문에 원하는 위상차를 얻기 위해서는 막 두께를 두껍게 할 필요가 있고, 또한 어스펙트비가 작으므로, 배향 균일성을 제어하기 어렵고, 또한 합성 루트가 길므로, 제조가 어려운 점 등의 문제가 우려된다. 특허 문헌 7 및 8에 기재된 화합물은 가시 영역에 흡수를 가지므로, 투과율의 저하나 색상 불균일 등이 생기기 쉽고, 광학용도의 사용에는 적합하지 않다. 특허 문헌 9 및 10에 기재된 화합물은 광학 특성이나 제조 프로세스는 비교적 양호하지만, 그 중합체에 대한 기계적 강도, 기판에 대한 밀착성, 내열성 등의 점에서 특성 향상이 더욱 요구되고 있다.However, since the compound described in Patent Document 6 has a low refractive index anisotropy, it is necessary to increase the film thickness in order to obtain a desired retardation. Moreover, since the aspect ratio is small, it is difficult to control the orientation uniformity and the synthesis route is long, There is a concern that the production is difficult. Since the compounds described in Patent Documents 7 and 8 have absorption in the visible region, the transmittance is likely to be low and color irregularity is likely to occur, and the compound is not suitable for use in optical applications. The compounds described in Patent Documents 9 and 10 have relatively good optical properties and a good production process, but they are further required to have improved properties in terms of mechanical strength, adhesiveness to a substrate, and heat resistance.
본 발명은, 파장에 의한 굴절율 이방성을 제어할 수 있는 저파장 분산 특성 나아가서는 역파장 분산성을 나타내고, 다른 액정성 화합물 및 유기용제에 대한 양호한 혼화성(miscibility)을 가지는 화합물, 및 상기 화합물을 포함하고 비교적 낮은 온도에서 양호한 액정상(液晶相)을 나타내고, 유기용제에 대한 양호한 용해성을 나타내는 액정 조성물, 또한 상기 액정 조성물을 사용하여 기계적 강도 및 내열성 등이 우수한 중합체를 형성하는 것에 있다.The present invention relates to a compound which exhibits a low wavelength dispersion property capable of controlling the refractive index anisotropy due to a wavelength and further exhibits an inverse wavelength dispersion property and has a good miscibility with other liquid crystalline compounds and organic solvents, A liquid crystal composition which exhibits a good liquid crystal phase (liquid crystal phase) at a relatively low temperature and exhibits good solubility in an organic solvent, and a liquid crystal composition which is excellent in mechanical strength and heat resistance by using the liquid crystal composition.
본 발명자들은 예의(銳意) 검토를 거듭한 결과, 벤조티오펜류, 벤조퓨란류 또는 인돌류 구조를 가지는 화합물이, 상기 과제를 해결하는 것을 발견하고, 본 발명을 완성시켰다. 즉 본 발명은 하기와 같다.As a result of intensive studies, the present inventors have found that a compound having a benzothiophene, a benzofuran or an indole structure solves the above problems, and has completed the present invention. That is, the present invention is as follows.
[1] 하기 식(1)으로 표시되는 화합물.[1] A compound represented by the following formula (1).
[화학식 1][Chemical Formula 1]
(상기 식(1) 중에서,(In the above formula (1)
A1 및 A2는 각각 독립적으로 1,4-페닐렌, 1,4-시클로헥실렌, 1,4-시클로헥세닐렌, 피리딘-2,5-디일 또는 나프탈렌-2,6-디일이며, 이들에 있어서, 적어도 1개의 수소는 불소, 염소, 시아노, 하이드록시, 포르밀, 트리플루오로아세틸, 디플루오로메틸, 트리플루오로메틸, 탄소수 1∼5의 알킬, 탄소수 1∼5의 알콕시, 탄소수 1∼5의 알킬에스테르 또는 탄소수 1∼5의 알카노일로 치환될 수도 있고;A 1 and A 2 are each independently 1,4-phenylene, 1,4-cyclohexylene, 1,4-cyclohexenylene, pyridine-2,5-diyl or naphthalene- Wherein at least one hydrogen is selected from the group consisting of fluorine, chlorine, cyano, hydroxy, formyl, trifluoroacetyl, difluoromethyl, trifluoromethyl, alkyl of 1 to 5 carbon atoms, alkoxy of 1 to 5 carbon atoms , An alkyl ester having 1 to 5 carbon atoms, or an alkanoyl having 1 to 5 carbon atoms;
Z1 및 Z2는 각각 독립적으로 단결합, -OCH2-, -CH2O-, -COO-, -OCO-, -COS-, -SCO-, -OCOO-, -CONH-, -NHCO-, -CF2O-, -OCF2-, -CH2CH2-, -CF2CF2-, -OCH2CH2O-, -CH=CHCOO-, -OCOCH=CH-, -CH2CH2COO-, -OCOCH2CH2-, -CH2CH2OCO-, -COOCH2CH2-, -CH=CH-, -N=CH-, -CH=N-, -N=CCH3-, -CCH3=N-, -N=N- 또는 -C≡C-이며;Z 1 and Z 2 are each independently a single bond, -OCH 2 -, -CH 2 O-, -COO-, -OCO-, -COS-, -SCO-, -OCOO-, -CONH-, -NHCO- , -CF 2 O-, -OCF 2 - , -CH 2 CH 2 -, -CF 2 CF 2 -, -OCH 2 CH 2 O-, -CH = CHCOO-, -OCOCH = CH-, -CH 2 CH 2 COO-, -OCOCH 2 CH 2 - , -CH 2 CH 2 OCO-, -COOCH 2 CH 2 -, -CH = CH-, -N = CH-, -CH = N-, -N = CCH 3 - , -CCH 3 = N-, -N = N- , or -C≡C-, and;
m 및 n은, 각각 독립적으로 0∼3의 정수이며, 또한 1≤m+n≤4이며;m and n are each independently an integer of 0 to 3, and 1? m + n? 4;
X1은 -O-, -S- 또는 -NR3-이며, R3는 수소, 탄소수 1∼5의 알킬, 또는 탄소수 1∼5의 알카노일이며;X 1 is -O-, -S- or -NR 3 -, and R 3 is hydrogen, alkyl of 1 to 5 carbon atoms, or alkanoyl of 1 to 5 carbon atoms;
Q1은 수소, 할로겐 또는 1가의 유기기이며; Q 1 is hydrogen, halogen or a monovalent organic group;
R1 및 R2는 각각 독립적으로 수소, 불소, 염소, 트리플루오로메틸, 트리플루오로메톡시, 시아노, 탄소수 1∼20의 알킬, 탄소수 2∼20의 알케닐, 탄소수 1∼20의 알콕시, 탄소수 1∼20의 알킬에스테르 또는 하기 식(2)으로 표시되는 기이다.R 1 and R 2 are each independently hydrogen, fluorine, chlorine, trifluoromethyl, trifluoromethoxy, cyano, alkyl of 1 to 20 carbon atoms, alkenyl of 2 to 20 carbon atoms, alkoxy of 1 to 20 carbon atoms, An alkyl ester having 1 to 20 carbon atoms or a group represented by the following formula (2).
[화학식 2](2)
상기 식(2) 중에서, Y1은 단결합, -O-, -COO-, -OCO- 또는 -OCOO-이며; Y2는 단결합 또는 탄소수 1∼20을 가지는 알킬렌이며, 상기 알킬렌에 있어서 적어도 1개의 -CH2-는 -O-, -COO-, -OCO-, -CH=CH- 또는 -C≡C-로 치환될 수도 있고; PG는 하기 식(PG-1)∼식(PG-8) 중 어느 하나로 표시되는 중합성 기이다. *는 결합 부위를 나타낸다.In the formula (2), Y 1 is a single bond, -O-, -COO-, -OCO- or -OCOO-; Y 2 is a single bond or alkylene having 1 to 20 carbon atoms, and at least one -CH 2 - in the alkylene is -O-, -COO-, -OCO-, -CH = CH- or -C≡ C-; PG is a polymerizable group represented by any one of the following formulas (PG-1) to (PG-8). * Represents the binding site.
[화학식 3](3)
상기 식(PG-1)∼식(PG-8) 중에서, R4는 각각 독립적으로 수소, 할로겐, 메틸, 에틸 또는 트리플루오로메틸이다.)In the formulas (PG-1) to (PG-8), R 4 is each independently hydrogen, halogen, methyl, ethyl or trifluoromethyl.
[2] 상기 식(1) 중에서, Q1이 하기 식(3) 또는 (4)으로 표시되는 기인 [1]에 기재된 화합물.[2] The compound according to [1], wherein in the formula (1), Q 1 is a group represented by the following formula (3) or (4).
[화학식 4][Chemical Formula 4]
(상기 식(3) 및 (4) 중에서,(In the above formulas (3) and (4)
Z3는 각각 독립적으로 단결합, -COO- 또는 -COS-이며;Z 3 are each independently a single bond, -COO- or -COS-;
Z4는 각각 독립적으로 단결합, -CH=CH-, -N=CH-, -CH=N-, -N=CCH3-, -CCH3=N-, -N=N- 또는 -C≡C-이며;Z 4 are each independently a single bond, -CH = CH-, -N = CH- , -CH = N-, -N = CCH 3 -, -CCH 3 = N-, -N = N- or -C≡ C-;
R5는 수소, 불소, 염소, 시아노, 탄소수 1∼20의 알킬이며, 상기 알킬에 있어서-CH2-는 -O-, -S-, -CO-, -COO-, -OCO-, -OCOO-로 치환될 수도 있고, 상기 알킬에 있어서 수소는 할로겐으로 치환될 수도 있고; R 5 is hydrogen, fluorine, chlorine, cyano or alkyl having 1 to 20 carbon atoms, and -CH 2 - in the alkyl is -O-, -S-, -CO-, -COO-, -OCO-, OCOO-, in which hydrogen may be substituted with halogen;
A3는 각각 독립적으로, 2가의, 5원환 또는 6원환의 방향환, 또는 이들의 축합환이며, A4는 1가의, 5원환 또는 6원환의 방향환, 또는 이들의 축합환이며, A3 및 A4에서의 방향환 또는 이들의 축합환중 적어도 1개의 수소는 불소, 염소, 시아노, 니트로, 트리플루오로메틸, 트리플루오로메톡시, 탄소수 1∼5의 알킬, 탄소수 1∼5의 알콕시, 탄소수 1∼5의 알킬에스테르, 탄소수 1∼5의 알카노일 또는 탄소수 1∼5의티오알킬로 치환될 수도 있고;A 3 is independently an aromatic ring of a divalent, a 5-membered or a 6-membered ring, or a condensed ring thereof, A 4 is an aromatic ring of a monovalent, 5-membered or 6-membered ring, or a condensed ring thereof, and A 3 And at least one hydrogen in the aromatic ring or the condensed ring thereof in A 4 is fluorine, chlorine, cyano, nitro, trifluoromethyl, trifluoromethoxy, alkyl of 1 to 5 carbon atoms, alkoxy of 1 to 5 carbon atoms , An alkyl ester having 1 to 5 carbon atoms, an alkanoyl having 1 to 5 carbon atoms, or a thioalkyl having 1 to 5 carbon atoms;
p는 0∼2의 정수이다.)and p is an integer of 0 to 2.)
[3] 상기 식(1) 중에서, R1 및 R2 중 적어도 1개가 상기 식(2)으로 표시되는 기인, [1] 또는 [2]에 기재된 화합물.[3] The compound according to [1] or [2], wherein in the formula (1), at least one of R 1 and R 2 is a group represented by the formula (2).
[4] 상기 식(1) 중에서, X1이 -S-인, [1]∼[3] 중 어느 한 항에 기재된 화합물.[4] The compound according to any one of [1] to [3], wherein in the formula (1), X 1 is -S-.
[5] 상기 식(1) 중에서, A1 및 A2가 각각 독립적으로 1,4-페닐렌 또는 1,4-시클로헥실렌이며, 이들에 있어서, 적어도 1개의 수소는 불소, 트리플루오로메틸, 탄소수 1∼5의 알킬, 탄소수 1∼5의 알콕시, 탄소수 1∼5의 알킬에스테르 또는 탄소수 1∼5의 알카노일로 치환될 수도 있고;[5] In the formula (1), A 1 and A 2 each independently represents 1,4-phenylene or 1,4-cyclohexylene, wherein at least one hydrogen is fluorine, trifluoromethyl , Alkyl of 1 to 5 carbon atoms, alkoxy of 1 to 5 carbon atoms, alkylester of 1 to 5 carbon atoms, or alkanoyl of 1 to 5 carbon atoms;
Z1 및 Z2가 각각 독립적으로 단결합, -OCH2-, -CH2O-, -COO-, -OCO-, -CH=CHCOO-, -OCOCH=CH-, -CH2CH2COO-, -OCOCH2CH2-, -CH2CH2OCO- 또는 -COOCH2CH2-인, [1]∼[4] 중 어느 한 항에 기재된 화합물.Z 1 and Z 2 are each independently a single bond, -OCH 2 -, -CH 2 O-, -COO-, -OCO-, -CH═CHCOO-, -OCOCH═CH-, -CH 2 CH 2 COO- , -OCOCH 2 CH 2 -, -CH 2 CH 2 OCO- or -COOCH 2 CH 2 - which, [1] to [4] the compound according to any one of the.
[6] 상기 식(1) 중에서, Q1이 상기 식(4)으로 표시되는 기이며, 상기 식(4) 중에서, Z4는 단결합이며, p는 0 또는 1의 정수인, [1]∼[5] 중 어느 한 항에 기재된 화합물.[6] In the above formula (1), Q 1 is a group represented by the formula (4), Z 4 in the formula (4) is a single bond, and p is an integer of 0 or 1. [5] The compound according to any one of [1] to [5].
[7] 상기 식(1) 중에서, A1 및 A2 중 적어도 1개가 1,4-시클로헥실렌인, [1]∼[6] 중 어느 한 항에 기재된 화합물.[7] The compound according to any one of [1] to [6], wherein in the formula (1), at least one of A 1 and A 2 is 1,4-cyclohexylene.
[8] 상기 식(1) 중에서, Z1 및 Z2 중 적어도 1개가 -CH2CH2COO-, -OCOCH2CH2-, -CH2CH2OCO- 또는 -COOCH2CH2-인 [1]∼[7] 중 어느 한 항에 기재된 화합물.[8] In the formula (1), at least one of Z 1 and Z 2 is -CH 2 CH 2 COO-, -OCOCH 2 CH 2 -, -CH 2 CH 2 OCO- or -COOCH 2 CH 2 - 1] to [7].
[9] 상기 식(1) 중에서, R1 및 R2가 상기 식(2)으로 표시되는 기이며, 상기 식(2) 중에서, PG가 상기 식(PG-1)으로 표시되는 중합성 기이며, R4가 수소 또는 메틸인, [1]∼[8] 중 어느 한 항에 기재된 화합물.In the above formula (1), R 1 and R 2 are groups represented by the above formula (2), PG is a polymerizable group represented by the above formula (PG-1) , And R < 4 > is hydrogen or methyl. [11] The compound according to any one of [1] to [8]
[10] Q1이 하기 식(4-1)∼식(4-9) 중 어느 하나로 표시되는 기인 [1]∼[9] 중 어느 한 항에 기재된 화합물.[10] The compound according to any one of [1] to [9], wherein Q 1 is a group represented by any one of the following formulas (4-1) to (4-9).
[화학식 5][Chemical Formula 5]
(상기 식(4-1)∼식(4-9) 중에서, X2는 -O- 또는 -S-이며, 적어도 1개의 -CH=는 -N=으로 치환될 수도 있고, 적어도 1개의 수소는 불소, 염소, 시아노, 트리플루오로아세틸, 트리플루오로메틸, 탄소수 1∼5의 알킬, 탄소수 1∼5의 알콕시, 탄소수 1∼5의 알킬에스테르 또는 탄소수 1∼5의 알카노일로 치환될 수도 있다. *는 결합 부위를 나타낸다)(In the formulas (4-1) to (4-9), X 2 is -O- or -S-, at least one -CH = may be substituted with -N =, and at least one hydrogen is Which may be substituted with fluorine, chlorine, cyano, trifluoroacetyl, trifluoromethyl, alkyl of 1 to 5 carbon atoms, alkoxy of 1 to 5 carbon atoms, alkyl ester of 1 to 5 carbon atoms or alkanoyl of 1 to 5 carbon atoms * Represents the binding site)
[11] [1]∼[10] 중 어느 한 항에 기재된 화합물 중 적어도 1개를 함유하는 액정 조성물.[11] A liquid crystal composition comprising at least one compound according to any one of [1] to [10].
[12] [1]∼[10] 중 어느 한 항에 기재된 화합물 중 적어도 1개와, 하기 식(M1) 및 식(M2)으로 표시되는 화합물군으로부터 선택되는 적어도 1개를 함유하는 액정 조성물.[12] A liquid crystal composition comprising at least one compound selected from the group consisting of [1] to [10] and at least one compound selected from the group of compounds represented by the following formulas (M1) and (M2)
[화학식 6][Chemical Formula 6]
(상기 식(M1) 및 (M2) 중에서,(In the formulas (M1) and (M2)
AM은 각각 독립적으로 1,4-페닐렌, 1,4-시클로헥실렌, 1,4-시클로헥세닐렌, 피리딘-2,5-디일, 나프탈렌-2,6-디일, 플루오레논-2,7-디일 또는 플루오렌-2,7-디일이며, 이들에 있어서, 적어도 1개의 수소는 불소, 염소, 시아노, 하이드록시, 포르밀, 트리플루오로아세틸, 디플루오로메틸, 트리플루오로메틸, 탄소수 1∼5의 알킬, 탄소수 1∼5의 알콕시, 탄소수 1∼5의 알킬에스테르 또는 탄소수 1∼5의 알카노일로 치환될 수도 있고;A M is each independently selected from the group consisting of 1,4-phenylene, 1,4-cyclohexylene, 1,4-cyclohexenylene, pyridine-2,5-diyl, naphthalene-2,6-diyl, Diyl or fluorene-2,7-diyl, wherein at least one of the hydrogens is fluorine, chlorine, cyano, hydroxy, formyl, trifluoroacetyl, difluoromethyl, trifluoro Methyl, alkyl of 1 to 5 carbon atoms, alkoxy of 1 to 5 carbon atoms, alkyl ester of 1 to 5 carbon atoms, or alkanoyl of 1 to 5 carbon atoms;
ZM은 각각 독립적으로 단결합, -OCH2-, -CH2O-, -COO-, -OCO-, -COS-, -SCO-, -OCOO-, -CONH-, -NHCO-, -CF2O-, -OCF2-, -CH2CH2-, -CF2CF2-, -CH=CHCOO-, -OCOCH=CH-, -CH2CH2COO-, -OCOCH2CH2-, -CH=CH-, -N=CH-, -CH=N-, -N=CCH3-, -CCH3=N-, -N=N- 또는 -C≡C-이며;Z M each independently represents a single bond, -OCH 2 -, -CH 2 O-, -COO-, -OCO-, -COS-, -SCO-, -OCOO-, -CONH-, -NHCO-, -CF 2 O-, -OCF 2 -, -CH 2 CH 2 -, -CF 2 CF 2 -, -CH = CHCOO-, -OCOCH = CH-, -CH 2 CH 2 COO-, -OCOCH 2 CH 2 -, -CH = CH-, -N = CH-, -CH = N-, -N = CCH 3 -, -CCH 3 = N-, -N = N- , or -C≡C-, and;
XM은 수소, 불소, 염소, 트리플루오로메틸, 트리플루오로메톡시, 시아노, 탄소수 1∼20의 알킬, 탄소수 2∼20의 알케닐, 탄소수 1∼20의 알콕시 또는 탄소수 1∼20의 알킬에스테르이며;X M is hydrogen, fluorine, chlorine, trifluoromethyl, trifluoromethoxy, cyano, alkyl of 1 to 20 carbon atoms, alkenyl of 2 to 20 carbon atoms, alkoxy of 1 to 20 carbon atoms or alkyl of 1 to 20 carbon atoms Ester;
q는 1∼4의 정수이며;q is an integer of 1 to 4;
a는 0∼20의 정수이며;a is an integer from 0 to 20;
RM은 수소 또는 메틸이며;R M is hydrogen or methyl;
YM은 단결합, -O-, -COO-, -OCO- 또는 -OCOO-이다.)Y M is a single bond, -O-, -COO-, -OCO- or -OCOO-.)
[13] [1]∼[10] 중 어느 한 항에 기재된 화합물 중 적어도 1개와 하기 식(M1)으로 표시되는 화합물 중 적어도 1개를 함유하는 액정 조성물.[13] A liquid crystal composition comprising at least one of the compounds described in any one of [1] to [10] and at least one of compounds represented by the following formula (M1).
[화학식 7](7)
(상기 식(M1) 중에서, (In the above formula (M1)
AM은 독립적으로 1,4-페닐렌 또는 1,4-시클로헥실렌이지만, AM 중 적어도 1개는 1,4-시클로헥실렌이며, 이들에 있어서, 적어도 1개의 수소는 불소, 염소, 트리플루오로아세틸, 디플루오로메틸, 트리플루오로메틸, 탄소수 1∼5의 알킬, 탄소수 1∼5의 알콕시, 탄소수 1∼5의 알킬에스테르 또는 탄소수 1∼5의 알카노일로 치환될 수도 있고;A M is independently 1,4-phenylene or 1,4-cyclohexylene, but at least one of A M is 1,4-cyclohexylene, wherein at least one hydrogen is fluorine, chlorine, Trifluoroacetyl, difluoromethyl, trifluoromethyl, alkyl of 1 to 5 carbon atoms, alkoxy of 1 to 5 carbon atoms, alkyl ester of 1 to 5 carbon atoms, or alkanoyl of 1 to 5 carbon atoms;
ZM은 각각 독립적으로 단결합, -OCH2-, -CH2O-, -COO-, -OCO-, -CH2CH2-, -CH2CH2COO- 또는 -OCOCH2CH2-이며;Z M each independently represents a single bond, -OCH 2 -, -CH 2 O-, -COO-, -OCO-, -CH 2 CH 2 -, -CH 2 CH 2 COO- or -OCOCH 2 CH 2 - ;
q는 1 또는 2의 정수이며;q is an integer of 1 or 2;
XM은 수소, 불소, 염소, 트리플루오로메틸, 트리플루오로메톡시, 시아노, 탄소수 1∼20의 알킬, 탄소수 1∼20의 알케닐, 탄소수 1∼20의 알콕시 또는 탄소수 1∼20의 알킬에스테르이며;X M is hydrogen, fluorine, chlorine, trifluoromethyl, trifluoromethoxy, cyano, alkyl of 1 to 20 carbon atoms, alkenyl of 1 to 20 carbon atoms, alkoxy of 1 to 20 carbon atoms or alkyl of 1 to 20 carbon atoms Ester;
a는 0∼20의 정수이며; a is an integer from 0 to 20;
RM은 수소 또는 메틸이며;R M is hydrogen or methyl;
YM은 단결합, -O-, -COO-, -OCO- 또는 -OCOO-이다.)Y M is a single bond, -O-, -COO-, -OCO- or -OCOO-.)
[14] [11]∼[13] 중 어느 한 항에 기재된 액정 조성물에 있어서, 키랄인 화합물을 적어도 1개 더 함유하는 액정 조성물.[14] A liquid crystal composition according to any one of [11] to [13], further comprising at least one chiral compound.
[15] [11]∼[14] 중 어느 한 항에 기재된 액정 조성물에 있어서, 2색성 색소 화합물을 적어도 1개 더 함유하는 액정 조성물.[15] A liquid crystal composition according to any one of [11] to [14], further comprising at least one dichroic dye compound.
[16] [11]∼[15] 중 어느 한 항에 기재된 액정 조성물에 자외광을 조사하여 얻어지는 중합체.[16] A polymer obtained by irradiating ultraviolet light to the liquid crystal composition according to any one of [11] to [15].
[17] [16]에 기재된 중합체가 광학적 이방성을 가지는 광학 이방성 필름.[17] An optically anisotropic film in which the polymer described in [16] has optical anisotropy.
[18] [17]에 기재된 광학 이방성 필름을 가지는 편광판.[18] A polarizer having the optically anisotropic film according to [17].
[19] [17]에 기재된 광학 이방성 필름을 가지는 표시 소자.[19] A display element having an optically anisotropic film according to [17].
[20] [18]에 기재된 편광판을 가지는 표시 소자.[20] A display element having a polarizing plate according to [18].
본 발명 식(1)으로 표시되는 화합물은, 단독으로, 또는 다른 공지의 액정 화합물 또는 수 종류의 이들을 포함하는 조성물에 혼합하고, 임의의 형태로 균일하게 배향시키는 것에 의해, 재료의 굴절율 이방성에 대한 파장 의존성을 저감하거나, 또는 상기에서 나타낸 바와 같은 역파장 분산성을 나타내는 재료를 제공한다. 또한 상기 액정 조성물은 비교적 낮은 온도에서 양호한 액정상을 나타내고, 유기용제에 대한 양호한 용해성을 나타내는 등의 특성이 우수하다. 또한, 본 발명의 액정 조성물을 중합하여 얻어지는 중합체 및 이 중합체를 포함하는 필름은, 상기한 파장 의존성에 미치는 효과뿐만 아니라, 광학 이방성, 투명성, 내열성, 밀착성, 치수 안정성 및 기계적 강도 등의 특성이 우수하다. 따라서, 본 발명의 중합체는, 예를 들면, 위상차막, 광학 보상막, 편광 소자, 원편광 소자, 타원 편광 소자, 색보상막, 및 시야각 보상막 등의 용도에 적합하다.The compound represented by the formula (1) of the present invention can be used alone or in combination with other known liquid crystal compounds or a composition containing several kinds thereof, and uniformly orienting the composition in an arbitrary form, thereby improving the refractive index anisotropy Thereby reducing the wavelength dependence or providing a material exhibiting the reverse wavelength dispersibility as shown above. The liquid crystal composition exhibits a good liquid crystal phase at a relatively low temperature and is excellent in properties such as good solubility in an organic solvent. The polymer obtained by polymerizing the liquid crystal composition of the present invention and the film containing the polymer are excellent in not only the effect on the wavelength dependency but also the excellent properties such as optical anisotropy, transparency, heat resistance, adhesion, dimensional stability and mechanical strength Do. Therefore, the polymer of the present invention is suitable for applications such as a retardation film, an optical compensation film, a polarizing element, a circularly polarizing element, an elliptically polarizing element, a color compensation film, and a viewing angle compensation film.
본 명세서에서의 용어의 사용법은 다음과 같다. 먼저 용어 「액정성」의 의미는, 액정상을 가지는 것만으로 한정되지 않는다. 즉 액정 화합물은, 액정상을 가지는 화합물 및 액정상을 가지고 있지 않지만 액정 조성물의 성분으로서 유용한 화합물의 총칭이다. 액정상은 네마틱상, 스멕틱상, 코레스테릭상 등이며, 대부분의 경우 네마틱상을 의미한다. 액정 하한 온도는, 액정상을 나타내는 하한의 온도이며, 액정상으로부터 결정으로 전이하는 온도이다. 중합성은, 광, 열, 촉매 등의 수단에 의해 단량체가 중합하고, 중합체를 제공하는 능력을 의미한다. 액정 화합물에 있어서 중합성 기를 가지는 액정 화합물을 중합성 액정 화합물이라고 하며, 중합성 액정 화합물은, 액정 화합물에 포함된다. 중합성 화합물은, 액정성을 나타내지 않는 중합성 기를 가지는 화합물을 의미한다. 화합물이 중합성 기를 1개 가지는 경우를, 단관능성 또는 단관능 화합물이라고 하는 경우가 있다. 또한, 화합물이 중합성 기를 복수 가지는 경우에는, 다관능성, 또는 중합성 기의 수에 대응한 호칭으로 부르는 경우가 있다. 식(1)으로 표시되는 화합물을, 화합물(1)로 표기하는 경우가 있다. 다른 식으로 표시되는 화합물에 대해서도 동일한 간략화법에 따라 칭하는 경우가 있다.The usage of the terms in this specification is as follows. First, the meaning of the term " liquid crystalline property " is not limited to having a liquid crystal phase. That is, the liquid crystal compound is a generic term of a compound having a liquid crystal phase and a compound which does not have a liquid crystal phase but is useful as a component of a liquid crystal composition. The liquid crystal phase is a nematic phase, a smectic phase, a cholesteric phase, etc. In most cases, it means a nematic phase. The liquid crystal lower limit temperature is a lower limit temperature indicating liquid crystal phase, and is a temperature transitioning from the liquid crystal phase to crystal. Polymerization means the ability of a monomer to polymerize and provide a polymer by means of light, heat, catalyst, or the like. A liquid crystal compound having a polymerizable group in a liquid crystal compound is referred to as a polymerizable liquid crystal compound, and a polymerizable liquid crystal compound is included in a liquid crystal compound. The polymerizable compound means a compound having a polymerizable group which does not exhibit liquid crystallinity. The case where the compound has one polymerizable group is sometimes referred to as a monofunctional or monofunctional compound. In the case where the compound has a plurality of polymerizable groups, the compound may be referred to as a polyfunctional or a name corresponding to the number of polymerizable groups. The compound represented by the formula (1) may be referred to as the compound (1). The compounds represented by other formulas may also be referred to by the same simplification method.
화합물의 구조를 설명할 때 사용하는 용어 「적어도 1개의」는, 위치뿐만 아니라 개수에 대해도 적어도 하나인 것을 의미한다. 예를 들면, 「적어도 1개의 A는 B, C 또는 D로 치환될 수도 있다」라는 표시는, 적어도 1개의 A가 B로 치환되는 경우, 적어도 1개의 A가 C로 치환되는 경우 및 적어도 1개의 A가 D로 치환되는 경우뿐만 아니라, 복수의 A가 B∼D 중 적어도 2개로 치환되는 경우도 포함하는 것을 의미한다. 다만, 적어도 1개의 -CH2-가 -O-로 치환될 수도 있다는 정의에는, 그 결과 결합기 -O-O-가 생기는 치환은 포함되지 않는다. 또한, 적어도 1개의 -CH2-가 -O-로 치환되는 경우, 탄소수가 기재된 범위를 초과하지는 않는다.The term " at least one " used in describing the structure of a compound means at least one as to the number as well as the position. For example, the expression " at least one A may be substituted with B, C or D " means that at least one A is substituted by B, at least one A is substituted by C, Means not only a case where A is substituted by D but also a case where a plurality of A is substituted with at least two of B to D. However, the definition that at least one -CH 2 - may be substituted with -O- does not include the substitution resulting from the linking group -OO-. When at least one -CH 2 - is substituted with -O-, the number of carbon atoms does not exceed the stated range.
예를 들면, 식(2)에서의 Y2는 탄소수 1∼20을 가지는 알킬렌이며, 이 알킬렌에 있어서 적어도 1개의 -CH2-는 -O- 등으로 치환될 수도 있지만, -O- 등으로의 치환을 포함하는 알킬렌의 탄소수는, 이 경우에 20을 초과하는 것은 아니다. 이 룰은, 다른 정의에 대해서도 마찬가지이다.For example, Y 2 in the formula (2) is alkylene having 1 to 20 carbon atoms, and at least one -CH 2 - in the alkylene may be substituted with -O- or the like, The number of carbon atoms of the alkylene, including the substitution of R < 1 >, does not exceed 20 in this case. This rule also applies to other definitions.
≪화합물≫«Compound»
본 발명의 효과인 굴절율 이방성의 파장 분산 제어의 목적으로는, 일반식(1)으로 표시되는 화합물이 사용된다. 이 때 이들 일반식(1)으로 표시되는 화합물로부터 1 종류를 선택할 수도 있지만, 2 종류 이상을 선택하여 사용할 수도 있다.For the purpose of wavelength dispersion control of refractive index anisotropy, which is an effect of the present invention, a compound represented by the general formula (1) is used. At this time, one kind may be selected from the compounds represented by the general formula (1), but two or more kinds may be selected and used.
액정성 화합물은, 통상, 방향환이나 지환을 코어 골격으로 하고, 알킬 등으로 이루어지는 플렉시블한 기가 여기에 결합한, 봉형(棒形) 또는 디스크형 분자 형상을 가진다. 본 발명의 화합물은 이 코어 골격으로서, 벤조티오펜류, 벤조퓨란류 또는 인돌류 구조를 가지는, 하기 식(1)의 구조를 가진다.The liquid crystalline compound usually has a rod-like or disk-like molecular shape in which a core of an aromatic ring or alicyclic is used as a core skeleton and a flexible group such as alkyl is bonded thereto. The compound of the present invention has the structure of the following formula (1) having the benzothiophene, benzofuran, or indole structure as the core skeleton.
[화학식 8][Chemical Formula 8]
상기 식(1) 중, A1 및 A2는 각각 독립적으로 1,4-페닐렌, 1,4-시클로헥실렌, 1,4-시클로헥세닐렌, 피리딘-2,5-디일, 또는 나프탈렌-2,6-디일이다. 여기서, n 및 m이 2 이상인 경우, 이 A1 및 A2는 그 반복 단위마다 상이할 수도 있다. 높은 액정성을 화합물에 부여하고, 다른 액정성 화합물 및 유기용제에 대한 양호한 혼화성을 가지기 위해서는, A1 또는 A2는 각각 독립적으로 1,4-페닐렌, 1,4-시클로헥실렌인 것이 바람직하고, 굴절율 이방성의 파장 분산성을 저하 또는 반대로 하기 위해서는, A1 또는 A2 중 적어도 1개가, 1,4-시클로헥실렌인 것이 더욱 바람직하다. 또한 상기1,4-페닐렌, 1,4-시클로헥실렌에 있어서, 적어도 1개의 수소는 불소, 염소, 시아노, 하이드록시, 포르밀, 트리플루오로아세틸, 디플루오로메틸, 트리플루오로메틸, 탄소수 1∼5의 알킬, 탄소수 1∼5의 알콕시, 탄소수 1∼5의 알킬에스테르 또는 탄소수 1∼5의 알카노일로 치환될 수도 있다. 그러나, 높은 액정성을 화합물에 부여하고, 화합물을 염가로 제조하기 위해서는, 상기 수소의 치환기로서는, 불소, 트리플루오로메틸, 탄소수 1∼5의 알킬, 탄소수 1∼5의 알콕시, 탄소수 1∼5의 알킬에스테르 또는 탄소수 1∼5의 알카노일이 더욱 바람직하다.In the formula (1), A 1 and A 2 each independently represents 1,4-phenylene, 1,4-cyclohexylene, 1,4-cyclohexenylene, pyridine-2,5-diyl or naphthalene Diyl. Here, when n and m are two or more, these A 1 and A 2 may be different for each repeating unit. In order to impart a high liquid crystallinity to a compound and to have good miscibility with other liquid crystalline compounds and organic solvents, A 1 or A 2 is independently 1,4-phenylene or 1,4-cyclohexylene It is more preferable that at least one of A 1 and A 2 is 1,4-cyclohexylene in order to decrease or reverse the wavelength dispersibility of the refractive index anisotropy. In the above 1,4-phenylene and 1,4-cyclohexylene, at least one hydrogen is fluorine, chlorine, cyano, hydroxy, formyl, trifluoroacetyl, difluoromethyl, trifluoro Methyl, alkyl of 1 to 5 carbon atoms, alkoxy of 1 to 5 carbon atoms, alkyl ester of 1 to 5 carbon atoms, or alkanoyl of 1 to 5 carbon atoms. However, in order to impart a high liquid crystallinity to the compound and to produce the compound at low cost, the substituent of the hydrogen is preferably fluorine, trifluoromethyl, alkyl of 1 to 5 carbon atoms, alkoxy of 1 to 5 carbon atoms, More preferably an alkyl ester of 1 to 5 carbon atoms or an alkanoyl of 1 to 5 carbon atoms.
식(1) 중, Z1 또는 Z2는 각각 독립적으로 단결합, -OCH2-, -CH2O-, -COO-, -OCO-, -COS-, -SCO-, -OCOO-, -CONH-, -NHCO-, -CF2O-, -OCF2-, -CH2CH2-, -CF2CF2-, -OCH2CH2O-, -CH=CHCOO-, -OCOCH=CH-, -CH2CH2COO-, -OCOCH2CH2-, -CH2CH2OCO-, -COOCH2CH2-, -CH=CH-, -N=CH-, -CH=N-, -N=CCH3-, -CCH3=N-, -N=N- 또는 -C≡C-이다. 여기서, n 및 m이 2 이상인 경우, 이 Z1 및 Z2는 그 반복 단위마다 상이할 수도 있다. 높은 액정성을 화합물에 부여하고, 다른 액정성 화합물 및 유기용제에 대한 양호한 혼화성을 가지고, 화합물을 염가로 제조하기 위해서는 Z1 및 Z2는 각각 독립적으로 단결합, -OCH2-, -CH2O-, -COO-, -OCO-, -CH=CHCOO-, -OCOCH=CH-, -CH2CH2COO-, -OCOCH2CH2-, -CH2CH2OCO- 또는 -COOCH2CH2-인 것이 바람직하다. 또한, 투명점이 낮은 것, 다른 액정성 화합물 및 유기용제에 대한 양호한 혼화성을 고려하면, Z1 및 Z2 중 적어도 1개가, -CH2CH2COO-, -OCOCH2CH2-, -CH2CH2OCO- 또는 -COOCH2CH2-인 것이 특히 바람직하다.In the formula (1), Z 1 or Z 2 each independently represents a single bond, -OCH 2 -, -CH 2 O-, -COO-, -OCO-, -COS-, -SCO-, CONH-, -NHCO-, -CF 2 O-, -OCF 2 -, -CH 2 CH 2 -, -CF 2 CF 2 -, -OCH 2 CH 2 O-, -CH = CHCOO-, -OCOCH = CH -, -CH 2 CH 2 COO-, -OCOCH 2 CH 2 -, -CH 2 CH 2 OCO-, -COOCH 2 CH 2 -, -CH = CH-, -N = CH-, -CH = N-, -N = CCH 3 -, a -CCH 3 = N-, -N = N-, or -C≡C-. Here, when n and m are two or more, these Z 1 and Z 2 may be different for each repeating unit. In order to impart a high liquid crystallinity to a compound, to have good compatibility with other liquid crystalline compounds and organic solvents, and to produce a compound at low cost, Z 1 and Z 2 each independently represents a single bond, -OCH 2 -, -CH 2 O-, -COO-, -OCO-, -CH = CHCOO-, -OCOCH = CH-, -CH 2 CH 2 COO-, -OCOCH 2 CH 2 -, -CH 2 CH 2 OCO- or -COOCH 2 CH 2 -. In consideration of low transparency and good compatibility with other liquid crystalline compounds and organic solvents, at least one of Z 1 and Z 2 is preferably -CH 2 CH 2 COO-, -OCOCH 2 CH 2 -, -CH 2 CH 2 OCO- or -COOCH 2 CH 2 -.
또한 식(1)의 화합물의 액정성을 향상시키고, 다른 액정성 화합물 및 유기용제에 대한 양호한 혼화성을 가지기 위해서는, m 및 n은 각각 0∼3의 정수이며, 또한 1≤m+n≤4인 것이 바람직하다.In order to improve the liquid crystallinity of the compound of formula (1) and to have good miscibility with other liquid crystalline compounds and organic solvents, m and n are each an integer of 0 to 3, and 1? M + n? 4 desirable.
식(1) 중, X1은 -O-, -S- 또는 -NR3-이며, R3는 수소, 탄소수 1∼5의 알킬, 탄소수 1∼5의 알카노일이다. 다른 액정성 화합물 및 유기용제에 대한 양호한 혼화성을 가지고, 굴절율 이방성의 파장 분산성을 저하 또는 반대로 하기 위해서는, X1은 -S-인 것이 바람직하다.In the formula (1), X 1 is -O-, -S- or -NR 3 -, and R 3 is hydrogen, alkyl of 1 to 5 carbon atoms, or alkanoyl of 1 to 5 carbon atoms. It is preferable that X 1 is -S- in order to have good compatibility with other liquid crystalline compounds and organic solvents and to lower or reverse the wavelength dispersibility of refractive index anisotropy.
식(1) 중, R1 및 R2는 각각 수소, 불소, 염소, 트리플루오로메틸, 트리플루오로메톡시, 시아노, 탄소수 1∼20의 알킬, 탄소수 1∼20의 알케닐, 탄소수 1∼20의 알콕시, 탄소수 1∼20의 알킬에스테르 또는 하기 식(2)으로 표시되는 기이다.Wherein R 1 and R 2 are each independently selected from the group consisting of hydrogen, fluorine, chlorine, trifluoromethyl, trifluoromethoxy, cyano, alkyl of 1 to 20 carbon atoms, alkenyl of 1 to 20 carbon atoms, An alkyl ester having 1 to 20 carbon atoms, or a group represented by the following formula (2).
[화학식 9][Chemical Formula 9]
상기 식(2) 중에서, Y1은 단결합, -O-, -COO-, -OCO- 또는 -OCOO-이며; Y2는 단결합 또는 탄소수 1∼20을 가지는 알킬렌이며, 상기 알킬렌에 있어서 임의의 -CH2-는 -O-, -COO-, -OCO-, -CH=CH- 또는 -C≡C-로 치환될 수도 있고; PG는 하기 식(PG-1)∼식(PG-8) 중 어느 하나로 표시되는 중합성 기이다. *는 결합 부위를 나타낸다.In the formula (2), Y 1 is a single bond, -O-, -COO-, -OCO- or -OCOO-; Y 2 is a single bond or alkylene having 1 to 20 carbon atoms, and any of -CH 2 - in the alkylene may be replaced by -O-, -COO-, -OCO-, -CH = CH- or -C≡C -; < / RTI > PG is a polymerizable group represented by any one of the following formulas (PG-1) to (PG-8). * Represents the binding site.
[화학식 10][Chemical formula 10]
상기 식(PG-1)∼식(PG-8) 중에서, R4는 각각 독립적으로 수소, 할로겐, 메틸, 에틸 또는 트리플루오로메틸이다.In the formulas (PG-1) to (PG-8), R 4 is each independently hydrogen, halogen, methyl, ethyl or trifluoromethyl.
상기 R1 또는 R2로 표시되는 기는, 본 기술을 필름 용도에 적용하는 경우, R1 또는 R2 중 적어도 1개를, 상기 식(2)으로 표시되는 기를 선택하는 것이 바람직하다. 여기서 식(PG-1)∼식(PG-8)으로 표시되는 중합성 기의 선택은, 필름의 제조 조건에 따라 적절한 것을 선택할 수 있다. 그러나, 통상 사용되는 광경화로 필름을 제작하는 경우, 식(PG-1)으로 표시되는 아크릴기나 메타크릴기를 선택하는 것이, 높은 경화성, 용제에 대한 용해성, 결정성이 낮고 배향 결함이 쉽게 생기지 않는 등의 점에서, 바람직하다.Groups represented by the R 1 or R 2, the case of applying the present techniques in film applications, it is preferred that at least one of R 1 or R 2, to choose a group represented by the formula (2). Here, the polymerizable group represented by the formulas (PG-1) to (PG-8) can be appropriately selected depending on the production conditions of the film. However, in the case of producing a photo-curing film which is usually used, it is preferable to select the acrylic group or methacryl group represented by the formula (PG-1) to have high curability, solubility in solvents, low crystallinity, In view of the above.
본 발명 식(1)으로 표시되는 화합물의 Q1은 수소, 할로겐 또는 1가의 유기기이며, 그 중에서도 하기 식(3) 또는 (4)으로 표시되는 기인 것이 바람직하다.Q 1 of the compound represented by the formula (1) of the present invention is hydrogen, halogen or a monovalent organic group, and is preferably a group represented by the following formula (3) or (4).
[화학식 11](11)
(상기 식(3) 및 (4) 중, Z3는 각각 독립적으로 단결합, -COO- 또는 -COS-이며; Z4는 각각 독립적으로 단결합, -CH=CH-, -N=CH-, -CH=N-, -N=CCH3-, -CCH3=N-, -N=N- 또는 -C≡C-이며; R5는 수소, 불소, 염소, 시아노, 탄소수 1∼20의 알킬이며, 상기 알킬에 있어서 -CH2-는 -O-, -S-, -CO-, -COO-, -OCO-, -OCOO-로 치환될 수도 있고, 상기 알킬에 있어서 수소는 할로겐으로 치환될 수도 있고; A3는 각각 독립적으로, 2가의, 5원환 또는 6원환의 방향환, 또는 이들의 축합환이며, A4는 1가의, 5원환 또는 6원환의 방향환, 또는 이들의 축합환이며, A3 및 A4에서의 방향환 또는 그축합환 중 적어도 1개의 수소는, 불소, 염소, 시아노, 니트로, 트리플루오로메틸, 트리플루오로메톡시, 탄소수 1∼5의 알킬, 탄소수 1∼5의 알콕시, 탄소수 1∼5의 알킬에스테르, 탄소수 1∼5의 알카노일 또는 탄소수 1∼5의 티오알킬로 치환될 수도 있고; p는 0∼2의 정수이다.(3) and (4), Z 3 is independently a single bond, -COO- or -COS-, Z 4 is each independently a single bond, -CH═CH-, -N═CH-, , -CH = N-, -N = CCH 3 -, -CCH 3 = N-, -N = N- , or -C≡C-, and; R 5 is hydrogen, fluorine, chlorine, cyano, having 1 to 20 carbon atoms -CH 2 - in the alkyl may be substituted with -O-, -S-, -CO-, -COO-, -OCO-, -OCOO-, and in the alkyl, hydrogen may be substituted with halogen A 4 is an aromatic ring of a monovalent, a 5-membered or 6-membered ring, or a condensed ring thereof, or a condensed ring thereof, and A 3 is a divalent aromatic ring, a 5-membered ring or a 6-membered aromatic ring, And at least one hydrogen in the aromatic rings or the condensed rings thereof in A 3 and A 4 is a substituent selected from the group consisting of fluorine, chlorine, cyano, nitro, trifluoromethyl, trifluoromethoxy, Alkoxy of 1 to 5 carbon atoms, alkyl ester of 1 to 5 carbon atoms, alkanoyl of 1 to 5 carbon atoms, And p is an integer of 0 to 2;
상기 Q1으로 표시되는 기에 있어서, 굴절율 이방성의 파장 분산성을 저하 또는 반대로 하기 위해서는 식(4)으로 표시되는 기인 것이 보다 바람직하고, 높은 액정성을 화합물에 부여하고, 다른 액정성 화합물 및 유기용제에 대한 양호한 혼화성을 가지기 위해서는, Q1은 하기 식(4-1)∼식(4-9)으로 표시되는 기로부터 선택되는 것이, 더욱 바람직하다.In order to lower or reverse the wavelength dispersibility of the refractive index anisotropy in the group represented by Q 1 , it is more preferable that the group represented by the formula (4) is a group which imparts a high liquid crystallinity to the compound and the other liquid crystalline compound and the organic solvent , It is more preferable that Q 1 is selected from the groups represented by the following formulas (4-1) to (4-9).
[화학식 12][Chemical Formula 12]
상기 식(4-1)∼식(4-9) 중에서, X2는 -O- 또는 -S-이며, 적어도 1개의 -CH=는 -N=으로 치환될 수도 있고, 적어도 1개의 수소는 불소, 염소, 시아노, 트리플루오로아세틸, 트리플루오로메틸, 탄소수 1∼5의 알킬, 탄소수 1∼5의 알콕시, 탄소수 1∼5의 알킬에스테르 또는 탄소수 1∼5의 알카노일로 치환될 수도 있다. *는 결합 부위를 나타낸다.In the formulas (4-1) to (4-9), X 2 is -O- or -S-, and at least one -CH═ may be substituted with -N═, and at least one hydrogen is fluorine , Chlorine, cyano, trifluoroacetyl, trifluoromethyl, alkyl of 1 to 5 carbon atoms, alkoxy of 1 to 5 carbon atoms, alkyl ester of 1 to 5 carbon atoms, or alkanoyl of 1 to 5 carbon atoms . * Represents the binding site.
상기 식(1)으로 표시되는 화합물 중에서도, 양호한 액정성을 나타내고, 투명점이 낮으며, 유기용제에 대한 용해성이 높고, 다른 화합물과의 상용성이 높은 등의 점에서, 하기 식(1-1-1)∼식(1-1-21), 식(1-2-1)∼식(1-2-6), 또는 식(1-3-1)∼식(1-3-5)으로 표시되는 구조가 바람직하다.Among the compounds represented by the above formula (1), from the viewpoints of good liquid crystallinity, low transparency, high solubility in organic solvents, high compatibility with other compounds, and the like, 1) to (1-1-21), (1-2-1) to (1-2-6), or (1-3-1) to (1-3-5) Is preferable.
[화학식 13][Chemical Formula 13]
[화학식 14][Chemical Formula 14]
[화학식 15][Chemical Formula 15]
[화학식 16][Chemical Formula 16]
[화학식 17][Chemical Formula 17]
[화학식 18][Chemical Formula 18]
상기 식(1-1-1)∼식(1-3-5)에 있어서, R1 및 R2는 각각 독립적으로 수소, 불소, 염소, 트리플루오로메틸, 트리플루오로메톡시, 시아노, 탄소수 1∼20의 알킬, 탄소수 1∼20의 알케닐, 탄소수 1∼20의 알콕시, 탄소수 1∼20의 알킬에스테르 또는 하기 식(2)으로 표시되는 기이다.In the formulas (1-1-1) to (1-3-5), R 1 and R 2 are each independently hydrogen, fluorine, chlorine, trifluoromethyl, trifluoromethoxy, cyano, Alkyl of 1 to 20 carbon atoms, alkenyl of 1 to 20 carbon atoms, alkoxy of 1 to 20 carbon atoms, alkyl ester of 1 to 20 carbon atoms, or a group represented by the following formula (2).
[화학식 19][Chemical Formula 19]
상기 식(2) 중에서, Y1은 단결합, -O-, -COO-, -OCO- 또는 -OCOO-이며; Y2는 단결합 또는 탄소수 1∼20을 가지는 알킬렌이며, 상기 알킬렌에 있어서 적어도 1개의 -CH2-는 -O-, -COO-, -OCO-, -CH=CH- 또는 -C≡C-로 치환될 수도 있고; PG는 하기 식(PG-1)∼식(PG-8) 중 어느 하나로 표시되는 중합성 기이다.In the formula (2), Y 1 is a single bond, -O-, -COO-, -OCO- or -OCOO-; Y 2 is a single bond or alkylene having 1 to 20 carbon atoms, and at least one -CH 2 - in the alkylene is -O-, -COO-, -OCO-, -CH = CH- or -C≡ C-; PG is a polymerizable group represented by any one of the following formulas (PG-1) to (PG-8).
[화학식 20][Chemical Formula 20]
상기 식(PG-1)∼식(PG-8) 중에서, R4는 각각 독립적으로 수소, 할로겐, 메틸, 에틸 또는 트리플루오로메틸이다. R3는 수소, 탄소수 1∼5의 알킬, 탄소수 1∼5의 알카노일이며, R5는 수소, 불소, 염소, 시아노, 탄소수 1∼20의 알킬이며, 상기 알킬에 있어서 -CH2-는 -O-, -S-, -CO-, -COO-, -OCO-, -OCOO-로 치환될 수도 있고, 상기 알킬에 있어서 수소는 할로겐으로 치환될 수도 있고, R6는 수소, 불소, 염소, 시아노, 니트로, 트리플루오로메틸, 트리플루오로메톡시, 탄소수 1∼5의 알킬, 탄소수 1∼5의 알콕시, 탄소수 1∼5의 알킬에스테르, 탄소수 1∼5의 알카노일 또는 탄소수 1∼5의티오알킬이다.In the formulas (PG-1) to (PG-8), R 4 is each independently hydrogen, halogen, methyl, ethyl or trifluoromethyl. R 3 is hydrogen, alkyl, alkanoyl of 1 to 5 carbon atoms of 1 to 5 carbon atoms, R 5 is an alkyl of hydrogen, fluorine, chlorine, cyano, having a carbon number of 1~20, -CH 2 in the alkyl-is -O-, -S-, -CO-, -COO-, -OCO-, -OCOO-, in the alkyl, hydrogen may be substituted with halogen, and R 6 is hydrogen, fluorine, chlorine , Alkyl of 1 to 5 carbon atoms, alkoxy of 1 to 5 carbon atoms, alkyl ester of 1 to 5 carbon atoms, alkanoyl of 1 to 5 carbon atoms, or alkanoyl of 1 to 5 carbon atoms Lt; / RTI >
본 발명의 식(1)으로 표시되는 화합물은, 공지의 유기 합성 화학의 방법을 조합함으로써 합성할 수 있다. 출발 물질에 목적으로 하는 말단기, 환 및 결합기를 도입하는 방법은, 호벤와일(Houben-Wyle, Methods of Organic Chemistry, Georg Thieme Verlag, Stuttgart), 오가닉·신세시즈(Organic Syntheses, John Wily & Sons, Inc.), 오가닉·리액션즈(Organic Reactions, John Wily & Sons Inc.), 콤프리헨시브·오가닉·신세시스(Comprehensive Organic Synthesis, Pergamon Press), 및 신실험 화학 강좌(마루젠) 등의 서적에 기재되어 있다. 그리고, 합성된 화합물의 구조는, 예를 들면, 프로톤 NMR 스펙트럼에 의해 확인할 수 있다.The compound represented by the formula (1) of the present invention can be synthesized by combining known organic synthesis chemical methods. Methods for introducing the desired end groups, rings and bonding groups into the starting materials are described in Houben-Wyle (Methods of Organic Chemistry, Georg Thieme Verlag, Stuttgart), Organic Syntheses (John Wily & Sons, Inc.), Organic Reactions (John Wily & Sons Inc.), Comprehensive Organic Synthesis (Pergamon Press), and New Experimental Chemistry Lectures (Maruzen) . The structure of the synthesized compound can be confirmed by, for example, a proton NMR spectrum.
≪액정 조성물≫<< Liquid Crystal Composition >>
본 발명의 액정 조성물은, 식(1)으로 표시되는 화합물의 군으로부터 선택되는 적어도 1개의 화합물을 함유한다. 본 발명의 액정 조성물은, 비교적 낮은 온도에서 네마틱상이나 스멕틱상의 액정상을 가진다. 본 발명의 액정 조성물을, 러빙 처리 등의 배향 처리가 되어 있는 플라스틱 기판 상이나 플라스틱의 박막으로 표면이 피복된 지지 기판 상에 도포하여 제막하는 경우, 호모지니어스 배향이나 하이브리드 배향이 된다. 또한, 본 발명의 액정 조성물에, 후술하는 비중합성 또는 중합성의 광학 활성 화합물을 첨가한 경우에는 트위스트 배향이 된다. 본 발명의 액정 조성물에 후술하는 카르도(cardo) 구조를 가지는 화합물, 또는 단관능의 액정 화합물을 가하면 호메오트로픽 배향을 얻을 수 있기 쉬워진다.The liquid crystal composition of the present invention contains at least one compound selected from the group of compounds represented by formula (1). The liquid crystal composition of the present invention has a nematic phase or a smectic phase liquid crystal phase at a relatively low temperature. When the liquid crystal composition of the present invention is coated on a plastic substrate subjected to alignment treatment such as rubbing treatment or on a support substrate coated with a thin film of plastic, a homogeneous orientation or a hybrid alignment is obtained. When the below-described non-polymerizable or polymerizable optically active compound is added to the liquid crystal composition of the present invention, twist orientation is obtained. When a compound having a cardo structure or a monofunctional liquid crystal compound described later is added to the liquid crystal composition of the present invention, homeotropic alignment can be easily obtained.
화합물(1) 이외의 구성 성분으로서는 그 외의 액정 화합물(중합성 액정 화합물은 제외함), 그 외의 중합성 액정 화합물, 계면활성제, 그 외의 중합성 화합물(단, 중합성 액정 화합물은 제외함), 중합 개시제, 광 증감제, 연쇄 이동제, 산화 방지제, 자외선 흡수제, 라디칼 포착제, 광 안정제, 광학 활성 화합물, 실란커플링제, 용제, 및 그 외의 첨가제 등을 본 발명의 효과를 손상시키지 않는 범위에서 함유할 수도 있다.As the component other than the compound (1), other liquid crystal compounds (excluding the polymerizable liquid crystal compound), other polymerizable liquid crystal compounds, surfactants, other polymerizable compounds (except for the polymerizable liquid crystal compound) A polymerization initiator, a photosensitizer, a chain transfer agent, an antioxidant, an ultraviolet absorber, a radical scavenger, a light stabilizer, an optically active compound, a silane coupling agent, a solvent and other additives, You may.
그 외의 액정성 화합물로서는, 액정성 화합물의 데이터베이스인 리크 리스트(LiqCryst, LCI Publisher GmbH, Hamburg, Germany)에 기재되어 있는 화합물로부터 선택할 수 있다. 그 중에서도 하기 식(LC)으로 표시되는 화합물이 바람직하다.Other liquid crystal compounds can be selected from the compounds described in LiqCryst, LCI Publisher GmbH, Hamburg, Germany, which is a database of liquid crystal compounds. Among them, a compound represented by the following formula (LC) is preferable.
[화학식 21][Chemical Formula 21]
상기 식(LC) 중에서, A5는 독립적으로 1,4-페닐렌, 1,4-시클로헥실렌, 피리딘-2,5-디일 및 나프탈렌-2,6-디일로부터 선택되는 어느 하나의 2가 기이며, 상기 2가 기에 있어서, 적어도 1개의 수소는 불소, 염소, 시아노, 하이드록시, 포르밀, 트리플루오로아세틸, 디플루오로메틸, 트리플루오로메틸, 탄소수 1∼5의 알킬, 탄소수 1∼5의 알콕시, 탄소수 1∼5의 알킬에스테르 또는 탄소수 1∼5의 알카노일로 치환될 수도 있고; Z5는 독립적으로 단결합 또는 탄소수 1∼20을 가지는 알킬렌이며, 상기 알킬렌에 있어서 적어도 1개의 -CH2-는 -O-, -CO-, -COO-, -OCO-, -CH=CH-, -CF=CF- 또는 -C≡C-로 치환될 수도 있고, 적어도 1개의 수소는 할로겐으로 치환될 수도 있고; b는 1∼5의 정수이며; R8은 각각 독립적으로 수소, 불소, 염소, 시아노, 하이드록시, 포르밀, 트리플루오로아세틸, 디플루오로메틸, 트리플루오로메틸, 탄소수 1∼10의 알킬 또는 탄소수 1∼10의 알콕시이며, 상기 알킬에 있어서 적어도 1개의 -CH2-는 -CH=CH-로 치환될 수도 있다.In the formula (LC), A 5 is independently selected from the group consisting of 1,4-phenylene, 1,4-cyclohexylene, pyridine-2,5-diyl and naphthalene-2,6- And at least one hydrogen in said divalent group is selected from the group consisting of fluorine, chlorine, cyano, hydroxy, formyl, trifluoroacetyl, difluoromethyl, trifluoromethyl, Alkoxy of 1 to 5 carbon atoms, alkyl ester of 1 to 5 carbon atoms, or alkanoyl of 1 to 5 carbon atoms; Z 5 is independently a single bond or alkylene having 1 to 20 carbon atoms, and at least one -CH 2 - in the alkylene is -O-, -CO-, -COO-, -OCO-, -CH = CH-, -CF = CF- or -C? C-, and at least one hydrogen may be substituted with halogen; b is an integer from 1 to 5; R 8 is each independently hydrogen, fluorine, chlorine, cyano, hydroxy, formyl, trifluoroacetyl, difluoromethyl, trifluoromethyl, alkyl of 1 to 10 carbon atoms or alkoxy of 1 to 10 carbon atoms , And at least one -CH 2 - in the alkyl may be substituted with -CH = CH-.
이하에서, 상기 식(LC)으로 표시되는 화합물의 구체예를 나타낸다.Hereinafter, specific examples of the compound represented by the formula (LC) are shown.
[화학식 22][Chemical Formula 22]
[화학식 23](23)
[화학식 24]≪ EMI ID =
본 발명의 액정 조성물은, 식(1)으로 표시되는 본 발명의 화합물군으로부터 선택되는 적어도 1종과 식(LC)으로 표시되는 공지의 화합물군으로부터 선택되는 적어도 1종의 합계량 100 중량%에 대하여, 식(1)으로 표시되는 본 발명의 화합물을 1∼90 중량%, 식(LC)으로 표시되는 화합물을 10∼99 중량% 함유하는 것이 바람직하다.The liquid crystal composition of the present invention is a liquid crystal composition comprising 100% by weight of a total amount of at least one member selected from the group consisting of at least one compound selected from the group of compounds of the present invention represented by formula (1) and the known compound represented by formula (LC) , 1 to 90% by weight of the compound of the present invention represented by the formula (1) and 10 to 99% by weight of the compound represented by the formula (LC).
그 외의 중합성 액정 화합물로서는, 하기 식(M1) 및 (M2)으로 표시되는 화합물이 바람직하다.As other polymerizable liquid crystal compounds, compounds represented by the following formulas (M1) and (M2) are preferable.
[화학식 25](25)
상기 식(M1) 및 (M2) 중에서, AM은 각각 독립적으로 1,4-페닐렌, 1,4-시클로헥실렌, 1,4-시클로헥세닐렌, 피리딘-2,5-디일, 나프탈렌-2,6-디일 또는 플루오렌-2,7-디일이며, 이들에 있어서, 적어도 1개의 수소는 불소, 염소, 시아노, 하이드록시, 포르밀, 트리플루오로아세틸, 디플루오로메틸, 트리플루오로메틸, 탄소수 1∼5의 알킬, 탄소수 1∼5의 알콕시, 탄소수 1∼5의 알킬에스테르 또는 탄소수 1∼5의 알카노일로 치환될 수도 있고; ZM은 각각 독립적으로 단결합, -OCH2-, -CH2O-, -COO-, -OCO-, -COS-, -SCO-, -OCOO-, -CONH-, -NHCO-, -CF2O-, -OCF2-, -CH2CH2-, -CF2CF2-, -CH=CHCOO-, -OCOCH=CH-, -CH2CH2COO-, -OCOCH2CH2-, -CH=CH-, -N=CH-, -CH=N-, -N=CCH3-, -CCH3=N-, -N=N- 또는 -C≡C-이며; XM은 수소, 불소, 염소, 트리플루오로메틸, 트리플루오로메톡시, 시아노, 탄소수 1∼20의 알킬, 탄소수 1∼20의 알케닐, 탄소수 1∼20의 알콕시 또는 탄소수 1∼20의 알킬에스테르이며; q는 1∼4의 정수이며;In the above formulas (M1) and (M2), A M is each independently selected from the group consisting of 1,4-phenylene, 1,4-cyclohexylene, 1,4-cyclohexenylene, pyridine- Diyl or fluorene-2,7-diyl, wherein at least one of the hydrogens is fluorine, chlorine, cyano, hydroxy, formyl, trifluoroacetyl, difluoromethyl, tri Fluoromethyl, alkyl of 1 to 5 carbon atoms, alkoxy of 1 to 5 carbon atoms, alkyl ester of 1 to 5 carbon atoms, or alkanoyl of 1 to 5 carbon atoms; Z M each independently represents a single bond, -OCH 2 -, -CH 2 O-, -COO-, -OCO-, -COS-, -SCO-, -OCOO-, -CONH-, -NHCO-, -CF 2 O-, -OCF 2 -, -CH 2 CH 2 -, -CF 2 CF 2 -, -CH = CHCOO-, -OCOCH = CH-, -CH 2 CH 2 COO-, -OCOCH 2 CH 2 -, -CH = CH-, -N = CH-, -CH = N-, -N = CCH 3 -, -CCH 3 = N-, -N = N- , or -C≡C-, and; X M is hydrogen, fluorine, chlorine, trifluoromethyl, trifluoromethoxy, cyano, alkyl of 1 to 20 carbon atoms, alkenyl of 1 to 20 carbon atoms, alkoxy of 1 to 20 carbon atoms or alkyl of 1 to 20 carbon atoms Ester; q is an integer of 1 to 4;
a는 0∼20의 정수이며; RM은 수소 또는 메틸이며; YM은 단결합, -O-, -COO-, -OCO- 또는 -OCOO-이다.a is an integer from 0 to 20; R M is hydrogen or methyl; Y M is a single bond, -O-, -COO-, -OCO- or -OCOO-.
여기서, q가 2 이상인 경우, 이 AM 및 ZM은 그 반복 단위마다 상이할 수도 있다.Here, when q is 2 or more, these A M and Z M may be different for each repeating unit.
상기 식(M1) 및 (M2)으로 표시되는 화합물에 있어서, 식(M1)으로 표시되는 화합물이 더욱 바람직하고, 식(M1) 중에서, AM은 독립적으로 1,4-페닐렌 또는 1,4-시클로헥실렌이지만, AM 중 적어도 1개는 1,4-시클로헥실렌이며, 상기 1,4-페닐렌 또는 1,4-시클로헥실렌에 있어서, 적어도 1개의 수소는 불소, 염소, 트리플루오로아세틸, 디플루오로메틸, 트리플루오로메틸, 탄소수 1∼5의 알킬, 탄소수 1∼5의 알콕시, 탄소수 1∼5의 알킬에스테르 또는 탄소수 1∼5의 알카노일로 치환될 수도 있고; ZM은 각각 독립적으로 단결합, -OCH2-, -CH2O-, -COO-, -OCO-, -CH2CH2-, -CH2CH2COO- 또는 -OCOCH2CH2-이며; q는 1 또는 2의 정수이며; XM은 수소, 불소, 염소, 트리플루오로메틸, 트리플루오로메톡시, 시아노, 탄소수 1∼20의 알킬, 탄소수 1∼20의 알케닐, 탄소수 1∼20의 알콕시 또는 탄소수 1∼20의 알킬에스테르이며; a는 0∼20의 정수이며; RM은 수소 또는 메틸이며; YM은 단결합, -O-, -COO-, -OCO- 또는 -OCOO-인 화합물이 바람직하다.In the compounds represented by the above formulas (M1) and (M2), a compound represented by the formula (M1) is more preferable, and in the formula (M1), A M is independently 1,4- -Cyclohexylene, but at least one of A M is 1,4-cyclohexylene and in said 1,4-phenylene or 1,4-cyclohexylene, at least one hydrogen is fluorine, chlorine, tri Fluoroacetyl, difluoromethyl, trifluoromethyl, alkyl of 1 to 5 carbon atoms, alkoxy of 1 to 5 carbon atoms, alkyl ester of 1 to 5 carbon atoms, or alkanoyl of 1 to 5 carbon atoms; Z M each independently represents a single bond, -OCH 2 -, -CH 2 O-, -COO-, -OCO-, -CH 2 CH 2 -, -CH 2 CH 2 COO- or -OCOCH 2 CH 2 - ; q is an integer of 1 or 2; X M is hydrogen, fluorine, chlorine, trifluoromethyl, trifluoromethoxy, cyano, alkyl of 1 to 20 carbon atoms, alkenyl of 1 to 20 carbon atoms, alkoxy of 1 to 20 carbon atoms or alkyl of 1 to 20 carbon atoms Ester; a is an integer from 0 to 20; R M is hydrogen or methyl; Y M is preferably a single bond, -O-, -COO-, -OCO- or -OCOO-.
그 외의 중합성 액정 화합물로서는, 하기 식(M3)으로 표시되는 화합물을 포함할 수도 있다.Other polymerizable liquid crystal compounds may include a compound represented by the following formula (M3).
[화학식 26](26)
상기 식(M3) 중에서, AM은 각각 독립적으로 1,4-페닐렌 또는 1,4-시클로헥실렌이며, 이들에 있어서, 적어도 1개의 수소는 불소, 염소, 시아노, 하이드록시, 포르밀, 트리플루오로아세틸, 디플루오로메틸, 트리플루오로메틸, 탄소수 1∼5의 알킬, 탄소수 1∼5의 알콕시, 탄소수 1∼5의 알킬에스테르 또는 탄소수 1∼5의 알카노일로 치환될 수도 있고; ZM은 각각 독립적으로 단결합, -OCH2-, -CH2O-, -COO-, -OCO-, -COS-, -SCO-, -OCOO-, -CONH-, -NHCO-, -CF2O-, -OCF2-, -CH2CH2-, -CF2CF2-, -CH=CHCOO-, -OCOCH=CH-, -CH2CH2COO-, -OCOCH2CH2-, -CH=CH-, -N=CH-, -CH=N-, -N=CCH3-, -CCH3=N-, -N=N- 또는 -C≡C-이며; c 및 d는 각각 0∼3의 정수이며, 또한 1≤m+n≤4이며; a는 0∼20의 정수이며; RM은 수소 또는 메틸이며; YM은 단결합, -O-, -COO-, -OCO- 또는 -OCOO-이다. 여기서, c, d가 2 이상인 경우, 이 AM 및 ZM은 그 반복 단위마다 상이할 수도 있다.In the formula (M3), A M is each independently 1,4-phenylene or 1,4-cyclohexylene, wherein at least one hydrogen is fluorine, chlorine, cyano, hydroxy, formyl , Trifluoroacetyl, difluoromethyl, trifluoromethyl, alkyl of 1 to 5 carbon atoms, alkoxy of 1 to 5 carbon atoms, alkyl ester of 1 to 5 carbon atoms, or alkanoyl of 1 to 5 carbon atoms ; Z M each independently represents a single bond, -OCH 2 -, -CH 2 O-, -COO-, -OCO-, -COS-, -SCO-, -OCOO-, -CONH-, -NHCO-, -CF 2 O-, -OCF 2 -, -CH 2 CH 2 -, -CF 2 CF 2 -, -CH = CHCOO-, -OCOCH = CH-, -CH 2 CH 2 COO-, -OCOCH 2 CH 2 -, -CH = CH-, -N = CH-, -CH = N-, -N = CCH 3 -, -CCH 3 = N-, -N = N- , or -C≡C-, and; c and d are each an integer of 0 to 3, and 1? m + n? 4; a is an integer from 0 to 20; R M is hydrogen or methyl; Y M is a single bond, -O-, -COO-, -OCO- or -OCOO-. Here, when c and d are two or more, these A M and Z M may be different for each repeating unit.
식(M1)으로 표시되는 화합물은 단관능 중합성 액정 화합물이며, 액정 조성물의 액정 온도 범위, 광학 특성 및 배향성을 제어하기 쉬우며, AM 중 적어도 1개에 1,4-시클로헥실렌을 가지는 화합물은, 파장 분산 특성이나 액정상의 온도 범위 등이 보다 제어하기 쉽다. 식(M2)으로 표시되는 화합물은 2관능 중합성 액정 화합물이며, 이 중합체는 3차원 구조가 되므로, 1개의 중합성 기를 가지는 식(M1)으로 표시되는 화합물과 비교하여 하드(hard)한 중합체가 된다. 식(M3)으로 표시되는 화합물은 3관능 중합성 액정 화합물이며, 이 중합체는 또한 견고한 네트워크를 형성할 수 있고, 1개 및 2개의 중합성 기를 가지는 화합물과 비교하여 더욱 하드한 중합체가 된다. 이후, 식(M1), (M2) 및 (M3)으로 표시되는 화합물이나, 이들로부터 파생하는 화합물의 총칭으로서 식(M)이라 하는 경우가 있다.The compound represented by the formula (M1) is a monofunctional polymerizable liquid crystal compound, and it is easy to control the liquid crystal temperature range, optical characteristics and orientation of the liquid crystal composition, and it is preferable that at least one of A M has 1,4- The compound is more easily controllable, such as the wavelength dispersion characteristics and the temperature range of the liquid crystal phase. The compound represented by the formula (M2) is a bifunctional polymerizable liquid crystal compound, and since the polymer has a three-dimensional structure, a hard polymer as compared with the compound represented by the formula (M1) having one polymerizable group do. The compound represented by the formula (M3) is a triblock polymerizable liquid crystal compound, which can also form a rigid network and becomes a harder polymer than a compound having one and two polymerizable groups. Hereinafter, the compounds represented by the formulas (M1), (M2) and (M3) and the compounds derived therefrom may be collectively referred to as the formula (M).
이하에서, 식(M1)으로 표시되는 화합물의 바람직한 예를 나타낸다.Hereinafter, preferred examples of the compound represented by the formula (M1) are shown.
[화학식 27](27)
[화학식 28](28)
식(M1-1)∼(M1-23)에 있어서, RM은 독립적으로 수소 또는 메틸이며, a는 독립적으로 1∼12의 정수이다.In the formulas (M1-1) to (M1-23), R M is independently hydrogen or methyl, and a is independently an integer of 1 to 12.
이하에서, 식(M2)으로 표시되는 화합물의 바람직한 예를 나타낸다.Hereinafter, preferred examples of the compound represented by the formula (M2) are shown.
[화학식 29][Chemical Formula 29]
[화학식 30](30)
[화학식 31](31)
식(M2-1)∼(M2-31)에 있어서, RM은 독립적으로 수소 또는 메틸이며, a는 독립적으로 1∼12의 정수이다. 식 중에 2개 이상의 a가 있을 때, 임의의 2개의 a는 동일할 수도 있고, 상이할 수도 있다.In the formulas (M2-1) to (M2-31), R M is independently hydrogen or methyl, and a is independently an integer of 1 to 12. When two or more a's are present in the formula, any two a's may be the same or different.
이하, 식(M3)으로 표시되는 화합물의 바람직한 예를 나타낸다.Hereinafter, preferred examples of the compound represented by the formula (M3) are shown.
[화학식 32](32)
[화학식 33](33)
식(M3-1)∼(M3-10)에 있어서, RM은 독립적으로 수소 또는 메틸이며, a는 독립적으로 1∼12의 정수이다. 식 중에 2개 이상의 a가 있을 때, 임의의 2개의 a는 동일할 수도 있고, 상이할 수도 있다.In the formulas (M3-1) to (M3-10), R M is independently hydrogen or methyl, and a is independently an integer of 1 to 12. When two or more a's are present in the formula, any two a's may be the same or different.
본 발명의 중합성 액정 조성물은, 식(1)으로 표시되는 본 발명의 화합물군으로부터 선택되는 적어도 1종과, 식(M1) 및 (M2)으로 표시되는 화합물군으로부터 선택되는 적어도 1개의 화합물과의, 합계량 100 중량%에 대하여, 식(1)으로 표시되는 본 발명의 화합물군으로부터 선택되는 적어도 1종을 10∼90 중량% 함유하는 것이 바람직하다. 액정 조성물 중의 상기 각 성분의 함유량이 전술한 범위에 있으면, 굴절율 이방성의 파장 분산 제어가 용이하며, 양호한 도포성을 가지는 액정 조성물을 얻을 수 있고, 또한 본 발명의 중합체의 효과를 현저하게 발현시킬 수 있다.The polymerizable liquid crystal composition of the present invention comprises at least one compound selected from the group of compounds of the present invention represented by formula (1) and at least one compound selected from the group of compounds represented by formulas (M1) and (M2) By weight of at least one compound selected from the group of the compounds of the present invention represented by the formula (1), based on 100% by weight of the total amount. When the content of each of the above components in the liquid crystal composition is in the above-mentioned range, it is possible to obtain a liquid crystal composition which is easy to control wavelength dispersion of refractive index anisotropy and which has good coating properties and can remarkably exhibit the effect of the polymer of the present invention have.
또한, 상기 식(LC) 또는 식(M3)으로 표시되는 화합물을 더 함유할 수도 있다.Further, it may further contain a compound represented by the formula (LC) or the formula (M3).
본 발명의 액정 조성물은, 계면활성제를 더 포함할 수도 있다. 계면활성제로서는 비이온성 계면활성제가 바람직하고, 비이온성 계면활성제가 액정 조성물에 포함된 경우에는, 그 액정 조성물로 형성되는 도포막의 평활성을 향상시키는 효과가 있다.The liquid crystal composition of the present invention may further comprise a surfactant. As the surfactant, a nonionic surfactant is preferable. When a nonionic surfactant is included in the liquid crystal composition, the smoothness of the coating film formed of the liquid crystal composition is improved.
비이온성 계면활성제를 첨가하는 경우의 바람직한 비율은, 식(1)으로 표시되는 화합물의 중량, 및 그 외의 액정 화합물이나 그 외의 중합성 액정 화합물을 함유하는 경우에는 식(1)으로 표시되는 화합물과의 합계 중량에 대한 중량비로 0.0001∼0.5이다. 더욱 바람직한 중량비의 범위는 0.0001∼0.005이다.When the nonionic surfactant is added, the preferable ratio is the weight of the compound represented by the formula (1), and when the other liquid crystal compound or other polymerizable liquid crystal compound is contained, the compound represented by the formula (1) Is 0.0001 to 0.5 in terms of the weight ratio with respect to the total weight. A more preferable range of the weight ratio is 0.0001 to 0.005.
비이온성 계면활성제로서는, 예를 들면, 실리콘계 비이온성 계면활성제, 불소계 비이온성 계면활성제, 탄화수소계 비이온성 계면활성제 등이 있다.Examples of the nonionic surfactant include silicone-based nonionic surfactants, fluorine-based nonionic surfactants, and hydrocarbon-based nonionic surfactants.
실리콘계 비이온성 계면활성제의 시판품으로서는, 예를 들면, 미변성 실리콘 또는 변성 실리콘을 주성분으로 한 쿄에이샤 화학(주)에서 제조한 폴리플로우 ATF-2, 글라놀 100, 글라놀 115, 글라놀 400, 글라놀 410, 글라놀 435, 글라놀 440, 글라놀 450, 글라놀 B-1484, 폴리플로우 KL-250, 폴리플로우 KL-260, 폴리플로우 KL-270, 폴리플로우 KL-280, BYK-300, BYK-302, BYK-306, BYK-307, BYK-310, BYK-315, BYK-320, BYK-322, BYK-323, BYK-325, BYK-330, BYK-331, BYK-333, BYK-337, BYK-341, BYK-342, BYK-344, BYK-345, BYK-346, BYK-347, BYK-348, BYK-370, BYK-375, BYK-377, BYK-378, BYK-3500, BYK-3510, 및 BYK-3570 등이 있다.Examples of commercial products of silicone-based nonionic surfactants include polyflow ATF-2, Glanol 100, Glanol 115, Glanol 400 (trade name, manufactured by Kyowa Chemical Industry Co., Ltd.) , POLYFLOW KL-260, POLYFLOW KL-270, POLYFLOW KL-280, BYK-300, GLYNOL 410, GLONOL 435, GLONOL 440, GLONOL 450, GLONOL B- , BYK-302, BYK-306, BYK-307, BYK-310, BYK-315, BYK-320, BYK-322, BYK-323, BYK-325, BYK-330, BYK-331, BYK- -377, BYK-341, BYK-342, BYK-344, BYK-345, BYK-346, BYK-347, BYK-348, BYK-370, BYK-375, , BYK-3510, and BYK-3570.
불소계 비이온성 계면활성제의 시판품으로서는, 예를 들면, BYK-340, 프타젠트 251, 프타젠트 221MH, 프타젠트 250, FTX-215M, FTX-218M, FTX-233M, FTX-245M, FTX-290M, FTX-209F, FTX-213F, 프타젠트 222F, FTX-233F, FTX-245F, FTX-208G, FTX-218G, FTX-240G, FTX-206D, 프타젠트 212D, FTX-218, FTX-220D, FTX-230D, FTX-240D, FTX-720C, FTX-740C, FTX-207S, FTX-211S, FTX-220S, FTX-230S, KB-L82, KB-L85, KB-L97, KB-L109, KB-L110, KB-F2L, KB-F2M, KB-F2S, KB-F3M, 및 KB-FaM 등이 있다.Examples of commercially available fluorine-based nonionic surfactants include BYK-340, POTGENT 251, POTGENT 221MH, POTGENT 250, FTX-215M, FTX-218M, FTX-233M, FTX-245M, FTX- FTX-218G, FTX-240G, FTX-206D, PtGent 212D, FTX-218, FTX-220D, FTX-230D, FTX-213F, FTX-213F, PtGent 222F, FTX-233F, FTX-245F, FTX- , FTX-240D, FTX-720C, FTX-740C, FTX-207S, FTX-211S, FTX-220S, FTX-230S, KB-L82, KB-L85, KB-L97, KB- -F2L, KB-F2M, KB-F2S, KB-F3M, and KB-FaM.
탄화수소계 비이온성 계면활성제의 시판품으로서는, 예를 들면, 아크릴계 폴리머를 주성분으로 한 폴리플로우 No.3, 폴리플로우 No.50EHF, 폴리플로우 No.54N, 폴리플로우 No.75, 폴리플로우 No.77, 폴리플로우 No.85HF, 폴리플로우 No.90, 폴리플로우 No.95, 폴리플로우 No.99C, BYK-350, BYK-352, BYK-354, BYK-355, BYK-358N, BYK-361N, BYK-380N, BYK-381, BYK-392, 및 BYK-Silclean3700 등이 있다.As commercially available products of the hydrocarbon-based nonionic surfactants, for example, Polyflow No. 3, Polyflow No. 50EHF, Polyflow No. 54N, Polyflow No. 75, Polyflow No. 77, 354, BYK-355, BYK-358N, BYK-361N, BYK-351, BYK- 380N, BYK-381, BYK-392, and BYK-Silclean3700.
그리고, 상기한 폴리플로우 및 글라놀은 모두 쿄에이샤 화학(주)으로부터 판매되고 있는 상품의 명칭이다. BYK는 빅케미·재팬(주)으로부터 판매되고 있는 상품의 명칭이다. 프타젠트, FTX 및 KB는 (주)네오스로부터 판매되고 있는 상품의 명칭이다.The above polyflow and glanol are all trade names of products sold by Kyowa Chemical Industry Co., Ltd. BYK is the name of a product sold by Big Chem Japan Co., Ltd. Phtagent, FTX and KB are the names of the products sold by Neos.
상기한 계면활성제는, 단독으로 사용할 수도 있고, 2개 이상을 혼합하여 사용할 수도 있다.The above-mentioned surfactants may be used alone or in combination of two or more.
다음으로, 그 외의 중합성 화합물, 첨가물, 유기용제를 예시한다. 이들 화합물은 시판품이라도 된다.Next, other polymerizable compounds, additives, and organic solvents are exemplified. These compounds may be commercially available products.
그 외의 중합성 화합물로서는, 비닐 유도체, 스티렌 유도체, (메타)아크릴산 유도체, 옥시란 유도체, 옥세탄 유도체, 소르빈산 유도체, 푸마르산 유도체, 이타콘산 유도체 등의 화합물로서 액정성을 가지고 있지 않은 것을 예로 들 수 있다. 이 액정성을 가지고 있지 않은 그 외의 중합성 화합물에는, 중합성 기를 1개 가지는 화합물, 중합성 기를 2개 가지는 화합물 및 중합성 기를 3개 이상 가지는 다관능성 화합물 등이 있다.Examples of other polymerizable compounds include compounds that do not have liquid crystallinity, such as vinyl derivatives, styrene derivatives, (meth) acrylic acid derivatives, oxirane derivatives, oxetane derivatives, sorbic acid derivatives, fumaric acid derivatives and itaconic acid derivatives have. Other polymerizable compounds having no liquid crystalline property include a compound having one polymerizable group, a compound having two polymerizable groups, and a polyfunctional compound having three or more polymerizable groups.
그 외의 중합성 화합물은, 액정상을 유지할 수 있는 한 첨가해도 된다. 식(1)으로 표시되는 화합물의 중량, 및 그 외의 액정 화합물이나 그 외의 중합성 액정 화합물을 함유하는 경우에는 식(1)으로 표시되는 화합물과의 합계 중량에 대한 중량비로 0.5 이하인 것이 바람직하다.The other polymerizable compound may be added as long as it can retain the liquid crystal phase. When the weight of the compound represented by the formula (1) and other liquid crystal compounds or other polymerizable liquid crystal compounds are contained, the weight ratio of the compound to the total weight of the compound represented by the formula (1) is preferably 0.5 or less.
중합성 기를 1개 가지는 화합물로서는, 예를 들면, 스티렌, 핵 치환 스티렌, 아크릴로니트릴, 염화 비닐, 염화 비닐리덴, 비닐피리딘, N-비닐피롤리돈, 비닐술폰산, 지방산 비닐(예: 아세트산 비닐), α,β-에틸렌성 불포화 카르본산(예: 아크릴산, 메타크릴산, 말레산, 푸마르산, 이타콘산 등), (메타)아크릴산의 알킬에스테르(알킬의 탄소수 1∼18), (메타)아크릴산의 하이드록시알킬에스테르(하이드록시 알킬의 탄소수 1∼18), (메타)아크릴산의 아미노알킬에스테르(아미노알킬의 탄소수 1∼18), (메타)아크릴산의 에테르 산소 함유 알킬에스테르(에테르 산소 함유 알킬의 탄소수 3∼18, 예: 메톡시에틸에스테르, 에톡시에틸에스테르, 메톡시프로필에스테르, 메틸카르빌에스테르, 에틸카르빌에스테르, 및 부틸카르빌에스테르), N-비닐 아세트아미드, p-tert-부틸벤조산 비닐, N,N-디메틸아미노벤조산 비닐, 벤조산 비닐, 피발산 비닐, 2,2-디메틸부티르산 비닐, 2,2-디메틸펜탄산 비닐, 2-메틸-2-부티르산 비닐, 프로피온산 비닐, 스테아르산 비닐, 2-에틸-2-메틸부티르산 비닐, 디시클로펜타닐옥실에틸(메타)아크릴레이트, 이소보르닐옥실에틸(메타)아크릴레이트, 이소보닐(메타)아크릴레이트, 아다만틸(메타)아크릴레이트, 디메틸아다만틸(메타)아크릴레이트, 디시클로펜타닐(메타)아크릴레이트, 디시클로펜테닐(메타)아크릴레이트, 2-아크릴로일옥시에틸숙신산, 2-아크릴로일옥시에틸헥사하이드로프탈산, 2-아크릴로일옥시에틸프탈산, 2-아크릴로일옥시에틸-2-하이드록시에틸 프탈산, 2-아크릴로일옥시에틸애시드 포스페이트, 2-메타크릴로일옥시에틸애시드 포스페이트, 중합도 1∼100의 폴리에틸렌글리콜, 폴리프로필렌글리콜, 에틸렌옥시드와 프로필렌 옥시드와의 공중합체 등의 폴리알킬렌글리콜의 모노(메타)아크릴산 에스테르 또는 디(메타)아크릴산 에스테르, 또는 말단이 탄소수 1∼6의 알킬기에 의해 캡된 중합도 1∼100의 폴리에틸렌글리콜, 폴리프로필렌글리콜, 및 에틸렌옥시드와 프로필렌 옥시드와의 공중합체 등의 폴리알킬렌글리콜의 모노(메타)아크릴산 에스테르 등이 있다.Examples of the compound having one polymerizable group include styrene, nuclear substituted styrene, acrylonitrile, vinyl chloride, vinylidene chloride, vinylpyridine, N-vinylpyrrolidone, vinylsulfonic acid, ), alpha, beta -ethylenically unsaturated carboxylic acids (e.g., acrylic acid, methacrylic acid, maleic acid, fumaric acid and itaconic acid), alkyl esters of (meth) acrylic acid (C1 to C18 of hydroxyalkyl), aminoalkyl ester of (meth) acrylic acid (having 1 to 18 carbon atoms of aminoalkyl), ether oxygen-containing alkyl ester of (meth) acrylic acid Such as methoxyethyl ester, ethoxyethyl ester, methoxypropyl ester, methylcarbyl ester, ethylcarbyl ester, and butylcarbyl ester), N-vinylacetamide, p-tert- butyl Benzo Vinyl benzoate, vinyl pivalate, vinyl 2,2-dimethylbutyric acid, vinyl 2,2-dimethylpentanoate, vinyl 2-methyl-2-butylacetate, vinyl propionate, stearic acid (Meth) acrylate, isobornyl (meth) acrylate, isobornyl (meth) acrylate, adamantyl (meth) acrylate, (Meth) acrylate, dicyclopentanyl (meth) acrylate, dicyclopentenyl (meth) acrylate, 2-acryloyloxyethylsuccinic acid, 2- acryloyloxyethyl hexahydrophthalic acid, Acryloyloxyethyl phthalic acid, 2-acryloyloxyethyl-2-hydroxyethylphthalic acid, 2-acryloyloxyethyl acid phosphate, 2-methacryloyloxyethyl acid phosphate, Polyethylene glycol, polypropylene glycol (Meta) acrylic acid esters or di (meth) acrylic acid esters of polyalkylene glycols such as a copolymer of ethylene oxide and propylene oxide, or a polymerization degree capped by an alkyl group having 1 to 6 carbon atoms (Meth) acrylic acid esters of polyalkylene glycols such as polyethylene glycol, polypropylene glycol, and copolymers of ethylene oxide and propylene oxide.
중합성 기를 2개 가지는 화합물로서는, 예를 들면, 1,4-부탄디올디아크릴레이트, 1,6-헥산디올디아크릴레이트, 1,9-노난디올디아크릴레이트, 네오펜틸글리콜 디아크릴레이트, 디메틸올트리시클로데칸디아크릴레이트, 트리에틸렌글리콜디아크릴레이트, 디프로필렌글리콜디아크릴레이트, 트리프로필렌글리콜디아크릴레이트, 테트라에틸렌글리콜디아크릴레이트, 비스페놀A EO 부가 디아크릴레이트, 비스페놀A 글리시딜디아크릴레이트(비스코트 V#700), 폴리에틸렌글리콜디아크릴레이트, 및 이들 화합물의 메타크릴레이트 화합물 등이 있다.Examples of the compound having two polymerizable groups include 1,4-butanediol diacrylate, 1,6-hexanediol diacrylate, 1,9-nonanediol diacrylate, neopentyl glycol diacrylate, dimethyl Triethylene glycol diacrylate, dipropylene glycol diacrylate, tripropylene glycol diacrylate, tetraethylene glycol diacrylate, bisphenol A EO-added diacrylate, bisphenol A glycidyldiacrylate (VISCOT V # 700), polyethylene glycol diacrylate, and methacrylate compounds of these compounds.
중합성 기를 3개 이상 가지는 화합물로서는, 예를 들면, 펜타에리트리톨트리(메타)아크릴레이트, 트리메틸올프로판트리(메타)아크릴레이트, 트리메틸올 EO 부가 트리(메타)아크릴레이트, 트리스(메타)아크릴로일옥시에틸포스페이트, 트리스((메타)아크릴로일옥시에틸)이소시아누레이트, 알킬 변성 디펜타에리트리톨트리(메타)아크릴레이트, EO 변성 트리메틸올프로판트리(메타)아크릴레이트, PO 변성 트리메틸올프로판트리(메타)아크릴레이트, 펜타에리트리톨테트라(메타)아크릴레이트, 알킬 변성 디펜타에리트리톨테트라(메타)아크릴레이트, 디트리메틸올프로판테트라(메타)아크릴레이트, 디펜타에리트리톨헥사(메타)아크릴레이트, 디펜타에리트리톨모노하이드록시펜타(메타)아크릴레이트, 알킬 변성 디펜타에리트리톨펜타(메타)아크릴레이트, 비스코트 V#802(관능기 수=8), 비스코트 V#1000(관능기 수=평균 14) 등이 있다. 「비스코트」는 오사카 유기 화학 주식회사의 상품명이다. 관능기가 16 이상인 것은 Perstorp Specialty Chemicals가 판매하고 있는 Boltorn H20(16관능), Boltorn H30(32관능), Boltorn H40(64관능)를 원료로 하여 이들을 아크릴화함으로써 얻어진다.Examples of the compound having three or more polymerizable groups include pentaerythritol tri (meth) acrylate, trimethylol propane tri (meth) acrylate, trimethylol EO added tri (meth) acrylate, tris (meth) (Meth) acryloyloxyethyl isocyanurate, alkyl-modified dipentaerythritol tri (meth) acrylate, EO-modified trimethylolpropane tri (meth) acrylate, PO-modified trimethyl (Meth) acrylate, ditrimethylolpropane tetra (meth) acrylate, dipentaerythritol hexa (meta) acrylate, dipentaerythritol tetra ) Acrylate, dipentaerythritol monohydroxypenta (meth) acrylate, alkyl-modified dipentaerythritol penta (meth) acrylate, bis Coat V # 802 (number of functional groups = 8), Viscot V # 1000 (number of functional groups = 14), and the like. "Viscot" is a trade name of Osaka Organic Chemical Co., Ltd. The functional groups of 16 or more are obtained by acrylating them using Boltorn H20 (16-functional), Boltorn H30 (32-functional) and Boltorn H40 (64-functional), which are sold by Perstorp Specialty Chemicals.
그 외의 중합성 화합물로서는, 카르도 구조를 가지는 중합성 플루오렌 유도체를 예로 들 수 있다. 이들 화합물은, 배향 방향의 제어나 중합체의 경화도를 더욱 높이는 데 적합하다. 카르도 구조를 가지는 중합성 플루오렌 유도체의 예를 하기 식(α-1)∼식(α-6)으로 나타낸다.Examples of other polymerizable compounds include polymerizable fluorene derivatives having a cardo structure. These compounds are suitable for controlling the orientation direction and further increasing the degree of curing of the polymer. Examples of polymerizable fluorene derivatives having a cardo structure are shown by the following formulas (? -1) to (? -6).
[화학식 34](34)
또한, 그 외의 중합성 화합물로서는, 비스페놀 구조를 가지는 중합성 화합물을 예로 들 수 있다. 이들 화합물은, 액정 조성물의 피막 형성 능력이나 배향 균일성의 보조에 적합하다. 중합성 비스페놀 유도체의 예를 하기 식(N-1)∼(N-6)으로 나타낸다.As the other polymerizable compound, a polymerizable compound having a bisphenol structure is exemplified. These compounds are suitable for assisting the film-forming ability and orientation uniformity of the liquid crystal composition. Examples of polymerizable bisphenol derivatives are represented by the following formulas (N-1) to (N-6).
[화학식 35](35)
상기한 그 외의 중합성 화합물은 단독으로 사용할 수도 있고, 2개 이상을 혼합하여 사용할 수도 있다. 또한, 이들 화합물은 시판품이라도 된다.The above other polymerizable compounds may be used alone, or two or more of them may be used in combination. These compounds may also be commercially available products.
중합 속도를 최적화하기 위하여, 중합 개시제를 액정 조성물에 첨가할 수도 있다. 중합 개시제로서는, 예를 들면, 광 라디칼 개시제가 있다. 광 라디칼 중합 개시제로서는, 예를 들면, 2-하이드록시-2-메틸-1-페닐프로판-1-온(다로큐어 1173), 1-하이드록시시클로헥실페닐케톤, 2,2-디메톡시-1,2-디페닐에탄-1-온(이르가큐어 651), 1-하이드록시-시클로헥실-페닐-케톤(이르가큐어 184), 이르가큐어 127, 이르가큐어 500(이르가큐어 184와 벤조페논의 혼합물), 이르가큐어 2959, 이르가큐어 907, 이르가큐어 369, 이르가큐어 379, 이르가큐어 754, 이르가큐어 1300, 이르가큐어 819, 이르가큐어 1700, 이르가큐어 1800, 이르가큐어 1850, 이르가큐어 1870, 다로큐어 4265, 다로큐어 MBF, 다로큐어 TPO, 이르가큐어 784, 이르가큐어 754, 이르가큐어 OXE01, 및 이르가큐어 OXE02 등이 있다. 상기한 다로큐어 및 이르가큐어는 모두 BASF 재팬(주)으로부터 판매되고 있는 상품의 명칭이다.In order to optimize the polymerization rate, a polymerization initiator may be added to the liquid crystal composition. As the polymerization initiator, for example, there is a photo radical initiator. Examples of the photo radical polymerization initiator include 2-hydroxy-2-methyl-1-phenylpropan-1-one (Darocure 1173), 1-hydroxycyclohexyl phenyl ketone, 2,2-dimethoxy- (Irgacure 651), 1 -hydroxy-cyclohexyl-phenyl-ketone (Irgacure 184), Irgacure 127, Irgacure 500 Benzophenone mixture), Irgacure 2959, Irgacure 907, Irgacure 369, Irgacure 379, Irgacure 754, Irgacure 1300, Irgacure 819, Irgacure 1700, Irgacure 1800 , Irgacure 1850, Irgacure 1870, Darocure 4265, Darocure MBF, Darocure TPO, Irgacure 784, Irgacure 754, Irgacure OXE01, Irgacure OXE02, and the like. The above-mentioned DARACURE and IRGACURE are all the names of the products sold by BASF Japan Co., Ltd.
상기 광 라디칼 중합 개시제로서는, p-메톡시페닐-2,4-비스(트리클로로메틸)트리아진, 2-(p-부톡시스티릴)-5-트리클로로메틸-1,3,4-옥사디아졸, 9-페닐아크리딘, 9,10-벤조페나진, 벤조페논/미힐러케톤 혼합물, 헥사아릴비이미다졸/머캅토벤즈이미다졸 혼합물, 1-(4-이소프로필페닐)-2-하이드록시-2-메틸프로판-1-온, 벤질디메틸케탈, 2-메틸-1-[4-(메틸티오)페닐]-2-모르폴리노프로판1-온, 2,4-디에틸크산톤/p-디메틸아미노벤조산 메틸 혼합물, 벤조페논/메틸트리에탄올아민 혼합물 등을 예로 들 수 있다.Examples of the photo radical polymerization initiator include p-methoxyphenyl-2,4-bis (trichloromethyl) triazine, 2- (p-butoxystyryl) -5-trichloromethyl- (4-isopropylphenyl) -2 (4-isopropylphenyl) -2, 4-isopropylphenoxypyridine, 2-methylpropan-1-one, benzyldimethyl ketal, 2-methyl-1- [4- (methylthio) / p-dimethylaminobenzoate mixture, benzophenone / methyltriethanolamine mixture, and the like.
광 라디칼 중합 개시제의 바람직한 첨가량은, 식(1)으로 표시되는 화합물의 중량, 및 그 외의 액정 화합물이나 그 외의 중합성 액정 화합물을 함유하는 경우에는 식(1)으로 표시되는 화합물과의 합계 중량에 대한 중량비로 0.0001∼0.20이다. 이 중량비의 보다 바람직한 범위는 0.001∼0.15이다. 더욱 바람직한 범위는 0.01∼0.15이다. 상기 광라디칼 개시제는 단독으로 사용할 수도 있고, 2개 이상을 혼합하여 사용할 수도 있다. 또한, 이들 중합 개시제는 시판품이라도 된다.The amount of the photo-radical polymerization initiator to be added is preferably in the range of from 1 to 100 parts by weight based on the weight of the compound represented by the formula (1) and the total weight of the liquid crystal compound or other polymerizable liquid crystal compound and the compound represented by the formula (1) Lt; / RTI > A more preferable range of the weight ratio is 0.001 to 0.15. A more preferred range is 0.01 to 0.15. The photoradical initiator may be used alone or in admixture of two or more. These polymerization initiators may be commercially available products.
또한, 이들 광 라디칼 중합 개시제에, 증감제를 첨가하여 사용해도 된다. 증감제로서는, 예를 들면, 이소프로필티옥산톤, 디에틸티옥산톤, 에틸-4디메틸아미노 벤조에이트(다로큐어 EDB), 2-에틸헥실-4-디메틸아미노벤조에이트(다로큐어 EHA) 등이 있다. 이들 증감제는 단독으로 사용할 수도 있고, 2개 이상을 혼합하여 사용할 수도 있다. 또한, 이들 증감제는 시판품이라도 된다.A sensitizer may be added to these photo radical polymerization initiators. Examples of the sensitizer include isopropyl thioxanthone, diethyl thioxanthone, ethyl-4 dimethylaminobenzoate (Darocure EDB), 2-ethylhexyl-4-dimethylaminobenzoate (Darocure EHA) . These sensitizers may be used alone or in combination of two or more. These sensitizers may also be commercially available products.
중합체의 중합 반응 비율이나 기계적 특성을 제어하기 위하여, 연쇄 이동제를 액정 조성물에 첨가할 수도 있다. 연쇄 이동제를 사용함으로써, 얻어지는 중합체의 반응 비율이나 쇄 길이를 제어할 수 있다. 연쇄 이동제의 양을 증대시키면, 중합 반응 비율이 저하하고, 폴리머쇄의 길이는 감소한다. 바람직한 연쇄 이동제는, 티올 화합물이나 스티렌 다이머이다. 이들 연쇄 이동제는 단독으로 사용할 수도 있고, 2개 이상을 혼합하여 사용할 수 있다. 또한, 이들 연쇄 이동제는 시판품이라도 된다.A chain transfer agent may also be added to the liquid crystal composition to control the polymerization reaction rate or mechanical properties of the polymer. By using a chain transfer agent, the reaction ratio and chain length of the obtained polymer can be controlled. When the amount of the chain transfer agent is increased, the polymerization reaction ratio is lowered and the length of the polymer chain is decreased. Preferred chain transfer agents are thiol compounds or styrene dimers. These chain transfer agents may be used alone or in combination of two or more. These chain transfer agents may be commercially available products.
상기 티올계 연쇄 이동제로서는, 단관능성 티올인, 도데칸 티올, 2-에틸헥실-3-머캅토프로피오네이트 등이나, 다관능성 티올인, 트리메틸올프로판트리스(3-머캅토프로피오네이트), 펜타에리트리톨테트라키스(3-머캅토프로피오네이트), 1,4-비스(3-머캅토부티릴옥시)부탄(카렌즈 MT BD1), 펜타에리트리톨테트라키스(3-머캅토부티레이트)(카렌즈 MT PE1), 및 1,3,5-트리스(3-머캅토부틸옥시에틸)-1,3,5-트리아진-2,4,6(1H,3H,5H)-트리온(카렌즈 MT NR1) 등을 예로 들 수 있다. 「카렌즈」는 쇼와전공 주식회사의 상품명이다.Examples of the thiol chain transfer agent include monofunctional thiol such as dodecanethiol, 2-ethylhexyl-3-mercaptopropionate and the like, and trimethylolpropane tris (3-mercaptopropionate), which is a multifunctional thiol, Pentaerythritol tetrakis (3-mercaptopropionate), 1,4-bis (3-mercaptobutyryloxy) butane (carboxy MT BD1), pentaerythritol tetrakis (3-mercaptobutyrate) Carboxylactone MT PE1), and 1,3,5-tris (3-mercaptobutyloxyethyl) -1,3,5-triazine-2,4,6 (1H, 3H, 5H) Lens MT NR1), and the like. &Quot; Car lens " is a trade name of Showa Denko KK.
상기 스티렌 다이머계 연쇄 이동제로서는, 2,4-디페닐-4-메틸-1-펜텐, 2,4-디페닐-1-부텐 등을 예로 들수 있다.Examples of the styrene dimer-based chain transfer agent include 2,4-diphenyl-4-methyl-1-pentene, 2,4-diphenyl-1-butene, and the like.
액정 조성물에는, 보존시의 중합 개시를 방지하기 위해 중합 방지제를 첨가할 수 있다. 공지의 중합 방지제를 사용할 수 있지만, 그 바람직한 예는, 2,5-디(tert-부틸)하이드록시톨루엔(BHT), 하이드로퀴논, 메틸렌 블루, 디페닐피크르산하이드라지드(DPPH), 페노티아진, N,N-디메틸-4-니트로소아닐린 등의 니트로소 화합물, o-하이드록시벤조페논, 및 2H-1,3-벤조티아진-2,4-(3H)디온 등의 벤조티아진 유도체이다.A polymerization inhibitor may be added to the liquid crystal composition in order to prevent polymerization initiation at the time of storage. (BHT), hydroquinone, methylene blue, diphenyl picric acid hydrazide (DPPH), phenothiazine (DPPH), or the like can be used. , And N, N-dimethyl-4-nitrosoaniline, benzothiazine derivatives such as o-hydroxybenzophenone and 2H-1,3-benzothiazin-2,4- to be.
액정 조성물의 보존성을 향상시키기 위하여, 중합 저해제를 첨가할 수도 있다. 액정 조성물이나 액정 조성물 용액 내에서 라디칼이 발생한 경우에는, 중합성 화합물의 중합 반응이 촉진된다. 이것을 방지할 목적으로 중합 저해제를 첨가하는 것이 바람직하다. 중합 저해제로서는, 페놀계 산화 방지제, 유황계 산화 방지제, 인산계 산화 방지제를 이용할 수 있다.In order to improve the preservability of the liquid crystal composition, a polymerization inhibitor may be added. When a radical is generated in the liquid crystal composition or the liquid crystal composition solution, the polymerization reaction of the polymerizable compound is promoted. It is preferable to add a polymerization inhibitor for the purpose of preventing this. As the polymerization inhibitor, phenol-based antioxidants, sulfur-based antioxidants, and phosphoric acid-based antioxidants can be used.
액정 조성물의 내후성(耐候性)을 더욱 향상시키기 위하여, 자외선 흡수제, 광 안정제(라디칼 포착제) 및 산화 방지제 등을 첨가할 수도 있다.In order to further improve the weather resistance of the liquid crystal composition, an ultraviolet absorber, a light stabilizer (radical scavenger) and an antioxidant may be added.
자외선 흡수제로서는, 예를 들면, 티누빈 PS, 티누빈 P, 티누빈 99-2, 티누빈 109, 티누빈 213, 티누빈 234, 티누빈 326, 티누빈 328, 티누빈 329, 티누빈384-2, 티누빈 571, 티누빈 900, 티누빈 928, 티누빈 1130, 티누빈 400, 티누빈 405, 티누빈 460, 티누빈 479, 티누빈 5236, 아데카스타브 LA-32, 아데카스타브 LA-34, 아데카스타브 LA-36, 아데카스타브 LA-31, 아데카스타브 1413, 및 아데카스타브 LA-51 등이 있다. 「티누빈」은 BASF 재팬(주)의 상품명이며, 「아데카스타브」는 ADEKA의 상품명이다. 이들 자외선 흡수제는 단독으로 사용할 수도 있고, 2개 이상을 혼합하여 사용할 수도 있다. 또한, 이들 자외선 흡수제는 시판품이라도 된다.Examples of ultraviolet absorbers include Tinuvin PS, Tinuvin P, Tinuvin 99-2, Tinuvin 109, Tinuvin 213, Tinuvin 234, Tinuvin 326, Tinuvin 328, Tinuvin 329, Tinuvin 384- 2, Tinuvin 571, Tinuvin 900, Tinuvin 928, Tinuvin 1130, Tinuvin 400, Tinuvin 405, Tinuvin 460, Tinuvin 479, Tinuvin 5236, Adecastab LA- 34, adecastab LA-36, adecastab LA-31, adecastab 1413, and adecastab LA-51. "Tinuvin" is a trade name of BASF Japan Ltd., and "Adekastab" is a trade name of ADEKA. These ultraviolet absorbers may be used alone or in admixture of two or more. These ultraviolet absorbers may be commercially available products.
광 안정제로서는, 예를 들면, 티누빈 111FDL, 티누빈 123, 티누빈 144, 티누빈 152, 티누빈 292, 티누빈 622, 티누빈 770, 티누빈 765, 티누빈 780, 티누빈 905, 티누빈 5100, 티누빈 5050, 5060, 티누빈 5151, 키마소브 119FL, 키마소브 944FL, 키마소브 944LD, 아데카스타브 LA-52, 아데카스타브 LA-57, 아데카스타브 LA-62, 아데카스타브 LA-67, 아데카스타브 LA-63P, 아데카스타브 LA-68LD, 아데카스타브 LA-77, 아데카스타브 LA-82, 아데카스타브 LA-87, 사이텍사에서 제조한 사이아소브 UV-3346, 및 굿리치사의 굿 라이트 UV-3034 등이 있다. 「키마소브」는 BASF 재팬(주)의 상품명이다. 이들 광 안정제는 단독으로 사용할 수도 있고, 2개 이상을 혼합하여 사용할 수도 있다. 또한, 이들 광 안정제는 시판품이라도 된다.Examples of the light stabilizers include Tinuvin 111FDL, Tinuvin 123, Tinuvin 144, Tinuvin 152, Tinuvin 292, Tinuvin 622, Tinuvin 770, Tinuvin 765, Tinuvin 780, Tinuvin 905, 5100, Tinuvin 5050, 5060, Tinuvin 5151, KIMASOV 119FL, KIMASOV 944FL, KIMASOV 944LD, Adecastab LA-52, Adecastab LA-57, Adecastab LA- Adabsorption LA-67, Adecastab LA-63P, Adecastab LA-68LD, Adecastab LA-77, Adecastab LA-82, Adecastab LA-87, 3346, and Goodrich UV-3034 from Goodrich. &Quot; KIMASOV " is a trade name of BASF Japan Co., Ltd. These light stabilizers may be used alone or in combination of two or more thereof. These light stabilizers may be commercially available products.
산화 방지제로서는, 예를 들면, ADEKA의 아데카스타브 AO-20, AO-30, AO-40, AO-50, AO-60, AO-80, 스미토모 화학(주)으로부터 판매되고 있는 스미라이저 BHT, 스미라이저 BBM-S, 및 스미라이저 GA-80, 및 BASF 재팬(주)으로부터 판매되고 있는 Irganox1076, Irganox1010, Irganox3114, 및 Irganox245 등이 있다. 이들 산화 방지제는 단독으로 사용할 수도 있고, 2개 이상을 혼합하여 사용할 수도 있다. 또한, 이들 산화 방지제는 시판품이라도 된다.As the antioxidant, for example, Adekastab AO-20, AO-30, AO-40, AO-50, AO-60, AO-80 of ADEKA, Sumilizer BHT sold by Sumitomo Chemical Co., Irganox1010, Irganox3114, and Irganox245 sold by BASF Japan Co., Ltd., and the like. These antioxidants may be used alone or in admixture of two or more. These antioxidants may be commercially available products.
기판과의 밀착성을 제어하는 등을 위하여, 실란커플링제를 액정 조성물에 첨가할 수도 있다. 실란커플링제로서는, 예를 들면, 비닐트리알콕시실란, 3-이소시아네이트프로필트리에톡시실란, N-(2-아미노에틸)3-아미노프로필트리알콕시실란, N-(1,3-디메틸부틸리덴)-3-(트리알콕시실릴)-1-프로판아민, 3-글리시독시프로필트리알콕시실란, 3-클로로트리알콕시실란, 3-아크릴록시프로필트리메톡시실란, 3-메타크릴록시프로필트리알콕시실란 등이 있다. 또한, 상기 알콕시실란에 있어서, 알콕시기(3개) 중 1개를 메틸로 치환한 디알콕시메틸실란도, 실란커플링제로서 사용할 수 있다. 이들 실란커플링제는 단독으로 사용할 수도 있고, 2개 이상을 혼합하여 사용할 수도 있다. 또한, 이들 실란커플링제는 시판품이라도 된다.A silane coupling agent may be added to the liquid crystal composition for the purpose of controlling the adhesion with the substrate or the like. Examples of the silane coupling agent include vinyltrialkoxysilane, 3-isocyanatopropyltriethoxysilane, N- (2-aminoethyl) 3-aminopropyltrialkoxysilane, N- (1,3-dimethylbutylidene ) Trialkoxysilyl) -1-propanamine, 3-glycidoxypropyltrialkoxysilane, 3-chlorotrialkoxysilane, 3-acryloxypropyltrimethoxysilane, 3-methacryloxypropyltrialkoxy And silane. Further, dialkoxymethylsilane in which one of the alkoxy groups (3) in the alkoxysilane is substituted with methyl can also be used as a silane coupling agent. These silane coupling agents may be used alone or in admixture of two or more. These silane coupling agents may be commercially available products.
본 발명의 액정 조성물은, 도포를 용이하게 하기 위하여, 용제를 사용하여 액정 조성물을 희석하거나, 또는 용제에 액정 조성물의 각 성분을 용해하여, 액정 조성물과 용제로 이루어지는 액정 조성물의 용액을 조제하고, 이 용액을 도포해도 된다. 용제로서는, 예를 들면, 에스테르계 용제, 아미드계 용제, 알코올계 용제, 에테르계 용제, 글리콜모노알킬에테르계 용제, 방향족 탄화수소계 용제, 할로겐화 방향족 탄화수소계 용제, 지방족 탄화수소계 용제, 할로겐화 지방족 탄화수소계 용제, 지환식 탄화수소계 용제, 케톤계 용제, 및 아세테이트계 용제 등이 있다.The liquid crystal composition of the present invention is prepared by diluting the liquid crystal composition using a solvent or dissolving each component of the liquid crystal composition in a solvent to prepare a solution of a liquid crystal composition comprising a liquid crystal composition and a solvent, This solution may be applied. Examples of the solvent include ester solvents, amide solvents, alcohol solvents, ether solvents, glycol monoalkyl ether solvents, aromatic hydrocarbon solvents, halogenated aromatic hydrocarbon solvents, aliphatic hydrocarbon solvents, halogenated aliphatic hydrocarbon solvents Solvents, alicyclic hydrocarbon solvents, ketone solvents, and acetate solvents.
에스테르계 용제로서는, 아세트산 알킬(예: 아세트산 메틸, 아세트산 에틸, 아세트산 프로필, 아세트산 이소프로필, 아세트산 부틸, 아세트산 3-메톡시부틸, 아세트산 이소부틸, 아세트산 펜틸 및 아세트산 이소펜틸), 트리플루오로아세트산 에틸, 프로피온산 알킬(예: 프로피온산 메틸, 3-메톡시프로피온산 메틸, 프로피온산 에틸, 프로피온산 프로필 및 프로피온산 부틸), 부티르산 알킬(예: 부티르산 메틸, 부티르산 에틸, 부티르산 부틸, 부티르산 이소부틸 및 부티르산 프로필), 말론산 디알킬(예: 말론산 디에틸), 글리콜산 알킬(예: 글리콜산 메틸 및 글리콜산 에틸), 락트산 알킬(예: 락트산 메틸, 락트산 에틸, 락트산 이소프로필, 락트산 n-프로필, 락트산 부틸 및 락트산 에틸헥실), 모노아세틴, γ-부티로락톤 및 γ-발레로락톤 등이 바람직하다.Examples of the ester solvent include alkyl acetates such as methyl acetate, ethyl acetate, propyl acetate, isopropyl acetate, butyl acetate, 3-methoxybutyl acetate, isobutyl acetate, pentyl acetate and isopentyl acetate, ethyl trifluoroacetate , Alkyl propionates such as methyl propionate, methyl 3-methoxypropionate, ethyl propionate, propyl propionate and butyl propionate, alkyl butyrates such as methyl butyrate, butyl butyrate, isobutyl butyrate and butyrate propyl, Alkyl alcohols such as methyl lactate, diethyl malonate, alkyl glycolates such as methyl glycolate and ethyl glycolate, alkyl lactates such as methyl lactate, ethyl lactate, isopropyl lactate, n-propyl lactate, Ethylhexyl), monoacetin,? -Butyrolactone and? -Valerolactone, and the like are preferable.
아미드계 용제로서는, N-메틸-2-피롤리돈, N,N-디메틸아세트아미드, N-메틸프로피온아미드, N,N-디메틸포름아미드, N,N-디에틸포름아미드, N,N-디에틸아세트 아미드, N,N-디메틸아세트아미드디메틸아세탈, N-메틸카프로락탐 및 디메틸이미다졸리디논 등이 바람직하다.Examples of the amide solvent include N, N-dimethylacetamide, N, N-dimethylformamide, N, N-diethylformamide, N, N- Diethylacetamide, N, N-dimethylacetamide dimethylacetal, N-methylcaprolactam, and dimethylimidazolidinone are preferable.
알코올계 용제로서는, 메탄올, 에탄올, 1-프로판올, 2-프로판올, 1-메톡시-2-프로판올, tert-부틸 알코올, sec-부틸 알코올, 부탄올, 2-에틸 부탄올, n-헥사노르, n-헵탄올, n-옥탄올, 1-도데칸올, 에틸헥산올, 3,5,5-트리메틸헥산올, n-아밀알코올, 헥사플루오로-2-프로판올, 글리세린, 에틸렌글리콜, 디에틸렌글리콜, 트리에틸렌글리콜, 테트라에틸렌글리콜, 프로필렌글리콜, 디프로필렌글리콜, 트리프로필렌글리콜, 헥실렌글리콜, 1,3-부탄디올, 1,4-부탄디올, 2,3-부탄디올, 1,5-펜탄디올, 2,4-펜탄 디올, 2,5-헥산디올, 3-메틸-3-메톡시부탄올, 시클로헥산올 및 메틸시클로헥산올 등이 바람직하다.Examples of the alcohol solvents include alcohols such as methanol, ethanol, 1-propanol, 2-propanol, 1-methoxy-2-propanol, tert -butyl alcohol, sec-butyl alcohol, Propanol, glycerin, ethylene glycol, diethylene glycol, triethylene glycol, triethylene glycol, triethylene glycol, triethylene glycol, triethylene glycol, Ethylene glycol, tetraethylene glycol, propylene glycol, dipropylene glycol, tripropylene glycol, hexylene glycol, 1,3-butanediol, 1,4-butanediol, 2,3-butanediol, - pentanediol, 2,5-hexanediol, 3-methyl-3-methoxybutanol, cyclohexanol and methylcyclohexanol are preferred.
에테르계 용제로서는, 에틸렌글리콜디메틸에테르, 디에틸렌글리콜디메틸에테르, 비스(2-프로필)에테르, 1,4-디옥산 및 테트라하이드로퓨란(THF) 등이 바람직하다.As the ether solvent, ethylene glycol dimethyl ether, diethylene glycol dimethyl ether, bis (2-propyl) ether, 1,4-dioxane and tetrahydrofuran (THF) are preferable.
글리콜모노알킬에테르계 용제로서는, 에틸렌글리콜모노알킬 에테르(예: 에틸렌글리콜모노메틸에테르 및 에틸렌글리콜모노부틸에테르), 디에틸렌글리콜모노알킬에테르(예: 디에틸렌글리콜모노에틸에테르), 트리에틸렌글리콜모노알킬에테르, 프로필렌글리콜모노알킬에테르(예: 프로필렌글리콜모노부틸에테르), 디프로필렌글리콜모노알킬에테르(예: 디프로필렌글리콜모노메틸에테르), 에틸렌글리콜모노알킬에테르아세테이트(예: 에틸렌글리콜모노부틸에테르아세테이트), 디에틸렌글리콜모노알킬에테르아세테이트(예: 디에틸렌글리콜모노에틸에테르아세테이트), 트리에틸렌글리콜모노알킬에테르아세테이트, 프로필렌글리콜모노알킬에테르아세테이트(예: 프로필렌글리콜모노메틸에테르아세테이트, 프로필렌글리콜모노에틸에테르아세테이트 및 프로필렌글리콜모노부틸에테르아세테이트), 디프로필렌글리콜모노알킬에테르아세테이트(예: 디프로필렌글리콜모노메틸에테르아세테이트), 및 디에틸렌글리콜메틸에틸에테르 등이 바람직하다.Examples of the glycol monoalkyl ether solvents include ethylene glycol monoalkyl ethers (e.g., ethylene glycol monomethyl ether and ethylene glycol monobutyl ether), diethylene glycol monoalkyl ethers (e.g., diethylene glycol monoethyl ether), triethylene glycol mono Alkyl ethers such as propylene glycol monoalkyl ethers such as propylene glycol monobutyl ether, dipropylene glycol monoalkyl ethers such as dipropylene glycol monomethyl ether, ethylene glycol monoalkyl ether acetates such as ethylene glycol monobutyl ether acetate ), Diethylene glycol monoalkyl ether acetates (e.g., diethylene glycol monoethyl ether acetate), triethylene glycol monoalkyl ether acetates, propylene glycol monoalkyl ether acetates (e.g., propylene glycol monomethyl ether acetate, propylene glycol monoethyl ether Acetate and Propylene glycol monobutyl ether acetate), dipropylene glycol monoalkyl ether acetate (e.g., dipropylene glycol monomethyl ether acetate), and diethylene glycol methyl ethyl ether.
방향족 탄화수소계 용제로서는, 벤젠, 톨루엔, 크실렌, 메시틸렌, 에틸벤젠, 디에틸벤젠, i-프로필 벤젠, n-프로필 벤젠, tert-부틸 벤젠, sec-부틸 벤젠, n-부틸 벤젠, 및 테트랄린이다. 할로겐화 방향족 탄화수소계 용제의 바람직한 예는 클로로벤젠 등이 바람직하다. 지방족 탄화수소계 용제로서는, 헥산 및 헵탄 등이 바람직하다. 할로겐화 지방족 탄화수소계 용제로서는, 클로로포름, 디클로로메탄, 사염화탄소, 디클로로에탄, 트리클로로에틸렌 및 테트라클로로에틸렌 등이 바람직하다. 지환식 탄화수소계 용제로서는, 시클로헥산 및 데칼린 등이 바람직하다.Examples of the aromatic hydrocarbon solvents include benzene, toluene, xylene, mesitylene, ethylbenzene, diethylbenzene, i-propylbenzene, n-propylbenzene, tert-butylbenzene, sec- It is Lin. Preferable examples of the halogenated aromatic hydrocarbon solvents are chlorobenzene and the like. As the aliphatic hydrocarbon solvent, hexane, heptane and the like are preferable. As the halogenated aliphatic hydrocarbon solvent, chloroform, dichloromethane, carbon tetrachloride, dichloroethane, trichlorethylene, tetrachlorethylene and the like are preferable. As the alicyclic hydrocarbon solvent, cyclohexane and decalin are preferable.
케톤계 용제로서는, 아세톤, 메틸에틸케톤, 메틸이소부틸케톤, 시클로헥사논, 시클로펜타논, 및 메틸프로필케톤 등이 바람직하다.As the ketone solvent, acetone, methyl ethyl ketone, methyl isobutyl ketone, cyclohexanone, cyclopentanone, methyl propyl ketone and the like are preferable.
아세테이트계 용제로서는, 에틸렌글리콜모노메틸에테르아세테이트, 프로필렌글리콜모노메틸에테르아세테이트, 프로필렌글리콜모노에틸에테르아세테이트, 아세토아세트산 메틸, 및 1-메톡시-2-프로필아세테이트 등이 바람직하다.As the acetate solvent, ethylene glycol monomethyl ether acetate, propylene glycol monomethyl ether acetate, propylene glycol monoethyl ether acetate, methyl acetoacetate, 1-methoxy-2-propyl acetate and the like are preferable.
액정 화합물의 용해성의 관점에서는, 아미드계 용제, 방향족 탄화수소계, 케톤계 용제의 사용이 바람직하고, 용제의 비점(沸点)을 고려하면, 에스테르계 용제, 알코올계 용제, 에테르계 용제, 글리콜모노알킬에테르계 용제의 병용하는 것도 바람직하다. 용제의 선택에 대하여 특별히 제한은 없지만, 지지 기재(基材)로서 플라스틱 기판을 사용하는 경우에는, 기판의 변형을 방지하기 위해 건조 온도를 낮게 하고, 및 용제가 기판을 침식하지 않도록 할 필요가 있다. 이와 같은 경우에 바람직하게 사용되는 용제로서는, 방향족 탄화수소계 용제, 케톤계 용제, 에스테르계 용제, 에테르계 용제, 알코올계 용제, 아세테이트계 용제, 글리콜모노알킬에테르계 용제이다.From the viewpoint of the solubility of the liquid crystal compound, it is preferable to use an amide type solvent, an aromatic hydrocarbon type or a ketone type solvent. In consideration of the boiling point of the solvent, ester type solvents, alcohol type solvents, ether type solvents, glycol monoalkyl It is also preferable to use an ether type solvent in combination. There is no particular limitation on the choice of the solvent. However, when a plastic substrate is used as the substrate, it is necessary to lower the drying temperature and prevent the substrate from eroding the substrate in order to prevent deformation of the substrate . The solvent preferably used in this case is an aromatic hydrocarbon solvent, a ketone solvent, an ester solvent, an ether solvent, an alcohol solvent, an acetate solvent or a glycol monoalkyl ether solvent.
액정 조성물의 용액에서의 고형분의 비율은, 이 용액의 전체 중량을 기준으로 5∼70 중량%이다. 이 비율의 바람직한 범위는 10∼50 중량%이며, 더욱 바람직한 범위는 10∼40 중량%이다. 이들 용제는 단독으로 사용할 수도 있고, 2개 이상을 혼합하여 사용할 수도 있다. 이들 용제는 시판품이라도 된다.The proportion of the solid content in the solution of the liquid crystal composition is 5 to 70% by weight based on the total weight of the solution. A preferable range of this ratio is 10 to 50 wt%, and a more preferable range is 10 to 40 wt%. These solvents may be used alone or in admixture of two or more. These solvents may be commercially available products.
이하의 설명에서는, 액정 조성물을 중합하여 얻어지는 중합체(광학 이방성 필름)를 액정 필름이라고 하는 경우가 있다. 액정 필름은, 다음과 같이 하여 얻을 수 있다. 먼저, 액정 조성물을 유동성이 있는 상태에서 지지 기판 상에 도포하여, 도막을 형성한다. 액정 조성물의 용액을 조제한 경우에는, 지지 기판 상에 도포하고, 이것을 건조시켜 도막을 형성한다. 그 도막에 광 조사하여 액정 조성물을 중합시키고, 도막 중의 조성물이 액정 상태에서 형성하는 네마틱 배향을 고정화한다. 사용할 수 있는 지지 기판의 재질로서는, 유리 및 플라스틱 등을 예로 들 수 있다. 플라스틱으로서는, 폴리이미드, 폴리아미드이미드, 폴리아미드, 폴리에테르이미드, 폴리에테르에테르케톤, 폴리에테르케톤, 폴리케톤술피드, 폴리에테르술폰, 폴리술폰, 폴리페닐렌술피드, 폴리페닐렌옥사이드, 폴리에틸렌테레프탈레이트, 폴리부틸렌테레프탈레이트, 폴리에틸렌나프탈레이트, 폴리아세탈, 폴리카보네이트, 폴리아릴레이트, 아크릴 수지, 폴리비닐알코올, 폴리프로필렌, 셀룰로오스, 트리아세틸셀룰로오스 및 그 부분 비누화물, 에폭시 수지, 페놀 수지, 및 시클로올레핀계 수지 등을 예로 들 수 있다. 지지 기판은, 통상 시트형 또는 필름형이다.In the following description, a polymer (optically anisotropic film) obtained by polymerizing a liquid crystal composition is sometimes referred to as a liquid crystal film. The liquid crystal film can be obtained as follows. First, the liquid crystal composition is applied on a support substrate in a fluid state to form a coating film. When a solution of a liquid crystal composition is prepared, it is coated on a support substrate and dried to form a coating film. The coating film is irradiated with light to polymerize the liquid crystal composition, and the nematic alignment formed in the liquid crystal state of the composition in the coating film is fixed. Examples of the material of the usable support substrate include glass and plastic. Examples of the plastic include polyimide, polyamideimide, polyamide, polyetherimide, polyetheretherketone, polyetherketone, polyketone sulfide, polyether sulfone, polysulfone, polyphenylene sulfide, polyphenylene oxide, polyethylene terephthalate Polybutylene terephthalate, polyethylene naphthalate, polyacetal, polycarbonate, polyarylate, acrylic resin, polyvinyl alcohol, polypropylene, cellulose, triacetylcellulose and its partial saponification, epoxy resin, phenolic resin, and Cycloolefin-based resins, and the like. The supporting substrate is usually a sheet or film type.
시클로올레핀계 수지로서 노르보르넨계 수지, 디시클로펜타디엔계 수지 등을 예로 들 수 있지만, 이들로 한정되지 않는다. 이들 중에서, 불포화 결합을 가지지 않거나, 또는 불포화 결합이 수소 첨가된 것이 바람직하게 사용된다. 예를 들면, 1종 또는 2종 이상의 노르보르넨계 모노머의 개환 (공)중합체의 수소 첨가물, 1종 또는 2종 이상의 노르보르넨계 모노머의 부가 (공)중합체, 노르보르넨계 모노머와 올레핀계 모노머(에틸렌 등의 α-올레핀)와의 부가 공중합체, 노르보르넨계 모노머와 시클로올레핀계 모노머(시클로펜텐, 시클로옥텐, 5,6-디하이드로디시클로펜타디엔 등)와의 부가 공중합체, 및 이들의 변성물 등이 있으며, 구체적으로는, ZEONEX, ZEONOR(모두 상품명, 일본 제온(주) 제조), ARTON(상품명, JSR(주) 제조), TOPAS(상품명, 티코나사 제조), APEL(상품명, 미쓰이화학(주) 제조), 에스시나(상품명, 세키스이 화학공업(주) 제조), OPTOREZ(상품명, 히타치 화성(주) 제조)를 예로 들 수 있다. Examples of the cycloolefin-based resin include norbornene-based resins and dicyclopentadiene-based resins, but are not limited thereto. Of these, those having no unsaturated bond or having an unsaturated bond hydrogenated are preferably used. For example, hydrogenated products of ring-opening (co) polymers of one or more norbornene monomers, addition (co) polymers of one or more norbornene monomers, copolymers of norbornene monomers and olefin monomers ( An addition copolymer of a norbornene monomer and a cycloolefin monomer (cyclopentene, cyclooctene, 5,6-dihydrodicyclopentadiene, etc.), and a modified product thereof Specific examples thereof include ZEONEX, ZEONOR (all trade names, manufactured by Nippon Zeon), ARTON (trade name, manufactured by JSR Corporation), TOPAS (trade name, manufactured by Tico Corporation), APEL (Trade name, manufactured by Sekisui Chemical Co., Ltd.) and OPTOREZ (trade name, manufactured by Hitachi Chemical Co., Ltd.).
지지 기판으로서 사용할 수 있는 이들 플라스틱으로 이루어지는 필름(플라스틱 필름)은, 1축 연신 필름이라도 되고, 2축 연신 필름이라도 된다. 이들 필름은, 예를 들면, 코로나 처리나 플라즈마 처리 등의 친수화 처리, 또는 소수화 처리 등의 표면 처리를 행한 것이라도 된다. 친수화 처리 방법은 특별히 제한은 없지만, 코로나 처리 또는 플라즈마 처리가 바람직하고, 특히 바람직한 방법은 플라즈마 처리이다. 플라즈마 처리는, 일본공개특허 제2002-226616호 공보, 일본공개특허 제2002-121648호 공보 등에 기재되어 있는 방법을 사용해도 된다. 또한, 액정 필름과 플라스틱 필름과의 밀착성을 개량하기 위해 앵커 코팅층을 형성시켜도 된다. 이와 같은 앵커 코팅층은 액정 필름과 플라스틱 필름의 밀착성을 높이는 것이면, 무기계 재료, 유기계 재료 중 어느 것이라도 아무런 문제는 없다. 또한, 플라스틱 필름은 적층 필름이라도 된다. 플라스틱 필름 대신, 표면에 슬릿형의 홈이 형성된 알루미늄, 철, 동 등의 금속 기판이나, 표면이 슬릿형으로 에칭 가공된 알칼리 유리, 붕규산 유리, 납 유리 등의 유리 기판 등을 사용할 수도 있다.These plastic films (plastic films) which can be used as support substrates may be uniaxially stretched films or biaxially stretched films. These films may be subjected to surface treatment such as hydrophilization treatment such as corona treatment or plasma treatment or hydrophobic treatment. The hydrophilization treatment method is not particularly limited, but a corona treatment or a plasma treatment is preferable, and a particularly preferable method is a plasma treatment. As the plasma treatment, a method described in Japanese Unexamined Patent Application Publication No. 2002-226616 and Japanese Unexamined Patent Publication No. 2002-121648 may be used. An anchor coating layer may be formed to improve the adhesion between the liquid crystal film and the plastic film. Such an anchor coating layer may be either an inorganic material or an organic material as long as it enhances adhesion between the liquid crystal film and the plastic film. The plastic film may be a laminated film. Instead of the plastic film, a metal substrate such as aluminum, iron, or copper having a slit-shaped groove formed on its surface, or a glass substrate such as alkali glass, borosilicate glass, or lead glass whose surface has been subjected to a slit etching process may be used.
이들 유리 기판, 플라스틱 필름 등의 지지 기판에는, 액정 조성물의 도막 형성에 앞서, 호모지니어스 배향 및 하이브리드 배향의 액정 필름을 형성하는 경우에는, 러빙 등에 의한 물리적, 기계적인 표면 처리를 행한다. 호메오트로픽 배향의 액정 필름을 형성하는 경우에는 러빙 등의 표면 처리를 행하지 않는 경우가 많지만, 배향 결함 등을 방지하는 점에서 러빙 처리를 행할 수도 있다. 러빙 처리에는 임의의 방법을 채용할 수 있지만, 통상은 레이온, 면, 폴리아미드 등의 소재로 이루어지는 러빙포를 금속 롤 등에 권취하고, 지지 기판 또는 중합체 피막에 접한 상태로 롤을 회전시키면서 이동시키는 방법, 롤이 고정된 지지 기판측을 이동시키는 방법 등이 채용된다. 러빙 처리는 지지 기판에 직접 행해질 수도 있고, 또는 지지 기판 상에 사전에 일반적으로 배향막으로 불리는 폴리이미드 등의 중합체 피막을 형성하고, 그 중합체 피막에 러빙 처리를 행할 수도 있다. 러빙 처리 방법은 전술한 바와 같다. 지지 기판의 종류에 따라서는, 그 표면에 산화 규소를 경사 증착하여 배향능을 부여할 수도 있다.When a liquid crystal film of a homogeneous orientation or a hybrid orientation is formed on a support substrate such as a glass substrate or a plastic film prior to the formation of the coating film of the liquid crystal composition, physical and mechanical surface treatment by rubbing or the like is performed. In the case of forming a liquid crystal film of homeotropic orientation, surface treatment such as rubbing is often not performed, but rubbing treatment can also be performed in order to prevent alignment defects and the like. Any method can be employed for the rubbing treatment, but usually a method in which a rubbing cloth made of a material such as rayon, cotton or polyamide is wound on a metal roll or the like, and the roll is rotated while being in contact with the support substrate or the polymer film , A method of moving the support substrate side on which the roll is fixed, and the like. The rubbing treatment may be carried out directly on the support substrate, or a polymer film such as polyimide, which is generally referred to as an orientation film, may be formed on the support substrate in advance, and the polymer film may be rubbed. The rubbing treatment method is as described above. Depending on the type of the support substrate, the silicon oxide may be deposited on the surface of the support substrate in an oblique manner to give the alignment ability.
또한, 호모지니어스 배향 및 하이브리드 배향의 액정 필름을 형성하는 경우에는, 러빙 등에 의한 물리적, 기계적인 표면 처리를 행하는 것 이외에, 지지 기판 상에 사전에 일반적으로 광 배향막으로 불리는 폴리이미드나 폴리아크릴레이트 등의 중합체 피막을 형성하고, 그 중합체 피막에 편광 UV 처리를 행할 수도 있다.In addition, in the case of forming a liquid crystal film of homogeneous alignment and hybrid alignment, in addition to performing physical and mechanical surface treatment by rubbing or the like, polyimide, polyacrylate, or the like, which is generally called a photo alignment film, And a polarizing UV treatment may be applied to the polymer coating.
액정 조성물 또는 그 용액을 도포할 때, 균일한 막 두께를 얻기 위한 도포 방법의 예는, 스핀 코팅법, 마이크로 그라비아 코팅법, 그라비아 코팅법, 와이어 바 코팅법, 디핑(dipping) 코팅법, 스프레이 코팅법, 메니스커스 코팅법 및 다이(die) 코팅법이다. 특히, 도포시에 액정 조성물 전단(剪斷) 응력이 걸리는 와이어 바 코팅법 등을, 러빙 등에 의한 기판의 표면 처리를 행하지 않고 액정 조성물의 배향을 제어하는 경우에 사용할 수도 있다.Examples of a coating method for obtaining a uniform film thickness when applying the liquid crystal composition or its solution include spin coating method, micro gravure coating method, gravure coating method, wire bar coating method, dipping coating method, spray coating A meniscus coating method, and a die coating method. In particular, it may be used in a case where the orientation of the liquid crystal composition is controlled without performing surface treatment of the substrate by rubbing or the like, such as a wire bar coating method in which a shearing stress is applied to a liquid crystal composition at the time of application.
본 발명의 액정 조성물의 용액을 도포할 때, 도포 후에 지지 기판 상에 막 두께가 균일한 중합성 액정층, 즉 액정 조성물의 층을 형성시키기 위하여, 열처리를 행해도 된다. 열처리는, 핫 플레이트나, 건조노, 온풍이나 열풍의 분사 등을 이용할 수 있다.When applying the solution of the liquid crystal composition of the present invention, heat treatment may be performed after the application to form a polymerizable liquid crystal layer, that is, a liquid crystal composition layer having a uniform film thickness on the support substrate. As the heat treatment, a hot plate, a drying furnace, hot air or hot air spraying can be used.
도막을 열처리할 때의 온도 및 시간, 광조사에 사용되는 광의 파장, 광원으로부터 조사하는 광의 양 등은, 액정 조성물에 사용하는 화합물의 종류와 조성비, 광중합 개시제의 첨가의 유무나 그 첨가량 등에 따라, 바람직한 범위가 상이하다. 따라서, 이하에서 설명하는 도막의 열처리의 온도 및 시간, 광조사에 사용되는 광의 파장, 및 광원으로부터 조사하는 광의 양에 대한 조건은, 어디까지나 대략의 범위를 나타낸 것이다.The temperature and time at the time of heat treatment of the coating film, the wavelength of light used for light irradiation, the amount of light irradiated from the light source, and the like depend on the type and composition ratio of the compound used in the liquid crystal composition, the presence or absence of addition of a photopolymerization initiator, The preferred ranges are different. Therefore, the conditions for the temperature and time of the heat treatment of the coating film, the wavelength of the light used for the light irradiation, and the amount of the light irradiated from the light source, which will be described below,
도막의 열처리는, 중합성 액정의 균일 배향성을 얻을 수 있는 조건 하에서 행하는 것이 바람직하다. 액정 조성물의 액정 상전이점(相轉移点) 이상에서 행할 수도 있다. 열처리 방법의 일례는, 상기 액정 조성물이 네마틱 액정상을 나타내는 온도까지 도막을 가온하여, 도막 중의 액정 조성물에 네마틱 배향을 형성하는 방법이다. 액정 조성물이 네마틱 액정상을 나타내는 온도 범위 내에서, 도막의 온도를 변화시킴으로써 네마틱 배향을 형성시킬 수도 있다. 이 방법은, 상기 온도 범위의 고온역까지 도막을 가온함으로써 도막 중에 네마틱 배향을 거의 완성시키고, 이어서, 온도를 저하시킴으로써 더욱 질서있는 배향으로 하는 방법이다. 상기한 어느쪽의 열처리 방법을 채용하는 경우라도, 열처리 온도는 실온∼120℃이다. 이 온도의 바람직한 범위는 실온∼80℃이며, 더욱 바람직한 범위는 실온∼60℃이다. 열처리 시간은 5초∼2시간이다. 이 시간의 바람직한 범위는 10초∼40분이며, 더욱 바람직한 범위는 20초∼20분이다. 액정 조성물로 이루어지는 층의 온도를 소정의 온도까지 상승시키기 위해서는, 열처리 시간을 5초 이상으로 하는 것이 바람직하다. 생산성을 저하시키지 않기 위해서는, 열처리 시간을 2시간 이내로 하는 것이 바람직하다. 이와 같이 하여 본 발명의 중합성 액정층을 얻을 수 있다.The heat treatment of the coating film is preferably performed under a condition that uniform orientation of the polymerizable liquid crystal can be obtained. But may be performed at a liquid crystal phase transition point or more of the liquid crystal composition. One example of the heat treatment method is a method in which the coating film is heated to a temperature at which the liquid crystal composition exhibits a nematic liquid crystal phase to form a nematic orientation in the liquid crystal composition in the coating film. The nematic orientation may be formed by changing the temperature of the coating film within a temperature range in which the liquid crystal composition exhibits a nematic liquid crystal phase. This method is a method in which a nematic orientation is almost completed in the coating film by warming the coating film to a high temperature region within the above-mentioned temperature range, and then the temperature is lowered to make the orientation more orderly. In any of the heat treatment methods described above, the heat treatment temperature is from room temperature to 120 占 폚. The preferable range of the temperature is from room temperature to 80 deg. C, more preferably from room temperature to 60 deg. The heat treatment time is 5 seconds to 2 hours. The preferred range of this time is from 10 seconds to 40 minutes, more preferably from 20 seconds to 20 minutes. In order to raise the temperature of the layer made of the liquid crystal composition to a predetermined temperature, it is preferable to set the heat treatment time to 5 seconds or more. In order not to lower the productivity, it is preferable to set the heat treatment time within 2 hours. Thus, the polymerizable liquid crystal layer of the present invention can be obtained.
중합성 액정층 중에 형성된 액정 화합물의 네마틱 배향 상태는, 이 액정 화합물을 광조사에 의해 중합시킴으로써 고정화된다. 광조사에 사용되는 광의 파장은 특별히 한정되지 않는다. 전자선, 자외선, 가시광선, 적외선(열선) 등을 이용할 수 있다. 통상은, 자외선 또는 가시광선을 이용하면 된다. 파장의 범위는 150∼500 ㎚이다. 바람직한 범위는 250∼450 ㎚이며, 더욱 바람직한 범위는 300∼400 ㎚이다. 광원의 예는, 저압 수은 램프(살균 램프, 형광 케미컬 램프, 블랙 라이트), 고압 방전 램프(고압 수은 램프, 메탈 할라이드 램프), 쇼트 아크 방전 램프(초고압 수은 램프, 크세논 램프, 수은 크세논 램프)이다. 광원의 바람직한 예는, 메탈 할라이드 램프나 크세논 램프, 초고압 수은 램프 및 고압 수은 램프이다. 광원과 중합성 액정층의 사이에 필터 등을 설치하여 특정한 파장 영역만을 통과시킴으로써, 조사광원의 파장 영역을 선택할 수도 있다. 광원으로부터 조사하는 광량은, 도막면 도달 시에 2∼5000 mJ/cm2이다. 광량의 바람직한 범위는 10∼3000 mJ/cm2이며, 더욱 바람직한 범위는 100∼2000 mJ/cm2이다. 광조사 시의 온도 조건은, 상기한 열처리 온도와 동일하게 설정되는 것이 바람직하다. 또한, 중합 환경의 분위기는 질소 분위기, 불활성 가스 분위기, 공기 분위기 중 어느 하나라도 되지만, 질소 분위기 또는 불활성 가스 분위기가 경화성을 향상시키는 관점에서 바람직하다.The nematic alignment state of the liquid crystal compound formed in the polymerizable liquid crystal layer is fixed by polymerizing this liquid crystal compound by light irradiation. The wavelength of light used for light irradiation is not particularly limited. An electron beam, an ultraviolet ray, a visible ray, and an infrared ray (hot line). Usually, ultraviolet rays or visible rays may be used. The wavelength ranges from 150 to 500 nm. A preferable range is 250 to 450 nm, and a more preferable range is 300 to 400 nm. Examples of light sources are low pressure mercury lamps (sterilization lamps, fluorescent chemical lamps, black lights), high pressure discharge lamps (high pressure mercury lamps, metal halide lamps), short arc discharge lamps (ultra high pressure mercury lamps, xenon lamps, mercury xenon lamps) . Preferable examples of the light source include a metal halide lamp, a xenon lamp, an ultra-high pressure mercury lamp, and a high-pressure mercury lamp. A wavelength region of the irradiation light source can also be selected by passing a specific wavelength region through a filter or the like between the light source and the polymerizable liquid crystal layer. The amount of light irradiated from the light source is 2 to 5000 mJ / cm < 2 > A preferable range of the light amount is 10 to 3000 mJ / cm 2 , and a more preferable range is 100 to 2000 mJ / cm 2 . The temperature condition at the time of light irradiation is preferably set equal to the above-mentioned heat treatment temperature. The atmosphere of the polymerization environment may be any one of a nitrogen atmosphere, an inert gas atmosphere, and an air atmosphere, but a nitrogen atmosphere or an inert gas atmosphere is preferable from the viewpoint of improving curability.
본 발명의 중합성 액정층, 및 이것을 광이나 열등에 의해 중합시킨 액정 필름을 다양한 광학 소자에 사용하는 경우, 또는 액정 표시 장치에 사용하는 광학 보상 소자로서 적용하는 경우에는, 두께 방향에서의 틸트각의 분포의 제어가 극히 중요하게 된다.When the polymerizable liquid crystal layer of the present invention and a liquid crystal film obtained by polymerizing the polymerizable liquid crystal layer by light or heat are used for various optical elements or as an optical compensation element for use in liquid crystal display devices, It becomes extremely important to control the distribution.
틸트각을 제어하는 방법 중 하나는, 액정 조성물에 사용하는 액정 화합물의 종류나 조성비 등을 조정하는 방법이다. 이 액정 조성물에 다른 성분을 첨가함으로써도, 틸트각을 제어할 수 있다. 액정 필름의 틸트각은, 액정 조성물 중의 용제의 종류나 용질 농도, 다른 성분의 하나로서 가하는 계면활성제의 종류나 첨가량 등에 의해서도 제어할 수 있다. 지지 기판 또는 중합체 피막의 종류나 러빙 조건, 액정 조성물의 도막의 건조 조건이나 열처리 조건 등에 의해서도, 액정 필름의 틸트각을 제어할 수 있다. 또한, 배향 후의 광중합 공정에서의 조사 분위기나 조사 시의 온도 등도 액정 필름의 틸트각에 영향을 미친다. 즉, 액정 필름의 제조 프로세스에서의 거의 모든 조건이 약간이라도 틸트각에 영향을 미치는 것으로 생각해도 된다. 따라서, 액정 조성물의 최적화와 함께, 액정 필름의 제조 프로세스의 여러 조건을 적절하게 선택함으로써, 임의의 틸트각으로 할 수 있다.One of the methods for controlling the tilt angle is a method of adjusting the kind, the composition ratio, and the like of the liquid crystal compound used in the liquid crystal composition. The tilt angle can also be controlled by adding other components to the liquid crystal composition. The tilt angle of the liquid crystal film can be controlled also by the kind of the solvent in the liquid crystal composition, the concentration of the solute, and the type and amount of the surfactant to be added as another component. The tilt angle of the liquid crystal film can be controlled also by the kind of the support substrate or the polymer film, the rubbing condition, the drying condition of the coating film of the liquid crystal composition, the heat treatment condition and the like. In addition, the irradiation atmosphere and the temperature at the time of irradiation in the photopolymerization step after orientation also affect the tilt angle of the liquid crystal film. That is, almost all conditions in the manufacturing process of the liquid crystal film may be considered to affect the tilt angle even slightly. Accordingly, arbitrary tilt angle can be obtained by appropriately selecting various conditions of the liquid crystal film production process together with optimization of the liquid crystal composition.
호모지니어스 배향은, 틸트각이 기판 계면으로부터 자유계면에 걸쳐 균일하게 0° 근처, 특히 0∼5 °에 분포되어 있다. 이 배향 상태는, 본 발명의 액정 조성물을, 러빙 등의 표면 처리를 행한 지지 기판 표면에 도포하고, 도막을 형성함으로써 얻어진다.The homogeneous orientation is such that the tilt angle is uniformly distributed near 0 deg., Particularly 0 deg. To 5 deg., From the substrate interface to the free interface. This alignment state is obtained by applying the liquid crystal composition of the present invention to the surface of a support substrate subjected to a surface treatment such as rubbing to form a coating film.
본 발명의 액정 조성물에는 키랄인 화합물, 즉 광학 활성을 가지는 화합물을 첨가할 수도 있다. 광학 활성화합물의 적합예는, 식(Op-1)∼(Op-25)으로 표시되는 화합물이다. 이들 식에 있어서, Ak는 탄소수 1∼15의 알킬 또는 탄소수 1∼15의 알콕시를, Me, Et 및 Ph는 각각, 메틸, 에틸 및 페닐을 나타낸다. P2는 중합성 기이며, (메타)아크릴로일옥시, 비닐옥시, 옥시라닐, 또는 옥세타닐을 포함하는 기인 것이 바람직하다. 본 발명의 액정 조성물은 이하에서 설명하는 중합체의 원료로서 사용하는 것 외에, 액정 표시 소자의 구성 요소인 액정으로서 사용할 수도 있다.A chiral compound, that is, a compound having optical activity, may be added to the liquid crystal composition of the present invention. Examples of suitable optically active compounds are compounds represented by the formulas (Op-1) to (Op-25). In these formulas, Ak represents an alkyl of 1 to 15 carbon atoms or an alkoxy of 1 to 15 carbon atoms, and Me, Et and Ph represent methyl, ethyl and phenyl, respectively. P 2 is a polymerizable group, and is preferably a group containing (meth) acryloyloxy, vinyloxy, oxiranyl, or oxetanyl. The liquid crystal composition of the present invention can be used as a liquid crystal which is a component of a liquid crystal display element, in addition to being used as a raw material of the polymer described below.
[화학식 36](36)
[화학식 37](37)
구체예로서, 일본공개특허 제2011-148762호 공보의 p.70의 단락 0159∼p.81의 단락 0170에 기재된 것이 있다.As a specific example, there is one described in paragraph 0170 of paragraphs 0159 to 81 in p. 70 of Japanese Laid-Open Patent Publication No. 2011-148762.
광학 활성을 가지는 화합물을 적당량 함유한 액정 조성물, 또는 광학 활성을 가지는 중합성 화합물을 적당량 함유한 액정 조성물을, 배향 처리한 기판 상에 도포하여 중합함으로써, 나선 구조(트위스트 구조)를 나타낸 위상차 필름을 얻을 수 있다. 액정 조성물의 중합에 의해, 이 나선 구조가 고정된다. 얻어지는 액정 필름의 특성은, 얻어진 나선 구조의 나선 피치에 의존한다. 이 나선 피치 길이는, 광학 활성 화합물의 종류 및 첨가량에 의해 조정할 수 있다. 첨가하는 광학 활성 화합물은 1개라도 되지만, 나선 피치의 온도 의존성을 상쇄할 목적으로 복수의 광학 활성화합물을 사용할 수도 있다. 그리고, 액정 조성물에는, 광학 활성 화합물 외에, 그 외의 중합성 화합물이 포함될 수도 있다.A liquid crystal composition containing an optically active compound in an appropriate amount or a liquid crystal composition containing an optically active polymerizable compound in an appropriate amount is coated on a substrate subjected to orientation treatment and polymerized to form a retardation film exhibiting a helical structure Can be obtained. By polymerization of the liquid crystal composition, this helical structure is fixed. The properties of the resulting liquid crystal film depend on the helical pitch of the obtained helical structure. The length of the helix pitch can be adjusted by the kind of the optically active compound and the addition amount. There may be only one optically active compound to be added, but a plurality of optically active compounds may be used for the purpose of canceling the temperature dependency of the helical pitch. In addition to the optically active compound, the liquid crystal composition may contain other polymerizable compounds.
상기와 같은 액정 필름의 특성인 가시광의 선택 반사는, 나선 구조가 입사광에 작용하고, 원편광이나 타원 편광을 반사시키는 것이다. 선택 반사 특성은 λ=n·Pitch(λ는 선택 반사의 중심 파장, n은 평균 굴절율, Pitch는 나선 피치)로 표시되므로, n 또는 Pitch를 변경함으로써 중심 파장(λ) 및 파장폭(Δλ)을 적절하게 조정할 수 있다. 색 순도를 양호하게 하기 위해서는 파장폭(Δλ)을 작게 하면 되고, 광대역의 반사를 원할 때는 파장폭(Δλ)을 크게 하면 된다. 또한 이 선택 반사는 중합체의 두께의 영향도 많이 받는다. 색순도를 유지하기 위해서는, 두께가 지나치게 작아지지 않도록 해야만 한다. 균일한 배향성을 유지하기 위해서는, 두께가 지나치게 커지지 않도록 해야만 한다. 따라서, 적절한 두께의 조정이 필요하며, 0.5∼25 ㎛가 바람직하고, 1∼10 ㎛가 더욱 바람직하다.The selective reflection of visible light, which is a characteristic of the liquid crystal film, is such that the helical structure acts on incident light and reflects circularly polarized light or elliptically polarized light. Since the selective reflection characteristic is represented by λ = n · Pitch (λ is the central wavelength of selective reflection, n is the average refractive index, and Pitch is the helical pitch), the center wavelength λ and the wavelength width Δλ are changed by changing n or Pitch Can be adjusted appropriately. In order to improve the color purity, the wavelength width DELTA lambda can be made small, and when the wide band reflection is desired, the wavelength width DELTA lambda can be made large. This selective reflection is also greatly influenced by the thickness of the polymer. In order to maintain color purity, the thickness should not be too small. In order to maintain uniform orientation, the thickness must not be excessively large. Therefore, it is necessary to adjust the thickness appropriately, preferably 0.5 to 25 탆, more preferably 1 to 10 탆.
나선 피치를 가시광보다 더욱 짧게 함으로써, W. H. de Jeu, Physical Properties of Liquid Crystalline Materials, Gordon and Breach, New York(1980)에 기재된 네가티브형 C 플레이트(Negative C plate)를 조제할 수 있다. 나선 피치를 짧게 하기 위해서는, 비틀림력(HTP: 헬리컬·트위스팅·파워)이 큰 광학 활성화합물을 사용하고, 또한 그 첨가량을 증가시킴으로써 달성할 수 있다. 구체적으로는λ를 350 ㎚ 이하, 바람직하게는 200 ㎚ 이하로 함으로써, 네가티브형 C 플레이트를 조제할 수 있다. 이 네가티브형 C 플레이트는 액정 표시 소자 중 VAN형, VAC형, OCB형 등의 표시 소자에 적합한 광학 보상막이 된다.Negative C plate (Negative C plate) described in W. H. de Jeu, Physical Properties of Liquid Crystalline Materials, Gordon and Breach, New York (1980) can be prepared by making the spiral pitch shorter than visible light. In order to shorten the helical pitch, it can be achieved by using an optically active compound having a large twisting force (HTP: helical twisting power) and increasing the addition amount thereof. Concretely, by setting λ to 350 nm or less, preferably 200 nm or less, a negative C plate can be prepared. This negative type C plate is an optical compensation film suitable for a display element such as a VAN type, a VAC type or an OCB type of liquid crystal display element.
액정 필름은, 나선 피치를 가시광보다 길게함으로써 일본공개특허 제2004-333671호 공보에 기재되어 있는 반사파장 영역을 근적외(파장 800∼2500 ㎚)로 설정한 반사 필름에 사용할 수 있다. 나선 피치를 길게 하기 위해서는, 예를 들면, 비틀림력이 작은 광학 활성 화합물을 사용하고, 또는 광학 활성 화합물의 첨가량을 감소시킴으로써 달성할 수 있다.The liquid crystal film can be used for a reflective film whose reflection wavelength range described in Japanese Laid-Open Patent Publication No. 2004-333671 is set to near infrared (wavelength 800 to 2500 nm) by making the spiral pitch longer than visible light. In order to lengthen the spiral pitch, for example, it can be achieved by using an optically active compound having a small twisting force or by decreasing the amount of the optically active compound to be added.
상기 광학 활성화합물은, 나선 구조를 유도하고, 베이스가 되는 액정 조성물과 적절하게 혼합할 수 있으면, 어떤 광학 활성 화합물을 사용해도 된다. 또한, 중합성 화합물에서도 비중합성 화합물 중 어느 것이라도 되고, 목적에 따라 최적 화합물을 첨가할 수 있다. 내열성 및 내용제성을 고려한 경우, 중합성 화합물인 것이 바람직하다.The optically active compound may be any optically active compound as long as it can induce the helical structure and suitably mix with the liquid crystal composition serving as the base. Further, any of the polymerizable compound and the non-polymerizable compound may be used, and an optimum compound may be added according to the purpose. In consideration of heat resistance and solvent resistance, a polymerizable compound is preferable.
또한 상기 광학 활성화합물 중에서도, 비틀림력(HTP: 헬리컬·트위스팅·파워)이 큰 것은, 나선 피치를 짧게 하는 데 있어서 바람직하다. 비틀림력이 큰 화합물의 대표예가, GB2298202호 공보, DE10221751호 공보에 개시되어 있다.Among the above-mentioned optically active compounds, a larger twist force (HTP: helical twisting power) is preferable for shortening the helical pitch. Representative examples of compounds having a large twisting force are disclosed in GB 2298202 and DE 10221751.
액정 필름의 두께(막 두께)는, 목적으로 하는 소자에 따른 리타데이션(retardation)이나 액정 필름의 복굴절율(광학 이방성의 값)에 따라 적절한 두께가 상이하다. 따라서, 두께의 범위는 목적마다 상이하지만, 기준은 0.05∼100 ㎛이다. 보다 바람직한 범위는 0.1∼50 ㎛이며, 더욱 바람직한 범위는 0.5∼20 ㎛이다. 액정 필름의 바람직한 헤이즈값은 1.5% 이하이며, 바람직한 투과율은 80% 이상이다. 더욱 바람직한 헤이즈값은 1.0% 이하이며, 더욱 바람직한 투과율은 95% 이상이다. 투과율은, 가시광 영역에서 이들 조건을 만족시키는 것이 바람직하다.The thickness (film thickness) of the liquid crystal film is different depending on the retardation depending on the intended device or the birefringence (optical anisotropy value) of the liquid crystal film. Therefore, although the range of the thickness varies from purpose to purpose, the standard is 0.05 to 100 mu m. A more preferred range is 0.1 to 50 占 퐉, and a more preferable range is 0.5 to 20 占 퐉. A preferable haze value of the liquid crystal film is 1.5% or less, and a preferable transmittance is 80% or more. A more preferable haze value is 1.0% or less, and a more preferable transmittance is 95% or more. It is preferable that the transmittance satisfies these conditions in the visible light region.
액정 필름의 복굴절율(광학 이방성이 값)이 높을수록 두께를 얇게 할 수 있다. 두께가 얇을수록 헤이즈값이나 투과율 등의 광학 특성은 양호해지는 경향이 있다.As the birefringence (the value of optical anisotropy) of the liquid crystal film is higher, the thickness can be reduced. The thinner the thickness, the better the optical characteristics such as the haze value and the transmittance tend to become better.
액정 필름은, 액정 표시 소자(특히, 액티브 매트릭스형 및 패시브 매트릭스형의 액정 표시 소자)에 적용하는 광학 보상 소자로서 유효하다. 이 액정 필름을 광학 보상막으로서 사용하기에 적합한 액정 표시 소자의 형의 예는, IPS형(인·플레인·스위칭), OCB형(광학적으로 보상된 복굴절), TN형(트위스티드·네마틱), STN형(슈퍼·트위스티드·네마틱), ECB형(전기적으로 제어된 복굴절), DAP형(정렬상(整列相)의 변형 효과), CSH형(컬러·슈퍼·호메오트로픽), VAN/VAC형(수직 배향한 네마틱/코레스테릭), OMI형(광학 모드 간섭), SBE형(초복굴절 효과) 등이 있다. 또한 게스트-호스트형, 강유전성형, 반강유전성형 등의 표시 소자용 위상 리타더(retarder)로서, 이 액정 필름을 사용할 수도 있다. 그리고, 액정 필름에 요구되는 틸트각의 두께 방향의 분포나 두께 등의 파라미터의 최적값은, 보상해야 할 액정 표시 소자의 종류와 그 광학 파라미터에 강하게 의존하므로, 소자의 종류에 따라 상이하다.The liquid crystal film is effective as an optical compensation element applied to a liquid crystal display element (in particular, an active matrix type and a passive matrix type liquid crystal display element). Examples of the liquid crystal display element type suitable for using this liquid crystal film as an optical compensation film include IPS type (in-plane switching), OCB type (optically compensated birefringence), TN type (twisted nematic) (Super twisted nematic), ECB type (electrically controlled birefringence), DAP type (deformation effect of alignment phase), CSH type (color super-homeotropic), VAN / VAC Type (nematic / cholesteric), OMI type (optical mode interference), SBE type (super birefringence effect), and the like. The liquid crystal film may also be used as a phase retarder for a display element such as a guest-host type, a ferroelectric molding, or an anti-ferroelectric molding. The optimal values of the parameters such as the thickness distribution in the thickness direction and the thickness required for the liquid crystal film depend strongly on the type of the liquid crystal display element to be compensated and the optical parameters thereof,
액정 필름은, 편광판 등과 일체로 한 광학 소자로서도 사용할 수 있고, 이 경우에는 액정 셀의 외측에 배치시킨다. 한편, 광학 보상 소자로서의 액정 필름은, 셀에 충전된 액정으로의 불순물의 용출이 없거나 또는 적기 때문에, 액정 셀의 내부에 배치시키는 것도 가능하다. 예를 들면, 일본공개특허 제2008-01943호 공보에 개시되어 있는 방법을 응용하면, 컬러 필터 상에 본 발명의 중합성 액정층을 형성함으로써 컬러 필터의 기능을 더욱 향상시키는 것이 가능하게 된다. 또한 본 액정 필름이 적용할 수 있는 광학 소자에 사용되는 편광판의 종류에는, 특별히 제한은 없으며, 널리 실용화되고 있는 요오드를 도핑한 흡수형의 편광판은 물론, 와이어 그리드 편광판 등의 반사형 편광판의 광학 보상에도 바람직하게 사용할 수 있다.The liquid crystal film can also be used as an optical element integrated with a polarizing plate or the like, and in this case, it is disposed outside the liquid crystal cell. On the other hand, the liquid crystal film as the optical compensation element can be disposed inside the liquid crystal cell, since there is little or no elution of impurities into the liquid crystal filled in the cell. For example, by applying the method disclosed in Japanese Patent Application Laid-Open No. 2008-01943, it is possible to further improve the function of the color filter by forming the polymerizable liquid crystal layer of the present invention on the color filter. There is no particular limitation on the type of the polarizer used for the optical element to which the liquid crystal film can be applied, and there is no particular limitation on the polarizing plate of the absorbing type doped with iodine which is widely used, and the optical compensation of the reflective polarizing plate such as the wire grid polarizing plate Can be preferably used.
액정 필름은 2색성 색소 등의 첨가물을 함유할 수도 있다. 2색성 색소로서는 안트라퀴논, 나프토퀴논 또는 아조벤젠으로 이루어진 색소가 바람직하다. 2색성 색소와 복합화한 호모지니어스 배향의 액정 필름은, 흡수형 편광판으로서도 사용할 수 있다. 또한, 형광 색소와 복합화한 호모지니어스 배향의 액정 필름은, 편광 발광형 필름으로서도 사용할 수 있다.The liquid crystal film may contain an additive such as a dichroic dye. As the dichroic dye, a dye comprising anthraquinone, naphthoquinone or azobenzene is preferable. The liquid crystal film of the homogeneous orientation in which the dichroic dye and the dichroic dye are combined can also be used as an absorption type polarizing plate. Further, a homogeneous liquid crystal film composed of a fluorescent dye combined with a fluorescent dye can also be used as a polarized light emitting type film.
[실시예][Example]
이하에서, 실시예에 의해 본 발명을 더욱 구체적으로 설명하지만, 본 발명은 이들 실시예에 의해 제한되지 않는다.Hereinafter, the present invention will be described more specifically by way of examples, but the present invention is not limited to these examples.
<화합물의 구조 확인>≪ Identification of Structure of Compound &
500 MHz의 프로톤 NMR(브루커: DRX-500)의 측정에 의해 합성한 화합물의 구조를 확인하였다. 기재한 수치는 ppm를 나타내고, s는 싱글렛(singlet), d는 더블렛(doublet), t는 트리플렛(triplet), m은 멀트플렛(multiplet)을 나타낸다.The structure of the compound synthesized by measurement of proton NMR (Bruker: DRX-500) at 500 MHz was confirmed. The numerical values are expressed in ppm, s is singlet, d is doublet, t is triplet, and m is multiplet.
<상전이 온도><Phase transition temperature>
편광 현미경을 구비한 융점 측정 장치의 핫 플레이트에 시료를 두고, 3℃/분의 속도로 승온(昇溫)하였다. 상이 다른 상으로 전이하는 온도를 측정하였다. C는결정, N는 네마틱상, S는 스멕틱상, I는 등방성 액체를 의미한다. NI점은, 네마틱상의 상한 온도 또는 네마틱상으로부터 등방성 액체로의 전이 온도이다. 「C 50 N 63 I」는, 50℃에서 결정으로부터 네마틱상으로 전이하고, 63℃에서 네마틱상으로부터 등방성 액체로 전이한 것을 나타낸다. 괄호 내는 모노트로픽(monotropic) 피크의 액정상을 나타낸다.A sample was placed on a hot plate of a melting point measuring apparatus equipped with a polarizing microscope, and the temperature was raised at a rate of 3 ° C / minute. The temperature at which the phase migrates to the other phase was measured. C means crystal, N means nematic phase, S means Smectic phase, and I means isotropic liquid. The NI point is the upper limit temperature in the nematic phase or the transition temperature from the nematic phase to the isotropic liquid. &Quot; C 50 N 63 I " indicates transition from crystal to nematic phase at 50 ° C and transition from a nematic phase to an isotropic liquid at 63 ° C. The parentheses indicate the liquid crystal phase of a monotropic peak.
<중합 조건><Polymerization Conditions>
질소 분위기 하에 있어서, 실온에서 250 W의 초고압 수은등(우시오전기사 제조, 멀티 라이트-250)을 사용하여 30 mW/cm2(365 ㎚)의 강도의 광을 30초간 조사하였다.Under a nitrogen atmosphere, light of 30 mW / cm 2 (365 nm) was irradiated for 30 seconds using a 250 W ultra-high pressure mercury lamp at room temperature (Multilight-250 manufactured by Wuxi Mining Co., Ltd.).
<배향의 평가>≪ Evaluation of orientation >
(1) 러빙 처리된 배향막이 형성된 유리 기판의 제작(1) Production of a glass substrate on which a rubbed alignment film is formed
두께 1.1 ㎜의 유리 기판에, 저프리틸트각(수평 배향 모드)용 폴리아믹산(릭손 얼라이너: PIA-5370 JNC(주) 제조)을 스핀 코팅하고, 스핀 코팅한 도막으로부터 용제를 80℃의 핫 플레이트 상에서 제거한 후, 상기 도막을 230℃에서 30분간, 오븐에서 소성한 것을, 레이온포를 이용하여 러빙 처리하였다.Polyamic acid (Rixson aligner: PIA-5370 JNC) for low tilt angle (horizontal alignment mode) was spin-coated on a glass substrate having a thickness of 1.1 mm, and the solvent was hot-rolled from a coating film obtained by spin coating at 80 占 폚 After removal on the plate, the coating film was fired in an oven at 230 DEG C for 30 minutes, and then rubbed with a rayon cloth.
(2) 육안에 의한 관찰 방법(2) Visual observation method
크로즈 니콜로 배치한 2개의 편광판의 사이에 위상차 필름이 형성된 기판을 끼워서 관찰하고, 기판을 수평면 내에서 회전시키고, 명암 상태를 확인하였다. 위상차 필름이 형성된 기판을 편광 현미경으로 관찰하여, 배향 결함의 유무를 확인하였다.A substrate on which a retardation film was formed was observed between two polarizing plates arranged in a crossed Nicols state, and the substrate was rotated in a horizontal plane to check the contrast state. The substrate on which the retardation film was formed was observed with a polarizing microscope to confirm the presence of alignment defects.
(3) 편광 해석 장치에 의한 측정(3) Measurement by a polarization analyzer
신텍크(주)에서 제조한 OPTIPRO 편광 해석 장치를 사용하여, 위상차 필름이 형성된 기판에 파장 550 ㎚ 및 450 ㎚의 광을 조사하였다. 이들 광의 입사 각도를 필름면에 대하여 90°로부터 감소시키면서 리타데이션을 측정하였다. 리타데이션(retardation; 위상 지연)은 Δn×d로 표시된다. 기호 Δn은 광학 이방성 값이며, 기호 d는 중합체 필름의 두께이다.Using a OPTIPRO polarization analyzer manufactured by Shin-Tek Co., a substrate having a retardation film formed thereon was irradiated with light having wavelengths of 550 nm and 450 nm. And the retardation was measured while reducing the angle of incidence of these lights from 90 DEG with respect to the film surface. The retardation (retardation) is expressed as [Delta] nxd. The symbol Δn is the optical anisotropy value, and the symbol d is the thickness of the polymer film.
<막 두께 측정>≪ Measurement of film thickness &
액정 필름이 부착된 유리 기판의 액정 필름의 층을 깍아내고, 그 단차를 미세 형상 측정 장치(KLA TENCOR(주)에서 제조한 알파 스텝 IQ)를 사용하여 측정하였다.The layer of the liquid crystal film of the glass substrate on which the liquid crystal film was adhered was scratched off and the step was measured using a fine shape measuring device (Alpha Step IQ manufactured by KLA TENCOR Co.).
<광학 이방성(Δn)의 평가><Evaluation of optical anisotropy (? N)
호모지니어스 배향을 가지는 액정 필름에 대하여 구한 광의 입사 각도가 필름면에 대하여 90°일 때의 리타데이션과 막두께값으로부터, 광학 이방성(Δn)=리타데이션(Re)/막 두께(d)로서 산출하였다.(N) = retardation (Re) / film thickness (d) from the retardation and the film thickness value when the angle of incidence of light obtained with respect to the liquid crystal film having the homogeneous orientation is 90 DEG with respect to the film surface Respectively.
<파장 분산 특성의 평가>≪ Evaluation of wavelength dispersion characteristics >
파장 분산의 특성으로서, 이하의 식으로부터 구해지는 값을 지표로 하였다.As a characteristic of the wavelength dispersion, a value obtained from the following equation was taken as an index.
파장 분산의 특성=450 ㎚의 광으로 측정한 리타데이션(Re450㎚)/550 ㎚의 광으로 측정한 리타데이션(Re550㎚).Characteristics of wavelength dispersion = retardation (Re 450 nm ) measured with light at 450 nm / retardation (Re 550 nm ) measured with light at 550 nm.
즉, 상기 파장 분산의 특성값이 작은 쪽이, 저파장 분산성이 높고, 1 이하의 값인 경우에 역파장 분산 특성을 가지는 것을 나타낸다.That is, when the characteristic value of the wavelength dispersion is small, the low-wavelength dispersion property is high, and when the value is 1 or less, it has the reverse wavelength dispersion characteristic.
<연필 경도><Pencil hardness>
JIS 규격 「JIS-K-5400 8.4 연필긁기시험」방법에 준하여 측정하였다. 즉, 연필 경도계(요시미쓰 정밀 기계 제조, C-221)를 사용하여, 45°의 각도로 고정한 연필(미츠비시 연필(주) Uni)심을 긁어서, 흠이 생길 때의 연필심의 경도를 측정하였다.And measured according to JIS standard "JIS-K-5400 8.4 Pencil scratching test" method. That is, a pencil (Mitsubishi Pencil Co., Ltd.) Uni fixed at an angle of 45 ° was scratched using a pencil hardness tester (Yoshimitsu Precision Machinery Co., Ltd., C-221) to measure the hardness of the pencil lead at the time of occurrence of the scratch.
[실시예 1] 하기 화합물(1-1-2-1)을 다음과 같이 하여 합성하였다.[Example 1] The following compound (1-1-2-1) was synthesized as follows.
[화학식 38](38)
화합물(ex-1)은, Heterocyclic co㎜unications. 8, 2, 135(2002)에 따라 합성하였다.Compound (ex-1) can be prepared according to Heterocyclic specifications. 8, 2, 135 (2002).
화합물(ex-1) 16.0 g을, 에탄올 160 mL에 가하고, 질소 분위기 하, 10℃ 이하에서 교반하였다. 거기에, 수소화 붕소 나트륨 5.3 g을 첨가하였다. 그 후, 10℃ 이하에서 3시간 교반하였다. 반응액에 1 N 염산수를 160 mL 가하고, 이어서, 물을 160 mL 가하였다. 석출물을 여과하고, 대량의 물로 세정함으로써, 화합물(ex-2) 15.5 g을 얻었다.16.0 g of the compound (ex-1) was added to 160 mL of ethanol, and the mixture was stirred at 10 DEG C or lower under a nitrogen atmosphere. To this was added 5.3 g of sodium borohydride. Thereafter, the mixture was stirred at 10 DEG C or lower for 3 hours. 160 mL of 1 N hydrochloric acid water was added to the reaction solution, and then 160 mL of water was added. The precipitate was filtered and washed with a large amount of water to obtain 15.5 g of the compound (ex-2).
화합물(ex-2) 5.0 g, 4-펜틸시클로헥산카르본산 9.3 g, 및 4-디메틸아미노 피리딘(DMAP) 1.1 g을, 디클로로메탄 90 ml에 가하고, 질소 분위기 하에서 냉각하면서 교반하였다. 거기에, 1,3-디시클로헥실카르보디이미드(DCC) 9.7 g의 디클로로메탄 용액 20 mL를 적하하였다. 적하 후, 실온에서 16시간 교반하였다. 석출한 침전물을 여과하고, 유기층을 물로 세정하고, 무수 황산 마그네슘으로 건조하였다. 감압 하에서 디클로로메탄을 증류 제거하고, 잔사(殘渣)를 컬럼 크로마토그래피(실리카겔, 용리액: 톨루엔)로 정제하고, 메탄올로 재결정함으로써, 화합물(1-1-2-1) 8.2 g을 얻었다.5.0 g of the compound (ex-2), 9.3 g of 4-pentylcyclohexanecarboxylic acid and 1.1 g of 4-dimethylaminopyridine (DMAP) were added to 90 ml of dichloromethane and the mixture was stirred under cooling in a nitrogen atmosphere. To the solution, 20 mL of a dichloromethane solution containing 9.7 g of 1,3-dicyclohexylcarbodiimide (DCC) was added dropwise. After dropwise addition, the mixture was stirred at room temperature for 16 hours. The precipitated precipitate was filtered, and the organic layer was washed with water and dried over anhydrous magnesium sulfate. Dichloromethane was distilled off under reduced pressure, and the residue was purified by column chromatography (silica gel, eluent: toluene) and recrystallized from methanol to obtain 8.2 g of compound (1-1-2-1).
얻어진 화합물(1-1-2-1)의 상전이 온도 및 NMR 분석값은 하기와 같다.The phase transition temperature and NMR analysis value of the obtained compound (1-1-2-1) are as follows.
상전이 온도(℃): C 95 IPhase transition temperature (캜): C 95 I
1H-NMR(CDCl3; δppm): 7.96(s, 1H), 7.28(d, 1H), 7.17(d, 1H), 3.92(s, 3H), 2.65-2.55(m, 2H), 2.22(d, 4H), 1.92(d, 4H), 1.68-1.57(m, 4H), 1.38-1.19(m, 18H), 1.07-0.97(m, 4H), 0.90(t, 6H). 1 H-NMR (CDCl 3; δppm): 7.96 (s, 1H), 7.28 (d, 1H), 7.17 (d, 1H), 3.92 (s, 3H), 2.65-2.55 (m, 2H), 2.22 ( d, 4H), 1.92 (d, 4H), 1.68-1.57 (m, 4H), 1.38-1.19 (m, 18H), 1.07-0.97 (m, 4H), 0.90 (t, 6H).
[실시예 2][Example 2]
하기 화합물(1-1-19-1)을 다음과 같이 하여 합성하였다.The following compound (1-1-19-1) was synthesized as follows.
[화학식 39][Chemical Formula 39]
화합물(ex-3)은, Heterocyclic co㎜unications. 8, 2, 135(2002)에 따라 합성하였다.The compound (ex-3) can be prepared according to Heterocyclic specifications. 8, 2, 135 (2002).
화합물(ex-3) 5.0 g, 페놀 2.0 g, 및 DMAP 0.5 g을, 디클로로메탄 50 mL에 가하고, 질소 분위기 하에서 냉각하면서 교반하였다. 거기에, DCC 4.5 g의 디클로로메탄 용액 10 mL를 적하하였다. 적하 후, 실온에서 16시간 교반하였다. 석출한 침전물을 여과하고, 유기층을 물로 세정하고, 무수 황산 마그네슘으로 건조하였다. 감압 하에서 디클로로메탄을 증류 제거하고, 잔사를 컬럼 크로마토그래피(실리카겔, 용리액: 톨루엔)로 정제하고, 메탄올로 재결정함으로써, 화합물(ex-4) 4.8 g을 얻었다.5.0 g of the compound (ex-3), 2.0 g of phenol and 0.5 g of DMAP were added to 50 mL of dichloromethane, and the mixture was stirred under cooling in a nitrogen atmosphere. Then, 10 mL of a DCC 4.5 g dichloromethane solution was added dropwise. After dropwise addition, the mixture was stirred at room temperature for 16 hours. The precipitated precipitate was filtered, and the organic layer was washed with water and dried over anhydrous magnesium sulfate. Dichloromethane was distilled off under reduced pressure, and the residue was purified by column chromatography (silica gel, eluent: toluene) and recrystallized from methanol to obtain 4.8 g of compound (ex-4).
화합물(ex-4) 4.8 g을 아세토니트릴(MeCN) 150 mL에 가하고, 질소 분위기 하, 실온에서 교반하였다. 거기에, 질산 세륨(IV)암모늄(CAN) 17.6 g의 수용액 45 mL를 적하하였다. 적하 후, 실온에서 2시간 교반하였다. 톨루엔 및 물을 첨가하고 유기층을 추출하고, 또한 유기층을 물로 세정하고, 무수 황산 마그네슘으로 건조하였다. 감압 하에서 톨루엔을 증류 제거하고, 잔사를 톨루엔 및 메탄올의 혼합 용액에 의해 재결정함으로써, 화합물(ex-5) 4.2 g을 얻었다.4.8 g of the compound (ex-4) was added to 150 mL of acetonitrile (MeCN), and the mixture was stirred at room temperature under a nitrogen atmosphere. Thereto was added dropwise 45 mL of an aqueous solution of 17.6 g of cerium (IV) nitrate (CAN). After dropwise addition, the mixture was stirred at room temperature for 2 hours. Toluene and water were added and the organic layer was extracted, and the organic layer was washed with water and dried over anhydrous magnesium sulfate. Toluene was distilled off under reduced pressure, and the residue was recrystallized with a mixed solution of toluene and methanol to obtain 4.2 g of compound (ex-5).
화합물(ex-5) 4.2 g을, 에탄올 42 mL에 가하고, 질소 분위기 하, 10℃ 이하에서 교반하였다. 거기에, 수소화 붕소 나트륨 1.3 g을 첨가하였다. 그 후, 10℃ 이하에서 3시간 교반하였다. 반응액에 1 N 염산수를 40 mL 가하고, 이어서, 물을 40 mL 가하였다. 석출물을 여과하고, 대량의 물로 세정함으로써, 화합물(ex-6) 4.0 g을 얻었다.4.2 g of the compound (ex-5) was added to 42 mL of ethanol, and the mixture was stirred at 10 DEG C or lower under a nitrogen atmosphere. To this, 1.3 g of sodium borohydride was added. Thereafter, the mixture was stirred at 10 DEG C or lower for 3 hours. To the reaction mixture was added 40 mL of 1 N hydrochloric acid, and then 40 mL of water was added. The precipitate was filtered and washed with a large amount of water to obtain 4.0 g of Compound (ex-6).
화합물(ex-6) 4.0 g, 4-펜틸시클로헥산카르본산 5.8 g, 및 DMAP 0.3 g을, 디클로로메탄 60 mL에 가하고, 질소 분위기 하에서 냉각하면서 교반하였다. 거기에, DCC 3.0 g의 디클로로메탄 용액 10 mL를 적하하였다. 적하 후, 실온에서 16시간 교반하였다. 석출한 침전물을 여과하고, 유기층을 물로 세정하고, 무수 황산 마그네슘으로 건조하였다. 감압 하에서 디클로로메탄을 증류 제거하고, 잔사를 컬럼 크로마토그래피(실리카겔, 용리액: 톨루엔)로 정제하고, 메탄올로 재결정함으로써, 화합물(1-1-19-1) 4.9 g을 얻었다.4.0 g of the compound (ex-6), 5.8 g of 4-pentylcyclohexanecarboxylic acid and 0.3 g of DMAP were added to 60 mL of dichloromethane, and the mixture was stirred under cooling in a nitrogen atmosphere. 10 mL of a DCC solution of 3.0 g of dichloromethane was added dropwise thereto. After dropwise addition, the mixture was stirred at room temperature for 16 hours. The precipitated precipitate was filtered, and the organic layer was washed with water and dried over anhydrous magnesium sulfate. Dichloromethane was distilled off under reduced pressure, and the residue was purified by column chromatography (silica gel, eluent: toluene) and recrystallized from methanol to obtain 4.9 g of a compound (1-1-19-1).
얻어진 화합물(1-1-19-1)의 상전이 온도 및 NMR 분석값은 하기와 같다.The phase transition temperature and NMR analysis value of the obtained compound (1-1-19-1) are as follows.
상전이 온도(℃): C 110 IPhase transition temperature (캜): C 110 I
1H-NMR(CDCl3; δppm): 8.08(s, 1H), 7.45(t, 2H), 7.31(d, 2H), 7.27-7.22(m, 2H), 7.19(d, 1H), 2.65-2.56(m, 2H), 2.22(d, 4H), 1.92(d, 4H), 1.69-1.58(m, 4H), 1.36-1.19(m, 18H), 1.07-0.97(m, 4H), 0.89(t, 6H). 1 H-NMR (CDCl 3; δppm): 8.08 (s, 1H), 7.45 (t, 2H), 7.31 (d, 2H), 7.27-7.22 (m, 2H), 7.19 (d, 1H), 2.65- 2H), 2.22 (d, 4H), 1.92 (d, 4H), 1.69-1.58 (m, 4H), 1.36-1.19 (m, 18H), 1.07-0.97 t, 6H).
[실시예 3][Example 3]
하기 화합물(1-1-7-1)을 다음과 같이 하여 합성하였다.The following compound (1-1-7-1) was synthesized as follows.
[화학식 40](40)
화합물(ex-7)은, Heterocyclic co㎜unications. 8, 2, 135(2002)에 따라 합성하였다.The compound (ex-7) can be prepared according to Heterocyclic specifications. 8, 2, 135 (2002).
화합물(ex-7) 5.0 g, 벤질메르캅탄 3.2 g, 및 수산화 칼륨 2.9 g을, N,N-디메틸포름아미드(DMF) 50 ml에 가하고, 질소 분위기 하 100℃에서 가열하면서 4시간 교반하였다. 반응액에 물을 주입하고, 석출물을 여과하고, 물 및 메탄올로 세정하였다. 얻어진 결정을, 톨루엔 및 메탄올의 혼합 용액으로 재결정함으로써, 화합물(ex-8) 3.5 g을 얻었다.5.0 g of the compound (ex-7), 3.2 g of benzyl mercaptan and 2.9 g of potassium hydroxide were added to 50 ml of N, N-dimethylformamide (DMF) and stirred for 4 hours while heating at 100 占 폚 in a nitrogen atmosphere. Water was poured into the reaction solution, the precipitate was filtered, and washed with water and methanol. The crystals thus obtained were recrystallized from a mixed solution of toluene and methanol to obtain 3.5 g of the compound (ex-8).
화합물(ex-8) 3.0 g을 아세토니트릴(MeCN) 90 mL에 가하고, 질소 분위기 하, 실온에서 교반하였다. 거기에, CAN 12.8 g의 수용액 18 mL를 적하하였다. 적하 후, 실온에서 2시간 교반하였다. 톨루엔 및 물을 첨가하고 유기층을 추출하고, 또한 유기층을 물로 세정하고, 무수 황산 마그네슘으로 건조하였다. 감압 하에서 톨루엔을 증류 제거하고, 잔사를 톨루엔 및 메탄올의 혼합 용액에 의해 재결정함으로써, 화합물(ex-9) 1.4 g을 얻었다.3.0 g of the compound (ex-8) was added to 90 mL of acetonitrile (MeCN), and the mixture was stirred at room temperature under a nitrogen atmosphere. There, 18 mL of an aqueous solution of 12.8 g of CAN was added dropwise. After dropwise addition, the mixture was stirred at room temperature for 2 hours. Toluene and water were added and the organic layer was extracted, and the organic layer was washed with water and dried over anhydrous magnesium sulfate. Toluene was distilled off under reduced pressure and the residue was recrystallized with a mixed solution of toluene and methanol to obtain 1.4 g of a compound (ex-9).
화합물(ex-9) 1.4 g을, 에탄올 14 mL에 가하고, 질소 분위기 하, 10℃ 이하에서 교반하였다. 거기에, 수소화 붕소 나트륨 0.5 g을 첨가하였다. 그 후, 10℃ 이하에서 3시간 교반하였다. 반응액에 1 N 염산수를 14 mL 가하고, 이어서, 물을 14 mL 가하였다. 석출물을 여과하고, 대량의 물로 세정함으로써, 화합물(ex-10) 1.0 g을 얻었다.1.4 g of the compound (ex-9) was added to ethanol (14 mL), and the mixture was stirred at 10 ° C or lower under a nitrogen atmosphere. To this, 0.5 g of sodium borohydride was added. Thereafter, the mixture was stirred at 10 DEG C or lower for 3 hours. 14 mL of 1N hydrochloric acid was added to the reaction solution, and then 14 mL of water was added. The precipitate was filtered and washed with a large amount of water to obtain 1.0 g of Compound (ex-10).
ε-카프로락탐 20 g, 벤질클로라이드 60 mL, 및 수산화 칼륨 34 g을, 톨루엔 300 mL에 가하고, 질소 분위기 하 6시간 환류 교반하였다. 물을 첨가하고 수층을 추출하고, 수층을 헵탄으로 세정하였다. 진한 염산을 가하여 산성으로 만들고, 톨루엔을 가하여 유기층을 추출하였다. 유기층을 물로 세정하고, 무수 황산 마그네슘으로 건조하였다. 감압 하에서 톨루엔을 증류 제거함으로써, 화합물(ex-11) 24.4 g을 얻었다.20 g of? -caprolactam, 60 mL of benzyl chloride, and 34 g of potassium hydroxide were added to 300 mL of toluene, and the mixture was stirred under reflux for 6 hours under a nitrogen atmosphere. Water was added, the aqueous layer was extracted, and the aqueous layer was washed with heptane. Concentrated hydrochloric acid was added to make it acidic, and toluene was added to extract the organic layer. The organic layer was washed with water and dried over anhydrous magnesium sulfate. Toluene was distilled off under reduced pressure to obtain 24.4 g of compound (ex-11).
trans-4-하이드록시시클로헥산카르본산 25.0 g, 및 트리에틸아민 26.3 g을, DMF 125mL에 가하고, 질소 분위기 하 10℃ 이하에서 냉각하면서 교반하였다. 거기에, 클로로메틸메틸에테르 14.7 g을 천천히 적하하였다. 적하 후, 실온에서 8시간 교반하였다. 아세트산 에틸 및 물을 첨가하여 유기층을 추출하고, 유기층을 포화 중조수 및 물로 세정하고, 무수 황산 마그네슘으로 건조하였다. 감압 하에서 아세트산 에틸를 증류 제거하고, 잔사를 컬럼 크로마토그래피(실리카겔, 용리액: 톨루엔-아세트산 에틸 혼합물(용량비: 톨루엔/아세트산 에틸=2/1))로 정제하고, 감압 건조함으로써, 화합물(ex-12) 25.2 g을 얻었다.25.0 g of trans-4-hydroxycyclohexanecarboxylic acid and 26.3 g of triethylamine were added to 125 mL of DMF, and the mixture was stirred while being cooled at 10 ° C or lower in a nitrogen atmosphere. Thereto, 14.7 g of chloromethyl methyl ether was slowly added dropwise. After dropwise addition, the mixture was stirred at room temperature for 8 hours. Ethyl acetate and water were added to extract the organic layer, and the organic layer was washed with saturated aqueous sodium bicarbonate and water, and dried over anhydrous magnesium sulfate. The ethyl acetate was distilled off under reduced pressure and the residue was purified by column chromatography (silica gel, eluant: toluene-ethyl acetate mixture (volume ratio: toluene / ethyl acetate = 2/1) 25.2 g.
화합물(ex-11) 24 g, 화합물(ex-12) 20.3 g, 및 DMAP 2.6 g을, 디클로로메탄 240 mL에 가하고, 질소 분위기 하에서 냉각하면서 교반하였다. 거기에, DCC 22.9 g의 디클로로메탄 용액 50 mL를 적하하였다. 적하 후, 실온에서 16시간 교반하였다. 석출한 침전물을 여과하고, 유기층을 물로 세정하고, 무수 황산 마그네슘으로 건조하였다. 감압 하에서 디클로로메탄을 증류 제거하고, 잔사를 컬럼 크로마토그래피(실리카겔, 용리액: 톨루엔-아세트산 에틸 혼합물(용량비: 톨루엔/아세트산 에틸=10/1))로 정제함으로써, 화합물(ex-13) 34.3 g을 얻었다.24 g of the compound (ex-11), 20.3 g of the compound (ex-12) and 2.6 g of DMAP were added to 240 mL of dichloromethane and stirred under cooling in a nitrogen atmosphere. 50 mL of a dichloromethane solution containing 22.9 g of DCC was added dropwise thereto. After dropwise addition, the mixture was stirred at room temperature for 16 hours. The precipitated precipitate was filtered, and the organic layer was washed with water and dried over anhydrous magnesium sulfate. Dichloromethane was distilled off under reduced pressure and the residue was purified by column chromatography (silica gel, eluent: toluene-ethyl acetate mixture (volume ratio: toluene / ethyl acetate = 10/1)) to obtain 34.3 g of compound (ex- .
화합물(ex-13) 34.3 g, 및 Pd/C 2.5 g을, 에탄올 400 mL에 가하고, 오토클레이브(autoclave)를 사용하여 수소 분위기 하 실온에서 24시간 교반하였다. 불용물을 여과하고, 감압 하에서 에탄올을 증류 제거함으로써, 화합물(ex-14) 25.2 g을 얻었다.34.3 g of the compound (ex-13) and 2.5 g of Pd / C were added to 400 mL of ethanol, and the mixture was stirred at room temperature for 24 hours under hydrogen atmosphere using an autoclave. The insoluble matter was filtered off and the ethanol was distilled off under reduced pressure to obtain 25.2 g of the compound (ex-14).
화합물(ex-14) 25.2 g, 및 트리에틸아민 11.0 g을, 디클로로메탄 252 mL에 가하고, 질소 분위기 하 10℃ 이하에서 냉각하면서 교반하였다. 거기에, 아크릴산 클로라이드 8.3 g을 천천히 적하하였다. 적하 후, 실온에서 8시간 교반하였다. 물을 첨가하여 유기층을 추출하고, 유기층을 포화 중조수 및 물로 세정하고, 무수 황산 마그네슘으로 건조하였다. 감압 하에서 디클로로메탄을 증류 제거하고, 잔사를 컬럼 크로마토그래피(실리카겔, 용리액: 톨루엔-아세트산 에틸 혼합물(용량비: 톨루엔/아세트산 에틸=14/1))로 정제하고, 감압 건조하였다. 얻어진 잔사, 및 p-톨루엔 술폰산(pTSA) 0.9 g을, THF 35mL 및 2-프로판올(IPA) 17.5 mL의 혼합 용액에 가하고, 40℃에서 8시간 가열 교반하였다. 아세트산 에틸 및 물을 첨가하여 유기층을 추출하고, 유기층을 포화 식염수로 세정하고, 무수 황산 마그네슘으로 건조하였다. 감압 하에서 용제를 증류 제거하고, 잔사를 아세트산 에틸 및 헵탄의 혼합 용액으로 재결정함으로써, 화합물(ex-15) 7.4 g을 얻었다.25.2 g of the compound (ex-14) and 11.0 g of triethylamine were added to 252 mL of dichloromethane, and the mixture was stirred while being cooled at 10 占 폚 or lower in a nitrogen atmosphere. To this, 8.3 g of acrylic acid chloride was slowly added dropwise. After dropwise addition, the mixture was stirred at room temperature for 8 hours. Water was added to extract the organic layer, and the organic layer was washed with saturated aqueous sodium bicarbonate and water, and dried over anhydrous magnesium sulfate. The dichloromethane was distilled off under reduced pressure, and the residue was purified by column chromatography (silica gel, eluent: toluene-ethyl acetate mixture (volume ratio: toluene / ethyl acetate = 14/1)) and dried under reduced pressure. The obtained residue and 0.9 g of p-toluenesulfonic acid (pTSA) were added to a mixed solution of 35 mL of THF and 17.5 mL of 2-propanol (IPA), and the mixture was heated and stirred at 40 DEG C for 8 hours. Ethyl acetate and water were added to extract the organic layer, the organic layer was washed with saturated brine, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the residue was recrystallized from a mixed solution of ethyl acetate and heptane to obtain 7.4 g of compound (ex-15).
화합물(ex-10) 2.8 g, 화합물(ex-15) 7.4 g, 및 DMAP 0.6 g을, 디클로로메탄 75 mL에 가하고, 질소 분위기 하에서 냉각하면서 교반하였다. 거기에, DCC5.1 g의 디클로로메탄 용액 11 mL를 적하하였다. 적하 후, 실온에서 16시간 교반하였다. 석출한 침전물을 여과하고, 유기층을 물로 세정하고, 무수 황산 마그네슘으로 건조하였다. 감압 하에서 디클로로메탄을 증류 제거하고, 잔사를 컬럼 크로마토그래피(실리카겔, 용리액: 톨루엔-아세트산 에틸 혼합물(용량비: 톨루엔/아세트산 에틸=10/1))로 정제하고, 메탄올로 재결정함으로써, 화합물(1-1-7-1) 3.6 g을 얻었다.2.8 g of the compound (ex-10), 7.4 g of the compound (ex-15) and 0.6 g of DMAP were added to 75 mL of dichloromethane, and the mixture was stirred under cooling in a nitrogen atmosphere. To this was added 11 mL of a dichloromethane solution of 5.1 g of DCC dropwise. After dropwise addition, the mixture was stirred at room temperature for 16 hours. The precipitated precipitate was filtered, and the organic layer was washed with water and dried over anhydrous magnesium sulfate. Dichloromethane was distilled off under reduced pressure and the residue was purified by column chromatography (silica gel, eluent: toluene-ethyl acetate mixture (volume ratio: toluene / ethyl acetate = 10/1)) and recrystallized from methanol to obtain 1- 1-7-1) was obtained.
얻어진 화합물(1-1-7-1)의 상전이 온도 및 NMR 분석값은 하기와 같다.The phase transition temperature and NMR analysis values of the obtained compound (1-1-7-1) are as follows.
상전이 온도(℃): C 62 IPhase transition temperature (캜): C 62 I
1H-NMR(CDCl3; δppm): 7.69(s, 2H), 7.46(t, 2H), 7.41(t, 1H), 7.36(s, 1H), 7.26-7.20(m, 2H), 6.44(d, 2H), 6.19-6.12(m, 2H), 5.86(d, 2H), 4.88-4.80(m, 2H), 4.20(t, 4H), 2.76-2.67(m, 2H), 2.38-2.28(m, 8H), 2.21-2.13(m, 4H), 1.90-1.79(m, 4H), 1.77-1.68(m, 8H), 1.59-1.42(m, 8H). 1 H-NMR (CDCl 3; δppm): 7.69 (s, 2H), 7.46 (t, 2H), 7.41 (t, 1H), 7.36 (s, 1H), 7.26-7.20 (m, 2H), 6.44 ( (d, 2H), 6.19-6.12 (m, 2H), 5.86 (d, 2H), 4.88-4.80 m, 8H), 2.21-2.13 (m, 4H), 1.90-1.79 (m, 4H), 1.77-1.68 (m, 8H), 1.59-1.42 (m, 8H).
[실시예 4][Example 4]
하기 화합물(1-1-5-1)을 다음과 같이 하여 합성하였다.The following compound (1-1-5-1) was synthesized as follows.
[화학식 41](41)
4-하이드록시부틸아크릴레이트 50.0 g, 및 피리딘 50 mL를, 톨루엔 150 mL에 가하고, 질소 분위기 하 실온에서 교반하였다. 거기에, 토실클로라이드 72.8 g을 서서히 첨가하였다. 그 후, 실온에서 16시간 교반하였다. 또한, 물을 첨가하고 40℃에서 3시간 가열 교반하였다. 유기층을 추출하고, 5% 염산수 및 포화 중조수, 이어서, 물로 세정하고, 무수 황산 마그네슘으로 건조하고, 감압 하에서 톨루엔을 증류 제거했다. 얻어진 잔사, 하이드로퀴논 59.1 g, 및 탄산 칼륨 148.0 g을, DMF 400mL에 가하고, 질소 분위기 하 80℃에서 8시간 가열 교반하였다. 아세트산 에틸 및 물을 첨가하고 유기층을 추출하였다. 유기층을 포화 중층수 및 물로 세정하고, 무수 황산 마그네슘으로 건조하고, 감압 하에서 아세트산 에틸를 증류 제거하고, 잔사를 컬럼 크로마토그래피(실리카겔, 용리액: 톨루엔-아세트산 에틸 혼합물(용량비: 톨루엔/아세트산 에틸=4/1))로 정제함으로써, 화합물(ex-16) 22.9 g을 얻었다.50.0 g of 4-hydroxybutyl acrylate, and 50 mL of pyridine were added to 150 mL of toluene, and the mixture was stirred at room temperature under a nitrogen atmosphere. Thereto was slowly added 72.8 g of tosyl chloride. Thereafter, the mixture was stirred at room temperature for 16 hours. Further, water was added and the mixture was heated and stirred at 40 占 폚 for 3 hours. The organic layer was extracted, washed with 5% aqueous hydrochloric acid and saturated aqueous sodium bicarbonate, and then with water, dried over anhydrous magnesium sulfate, and then toluene was distilled off under reduced pressure. 59.1 g of the obtained residue, hydroquinone and 148.0 g of potassium carbonate were added to 400 mL of DMF, and the mixture was stirred under heating in a nitrogen atmosphere at 80 占 폚 for 8 hours. Ethyl acetate and water were added and the organic layer was extracted. The organic layer was washed with a saturated aqueous layer of water and water and dried over anhydrous magnesium sulfate. Ethyl acetate was distilled off under reduced pressure and the residue was purified by column chromatography (silica gel, eluent: toluene-ethyl acetate mixture (volume ratio: toluene / 1)) to obtain 22.9 g of the compound (ex-16).
trans-시클로헥산디카르본산 50.0 g, 및 탄산 칼륨 38.1 g을, DMF 250mL에 가하고, 질소 분위기 하 60℃에서 가열 교반하였다. 거기에, 벤질브로마이드 47.1 g을 천천히 적하하였다. 적하 후, 80℃에서 6시간 교반하였다. 톨루엔 및 3 N 염산수를 첨가하여 유기층을 추출하고, 유기층을 물로 세정하고, 무수 황산 마그네슘으로 건조하였다. 감압 하에서 톨루엔을 증류 제거함으로써, 화합물(ex-17) 43.7 g을 얻었다.50.0 g of trans-cyclohexanedicarboxylic acid, and 38.1 g of potassium carbonate were added to DMF (250 mL), and the mixture was heated and stirred at 60 占 폚 in a nitrogen atmosphere. To this, 47.1 g of benzyl bromide was slowly added dropwise. After dropwise addition, the mixture was stirred at 80 占 폚 for 6 hours. Toluene and 3 N aqueous hydrochloric acid were added to extract the organic layer, and the organic layer was washed with water and dried over anhydrous magnesium sulfate. Toluene was distilled off under reduced pressure to obtain 43.7 g of compound (ex-17).
화합물(ex-17) 43.7 g, 트리에틸아민 33.7 g을, 톨루엔 400 mL에 가하고, 질소 분위기 하 10℃ 이하에서 냉각하면서 교반하였다. 거기에, 클로로메틸메틸에테르 16.1 g을 천천히 적하하였다. 적하 후, 실온에서 5시간 교반하였다. 물을 첨가하여 유기층을 추출하고, 유기층을 포화 중조수 및 물로 세정하고, 무수 황산 마그네슘으로 건조하였다. 감압 하에서 톨루엔을 증류 제거하고, 잔사를 컬럼 크로마토그래피(실리카겔, 용리액: 톨루엔-아세트산 에틸 혼합물(용량비: 톨루엔/아세트산 에틸=10/1))로 정제하고, 감압 건조함으로써, 화합물(ex-18) 32.4 g을 얻었다.43.7 g of the compound (ex-17) and 33.7 g of triethylamine were added to 400 mL of toluene, and the mixture was stirred while cooling at 10 DEG C or lower in a nitrogen atmosphere. Thereto, 16.1 g of chloromethyl methyl ether was slowly added dropwise. After dropwise addition, the mixture was stirred at room temperature for 5 hours. Water was added to extract the organic layer, and the organic layer was washed with saturated aqueous sodium bicarbonate and water, and dried over anhydrous magnesium sulfate. The toluene was distilled off under reduced pressure and the residue was purified by column chromatography (silica gel, eluant: toluene-ethyl acetate mixture (volume ratio: toluene / ethyl acetate = 10/1) 32.4 g was obtained.
화합물(ex-18) 32.4 g, 및 Pd/C 1.5 g을, THF 330mL에 가하고, 오토클레이브를 사용하여 수소 분위기 하 실온에서 24시간 교반하였다. 불용물을 여과하고, 감압 하에서 THF를 증류 제거하고, 클로로포름을 가하여 결정을 여과하여, 화합물(ex-19) 7.1 g을 얻었다.32.4 g of the compound (ex-18) and 1.5 g of Pd / C were added to 330 mL of THF, and the mixture was stirred at room temperature under hydrogen atmosphere for 24 hours using an autoclave. The insoluble material was filtered off, and THF was distilled off under reduced pressure, and chloroform was added thereto, and the crystals were filtered to obtain 7.1 g of the compound (ex-19).
화합물(ex-16) 7.7 g, 화합물(ex-19) 7.1 g, 및 DMAP 0.8 g을, 디클로로메탄 80 mL에 가하고, 질소 분위기 하에서 냉각하면서 교반하였다. 거기에, DCC 7.0 g의 디클로로메탄 용액 15 mL를 적하하였다. 적하 후, 실온에서 16시간 교반하였다. 석출한 침전물을 여과하고, 유기층을 물로 세정하고, 무수 황산 마그네슘으로 건조하였다. 감압 하에서 디클로로메탄을 증류 제거하고, 잔사를 컬럼 크로마토그래피(실리카겔, 용리액: 톨루엔-아세트산 에틸 혼합물(용량비: 톨루엔/아세트산 에틸=8/1))로 정제하고, 감압 건조하였다. 얻어진 잔사, 및 p-톨루엔 술폰산(pTSA) 0.3 g을, THF 15mL 및 2-프로판올(IPA) 7.5 mL의 혼합 용액에 가하고, 40℃에서 8시간 가열 교반하였다. 아세트산 에틸 및 물을 첨가하여 유기층을 추출하고, 유기층을 포화 식염수로 세정하고, 무수 황산 마그네슘으로 건조하였다. 감압 하에서 용제를 증류 제거하고, 잔사를 아세트산 에틸 및 헵탄의 혼합 용액으로 재결정함으로써, 화합물(ex-20) 3.3 g을 얻었다.7.7 g of the compound (ex-16), 7.1 g of the compound (ex-19) and 0.8 g of DMAP were added to 80 mL of dichloromethane and stirred under cooling in a nitrogen atmosphere. Then, 15 mL of a DCC solution of 7.0 g of dichloromethane was added dropwise thereto. After dropwise addition, the mixture was stirred at room temperature for 16 hours. The precipitated precipitate was filtered, and the organic layer was washed with water and dried over anhydrous magnesium sulfate. The dichloromethane was distilled off under reduced pressure, and the residue was purified by column chromatography (silica gel, eluent: toluene-ethyl acetate mixture (volume ratio: toluene / ethyl acetate = 8/1)) and dried under reduced pressure. The obtained residue and 0.3 g of p-toluenesulfonic acid (pTSA) were added to a mixed solution of 15 mL of THF and 7.5 mL of 2-propanol (IPA), and the mixture was heated and stirred at 40 占 폚 for 8 hours. Ethyl acetate and water were added to extract the organic layer, the organic layer was washed with saturated brine, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the residue was recrystallized from a mixed solution of ethyl acetate and heptane to obtain 3.3 g of compound (ex-20).
실시예 3에 기재된 화합물(ex-10) 1.0 g, 화합물(ex-20) 3.3 g, 및 DMAP 0.2 g을, 디클로로메탄 40 mL에 가하고, 질소 분위기 하에서 냉각하면서 교반하였다. 거기에, DCC 1.8 g의 디클로로메탄 용액 5 mL를 적하하였다. 적하 후, 실온에서 16시간 교반하였다. 석출한 침전물을 여과하고, 유기층을 물로 세정하고, 무수 황산 마그네슘으로 건조하였다. 감압 하에서 디클로로메탄을 증류 제거하고, 잔사를 컬럼 크로마토그래피(실리카겔, 용리액: 톨루엔-아세트산 에틸 혼합물(용량비: 톨루엔/아세트산 에틸=4/1))로 정제하고, 메탄올로 재결정함으로써, 화합물(1-1-5-1) 1.8 g을 얻었다.1.0 g of the compound (ex-10) described in Example 3, 3.3 g of the compound (ex-20) and 0.2 g of DMAP were added to 40 mL of dichloromethane and stirred under cooling in a nitrogen atmosphere. 5 mL of a dichloromethane solution of 1.8 g of DCC was added dropwise thereto. After dropwise addition, the mixture was stirred at room temperature for 16 hours. The precipitated precipitate was filtered, and the organic layer was washed with water and dried over anhydrous magnesium sulfate. Dichloromethane was distilled off under reduced pressure and the residue was purified by column chromatography (silica gel, eluant: toluene-ethyl acetate mixture (volume ratio: toluene / ethyl acetate = 4/1)) and recrystallized from methanol to obtain 1- 1-5-1).
얻어진 화합물(1-1-5-1)의 상전이 온도 및 NMR 분석값은 하기와 같다.The phase transition temperature and NMR analysis value of the obtained compound (1-1-5-1) are as follows.
상전이 온도(℃): C 129 N 180 < IPhase transition temperature (캜): C 129 N 180 <I
("180 < I"는, 180℃ 부근에서 중합되어 투명점이 측정 불능이지만, 만일 중합하지 않는다면, 180℃ 이상에서 네마틱상으로부터 등방성 액체로의 전이 온도가 있는 것으로 예상된다는 의미임)("180 < I" means that the transparent point can not be measured by polymerization at around 180 DEG C, but if not polymerized, it is expected that there will be a transition temperature from nematic phase to isotropic liquid at 180 DEG C or higher)
1H-NMR(CDCl3; δppm): 7.70(d, 2H), 7.44(t, 2H), 7.41-7.36(m, 2H), 7.16-7.11(m, 2H), 7.00(d, 4H), 6.90(d, 4H), 6.41(d, 2H), 6.17-6.09(m, 2H), 5.83(d, 2H), 4.24(t, 4H), 3.99(t, 4H), 2.78-2.69(m, 2H), 2.67-2.59(m, 2H), 2.43-2.30(m, 8H), 1.93-1.67(m, 16H). 1 H-NMR (CDCl 3; δppm): 7.70 (d, 2H), 7.44 (t, 2H), 7.41-7.36 (m, 2H), 7.16-7.11 (m, 2H), 7.00 (d, 4H), 4H), 3.99 (t, 4H), 2.78-2.69 (m, 2H), 6.84 (d, 2H) 2H), 2.67-2.59 (m, 2H), 2.43-2.30 (m, 8H), 1.93-1.67 (m, 16H).
[실시예 5][Example 5]
하기 화합물(1-1-6-1)을 다음과 같이 하여 합성하였다.The following compound (1-1-6-1) was synthesized as follows.
[화학식 42](42)
6-클로로헥산올 50.0 g, 3-(4-하이드록시페닐프로피온산 메틸) 66.0 g, 탄산 칼륨 49.2 g, 및 요오드화 칼륨 6.1 g을, DMF 330mL에 가하고, 질소 분위기 하 80℃에서 10시간 가열 교반하였다. 톨루엔 및 물을 첨가하고 유기층을 추출하고, 유기층을 포화 중조수 및 물로 세정하고, 무수 황산 마그네슘으로 건조하고, 감압 하에서 톨루엔을 증류 제거했다. 얻어진 잔사, 및 수산화 칼륨 22.6 g을 메탄올 260 mL 및 물 260 mL에 가하고, 질소 분위기 하 3시간 환류 교반하였다. 감압 하에서 메탄올을 증류 제거하고, 아세트산 에틸 및 3 N 염산수를 가하고 유기층을 추출하였다. 유기층을 물로 세정하고, 무수 황산 마그네슘으로 건조하고, 감압 하에서 아세트산 에틸를 증류 제거하고, 잔사를 톨루엔 및 에탄올의 혼합 용액으로 재결정함으로써, 화합물(ex-21) 69.2 g을 얻었다.50.0 g of 6-chlorohexanol, 66.0 g of 3- (4-hydroxyphenylpropionic acid methyl), 49.2 g of potassium carbonate and 6.1 g of potassium iodide were added to 330 mL of DMF, and the mixture was heated and stirred at 80 DEG C for 10 hours under a nitrogen atmosphere . Toluene and water were added and the organic layer was extracted, and the organic layer was washed with saturated aqueous sodium hydrogencarbonate and water, dried over anhydrous magnesium sulfate, and toluene was distilled off under reduced pressure. The obtained residue and 22.6 g of potassium hydroxide were added to 260 mL of methanol and 260 mL of water, and the mixture was refluxed and stirred for 3 hours under a nitrogen atmosphere. Methanol was distilled off under reduced pressure, ethyl acetate and 3 N hydrochloric acid water were added, and the organic layer was extracted. The organic layer was washed with water, dried over anhydrous magnesium sulfate, and ethyl acetate was distilled off under reduced pressure, and the residue was recrystallized from a mixed solution of toluene and ethanol to obtain 69.2 g of a compound (ex-21).
화합물(ex-21) 69.2 g, 및 디메틸아닐린 44.1 g을, 톨루엔 700 mL에 가하고, 질소 분위기 하 10℃ 이하에서 냉각하면서 교반하였다. 거기에, 아크릴산 클로라이드 28.2 g을 천천히 적하하였다. 적하 후, 40℃에서 4시간 가열 교반하였다. 물을 가하여 유기층을 추출하고, 유기층을 물로 세정하고, 무수 황산 마그네슘으로 건조하였다. 감압 하에서 톨루엔을 증류 제거하고, 잔사를 톨루엔으로 재결정함으로써, 화합물(ex-22) 50.0 g을 얻었다.69.2 g of the compound (ex-21) and 44.1 g of dimethylaniline were added to 700 mL of toluene, and the mixture was stirred while being cooled at 10 DEG C or lower in a nitrogen atmosphere. Thereto, 28.2 g of acrylic acid chloride was slowly added dropwise. After the dropwise addition, the mixture was heated and stirred at 40 占 폚 for 4 hours. Water was added to extract the organic layer, and the organic layer was washed with water and dried over anhydrous magnesium sulfate. Toluene was distilled off under reduced pressure, and the residue was recrystallized with toluene to obtain 50.0 g of Compound (ex-22).
화합물(ex-22) 42.9 g, 실시예 3에 기재된 화합물(ex-12) 25.2 g, 및 DMAP 3.3 g을, 디클로로메탄 430 mL에 가하고, 질소 분위기 하에서 냉각하면서 교반하였다. 거기에, DCC 29.0 g의 디클로로메탄 용액 60 mL를 적하하였다. 적하 후, 실온에서 16시간 교반하였다. 석출한 침전물을 여과하고, 유기층을 포화 중조수 및 물로 세정하고, 무수 황산 마그네슘으로 건조하였다. 감압 하에서 디클로로메탄을 증류 제거하고, 잔사를 컬럼 크로마토그래피(실리카겔, 용리액: 톨루엔-아세트산 에틸 혼합물(용량비: 톨루엔/아세트산 에틸=12/1))로 정제하고, 감압 건조하였다. 얻어진 잔사, 및 p-톨루엔술폰산(pTSA) 2.1 g을, THF 110mL 및 IPA 55mL의 혼합 용액에 가하고, 40℃에서 8시간 가열 교반하였다. 아세트산 에틸 및 물을 가하여 유기층을 추출하고, 유기층을 포화 식염수로 세정하고, 무수 황산 마그네슘으로 건조하였다. 감압 하에서 용제를 증류 제거하고, 잔사를 아세트산 에틸 및 헵탄의 혼합 용액으로 재결정함으로써, 화합물(ex-23) 31.8 g을 얻었다.42.9 g of the compound (ex-22), 25.2 g of the compound (ex-12) described in Example 3 and 3.3 g of DMAP were added to 430 mL of dichloromethane and stirred under cooling in a nitrogen atmosphere. Then, 60 mL of a dichloromethane solution of 29.0 g of DCC was added dropwise. After dropwise addition, the mixture was stirred at room temperature for 16 hours. The precipitated precipitate was filtered, and the organic layer was washed with saturated aqueous sodium hydrogencarbonate and water, and dried over anhydrous magnesium sulfate. The dichloromethane was distilled off under reduced pressure, and the residue was purified by column chromatography (silica gel, eluent: toluene-ethyl acetate mixture (volume ratio: toluene / ethyl acetate = 12/1)) and dried under reduced pressure. The obtained residue and 2.1 g of p-toluenesulfonic acid (pTSA) were added to a mixed solution of 110 mL of THF and 55 mL of IPA, and the mixture was heated and stirred at 40 占 폚 for 8 hours. Ethyl acetate and water were added to extract the organic layer, and the organic layer was washed with saturated brine and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the residue was recrystallized from a mixed solvent of ethyl acetate and heptane to obtain 31.8 g of compound (ex-23).
실시예 3에 기재된 화합물(ex-10) 3.2 g, 화합물(ex-23) 12.1 g, 및 DMAP 0.7 g을, 디클로로메탄 40 mL에 가하고, 질소 분위기 하에서 냉각하면서 교반하였다. 거기에, DCC 5.9 g의 디클로로메탄 용액 12 mL를 적하하였다. 적하 후, 실온에서 16시간 교반하였다. 석출한 침전물을 여과하고, 유기층을 물로 세정하고, 무수 황산 마그네슘으로 건조하였다. 감압 하에서 디클로로메탄을 증류 제거하고, 잔사를 컬럼 크로마토그래피(실리카겔, 용리액: 톨루엔-아세트산 에틸 혼합물(용량비: 톨루엔/아세트산 에틸=4/1))로 정제하고, 메탄올로 재결정함으로써, 화합물(1-1-6-1) 10.7 g을 얻었다.3.2 g of the compound (ex-10) described in Example 3, 12.1 g of the compound (ex-23) and 0.7 g of DMAP were added to 40 mL of dichloromethane and stirred under cooling in a nitrogen atmosphere. 12 mL of a dichloromethane solution of 5.9 g of DCC was added dropwise thereto. After dropwise addition, the mixture was stirred at room temperature for 16 hours. The precipitated precipitate was filtered, and the organic layer was washed with water and dried over anhydrous magnesium sulfate. Dichloromethane was distilled off under reduced pressure and the residue was purified by column chromatography (silica gel, eluant: toluene-ethyl acetate mixture (volume ratio: toluene / ethyl acetate = 4/1)) and recrystallized from methanol to obtain 1- 1-6-1).
얻어진 화합물(1-1-6-1)의 상전이 온도 및 NMR 분석값은 하기와 같다.The phase transition temperature and NMR analysis value of the obtained compound (1-1-6-1) are as follows.
상전이 온도(℃): C 90 (N 70 ) IPhase transition temperature (캜): C 90 (N 70) I
1H-NMR(CDCl3; δppm): 7.67(d, 2H), 7.44(t, 2H), 7.38(t, 1H), 7.33(s, 1H), 7.15-7.08(m, 6H), 6.83(d, 4H), 6.40(d, 2H), 6.17-6.08(m, 2H), 5.81(d, 2H), 4.85-4.76(m, 2H), 4.17(t, 4H), 3.94(t, 4H), 2.90(t, 4H), 2.73-2.65(m, 2H), 2.62(t, 4H), 2.31-2.24(m, 4H), 2.15-2.07(m, 4H), 1.86-1.67(m, 12H), 1.56-1.41(m, 12H). 1 H-NMR (CDCl 3; δppm): 7.67 (d, 2H), 7.44 (t, 2H), 7.38 (t, 1H), 7.33 (s, 1H), 7.15-7.08 (m, 6H), 6.83 ( 4H), 3.94 (t, 4H), 4.80 (d, 2H) 2H), 2.62 (t, 4H), 2.31-2.24 (m, 4H), 2.15-2.07 (m, 4H), 1.86-1.67 (m, 12H) , 1.56-1.41 (m, 12H).
[실시예 6][Example 6]
하기 화합물(1-1-6-2)을 실시예 3에 기재된 합성법에 있어서 벤질메르캅탄을 4-클로로벤질메르캅탄으로 변경한 점 이외에는 동일한 방법으로 합성하였다.The following compound (1-1-6-2) was synthesized in the same manner as in Example 3, except that benzyl mercaptan was changed to 4-chlorobenzyl mercaptan.
[화학식 43](43)
얻어진 화합물(1-1-6-2)의 상전이 온도 및 NMR 분석값은 하기와 같다.The phase transition temperature and NMR analysis values of the obtained compound (1-1-6-2) are as follows.
상전이 온도(℃): C 90 (N 39 ) IPhase transition temperature (캜): C 90 (N 39) I
1H-NMR(CDCl3; δppm): 7.60(d, 2H), 7.41(d, 2H), 7.30(s, 1H), 7.15-7.08(m, 6H), 6.82(d, 4H), 6.40(d, 2H), 6.16-6.09(m, 2H), 5.81(d, 2H), 4.84-4.76(m, 2H), 4.17(t, 4H), 3.94(t, 4H), 2.90(t, 4H), 2.72-2.58(m, 6H), 2.31-2.23(m, 4H), 2.15-2.07(m, 4H), 1.86-1.67(m, 12H), 1.56-1.42(m, 12H). 1 H-NMR (CDCl 3; δppm): 7.60 (d, 2H), 7.41 (d, 2H), 7.30 (s, 1H), 7.15-7.08 (m, 6H), 6.82 (d, 4H), 6.40 ( 4H), 3.94 (t, 4H), 2.90 (t, 4H), 4.94 (m, 2H) , 2.72-2.58 (m, 6H), 2.31-2.23 (m, 4H), 2.15-2.07 (m, 4H), 1.86-1.67 (m, 12H), 1.56-1.42 (m, 12H).
[실시예 7][Example 7]
하기 화합물(1-1-15-1)을 다음과 같이 하여 합성하였다.The following compound (1-1-15-1) was synthesized as follows.
[화학식 44](44)
실시예 2에 기재된 화합물(ex-3) 5.0g, 및 DMF 0.02 mL를, 염화 티오닐 30 mL에 가하고, 질소 분위기 하 1시간 환류 교반하였다. 감압 하에서 염화 티오닐을 증류 제거하고, 또한 톨루엔을 가하고 감압 하에서 톨루엔을 증류 제거했다. 얻어진 잔사를, THF 100mL에 가하고, 질소 분위기 하 10℃ 이하에서 교반하였다. 거기에, 2-아미노벤젠티올 2.6 g을 적하하였다. 적하 후 1시간 10℃ 이하에서 교반하고, 또한 트리에틸아민 2.3 g을 첨가하였다. 첨가 후, 8시간 실온에서 교반하였다. 아세트산 에틸 및 물을 가하고 유기층을 추출하였다. 유기층을 포화 중조수 및 물로 세정하고, 무수 황산 마그네슘으로 건조하였다. 감압 하에서 THF 및 아세트산 에틸를 증류 제거하고, 잔사를 컬럼 크로마토그래피(실리카겔, 용리액: 톨루엔-디클로로메탄 혼합물(용량비: 톨루엔/디클로로메탄=2/1))로 정제하고, 감압 건조함으로써, 화합물(ex-24) 1.2 g을 얻었다.5.0 g of the compound (ex-3) described in Example 2 and 0.02 mL of DMF were added to 30 mL of thionyl chloride, and the mixture was stirred under reflux for 1 hour under a nitrogen atmosphere. Thionyl chloride was distilled off under reduced pressure, toluene was added, and toluene was distilled off under reduced pressure. The resulting residue was added to 100 mL of THF and stirred at 10 DEG C or lower in a nitrogen atmosphere. Then, 2.6 g of 2-aminobenzenethiol was added dropwise thereto. After the dropwise addition, the mixture was stirred at 10 DEG C or lower for 1 hour, and 2.3 g of triethylamine was further added. After the addition, the mixture was stirred at room temperature for 8 hours. Ethyl acetate and water were added and the organic layer was extracted. The organic layer was washed with saturated aqueous sodium hydrogencarbonate and water, and dried over anhydrous magnesium sulfate. THF and ethyl acetate were distilled off under reduced pressure and the residue was purified by column chromatography (silica gel, eluent: toluene-dichloromethane mixture (volume ratio: toluene / dichloromethane = 2/1)) and dried under reduced pressure, 24).
화합물(ex-24) 1.2 g을 아세토니트릴(MeCN) 24 mL에 가하고, 질소 분위기 하, 실온에서 교반하였다. 거기에, CAN 4.2 g의 수용액 10 mL를 적하하였다. 적하 후, 실온에서 4시간 교반하였다. 디클로로메탄 및 물을 가하고 유기층을 추출하고, 또한 유기층을 물로 세정하고, 무수 황산 마그네슘으로 건조하였다. 감압 하에서 디클로로메탄을 증류 제거함으로써, 화합물(ex-25) 1.0 g을 얻었다.1.2 g of the compound (ex-24) was added to 24 mL of acetonitrile (MeCN), and the mixture was stirred at room temperature under a nitrogen atmosphere. There, 10 mL of an aqueous solution of 4.2 g of CAN was added dropwise. After dropwise addition, the mixture was stirred at room temperature for 4 hours. Dichloromethane and water were added, the organic layer was extracted, and the organic layer was washed with water and dried over anhydrous magnesium sulfate. Dichloromethane was distilled off under reduced pressure to obtain 1.0 g of compound (ex-25).
화합물(ex-25) 1.0 g을, 에탄올 10 mL에 가하고, 질소 분위기 하, 10℃ 이하에서 교반하였다. 거기에, 수소화 붕소 나트륨 0.3 g을 첨가하였다. 그 후, 10℃ 이하에서 3시간 교반하였다. 반응액에 1 N 염산수를 10 mL 가하고, 이어서, 물을 10 mL 가하였다. 석출물을 여과하고, 대량의 물로 세정함으로써, 화합물(ex-26) 0.9 g을 얻었다.Compound (ex-25) (1.0 g) was added to ethanol (10 mL), and the mixture was stirred at 10 ° C or lower under a nitrogen atmosphere. To this, 0.3 g of sodium borohydride was added. Thereafter, the mixture was stirred at 10 DEG C or lower for 3 hours. 10 mL of 1 N hydrochloric acid was added to the reaction solution, and then 10 mL of water was added. The precipitate was filtered and washed with a large amount of water to obtain 0.9 g of Compound (ex-26).
화합물(ex-26) 0.9 g, 실시예 5에 기재된 화합물(ex-23) 2.8 g, 및 DMAP 0.2 g을, 디클로로메탄 30 mL에 가하고, 질소 분위기 하에서 냉각하면서 교반하였다. 거기에, DCC 1.3 g의 디클로로메탄 용액 5 mL를 적하하였다. 적하 후, 실온에서 16시간 교반하였다. 석출한 침전물을 여과하고, 유기층을 물로 세정하고, 무수 황산 마그네슘으로 건조하였다. 감압 하에서 디클로로메탄을 증류 제거하고, 잔사를 컬럼 크로마토그래피(실리카겔, 용리액: 톨루엔-아세트산 에틸 혼합물(용량비: 톨루엔/아세트산 에틸=4/1))로 정제하고, 메탄올로 재결정함으로써, 화합물(1-1-15-1) 1.0 g을 얻었다.0.9 g of the compound (ex-26), 2.8 g of the compound (ex-23) described in Example 5, and 0.2 g of DMAP were added to 30 mL of dichloromethane and stirred under cooling in a nitrogen atmosphere. Then, 5 mL of a dichloromethane solution of 1.3 g of DCC was added dropwise thereto. After dropwise addition, the mixture was stirred at room temperature for 16 hours. The precipitated precipitate was filtered, and the organic layer was washed with water and dried over anhydrous magnesium sulfate. Dichloromethane was distilled off under reduced pressure and the residue was purified by column chromatography (silica gel, eluent: toluene-ethyl acetate mixture (volume ratio: toluene / ethyl acetate = 4/1)) and recrystallized from methanol to obtain 1- 1-15-1) was obtained.
얻어진 화합물(1-1-15-1)의 상전이 온도 및 NMR 분석값은 하기와 같다.The phase transition temperature and NMR analysis values of the obtained compound (1-1-15-1) are as follows.
상전이 온도(℃): C 104 (N 79 ) IPhase transition temperature (캜): C 104 (N 79) I
1H-NMR(CDCl3; δppm): 8.10(d, 1H), 7.91(d, 1H), 7.71(s, 1H), 7.53(t, 1H), 7.44(t, 1H), 7.24(d, 1H), 7.18-7.11(m, 5H), 6.83(d, 4H), 6.40(d, 2H), 6.16-6.09(m, 2H), 5.81(d, 2H), 4.87-4.77(m, 2H), 4.17(t, 4H), 3.94(t, 4H), 2.92(t, 4H), 2.77-2.58(m, 6H), 2.34-2.24(m, 4H), 2.18-2.09(m, 4H), 1.87-1.67(m, 12H), 1.57-1.42(m, 12H). 1 H-NMR (CDCl 3; δppm): 8.10 (d, 1H), 7.91 (d, 1H), 7.71 (s, 1H), 7.53 (t, 1H), 7.44 (t, 1H), 7.24 (d, 2H), 5.81 (d, 2H), 4.87-4.77 (m, 2H), 7.18-7.11 (m, 5H), 6.83 (d, , 4.17 (t, 4H), 3.94 (t, 4H), 2.92 (t, 4H), 2.77-2.58 (m, 6H), 2.34-2.24 -1.67 (m, 12H), 1.57 - 1.42 (m, 12H).
[실시예 8][Example 8]
하기 화합물(1-1-20-1)을 다음과 같이 하여 합성하였다.The following compound (1-1-20-1) was synthesized as follows.
[화학식 45][Chemical Formula 45]
4-브로모메틸비페닐 8.0 g, 탄산 칼륨 9.8 g을, THF 40ml에 가하고, 질소 분위기 하 실온에서 교반하였다. 거기에, 티오아세트산 3.0 g을 적하하였다. 적하 후, 실온에서 1시간 교반하였다. 그 후, 반응액에 MeOH를 40 ml에 가하고, 1시간 더 교반했다. 3 N 염산 수용액을 적하함으로써 중화하고, 아세트산 에틸를 가하여 추출하였다. 또한, 유기층을 물로 세정하고, 무수 황산 마그네슘으로 건조하였다. 감압 하에서 용제를 증류 제거하여, 화합물(ex-27) 6.4 g을 얻었다.8.0 g of 4-bromomethylbiphenyl and 9.8 g of potassium carbonate were added to 40 ml of THF, and the mixture was stirred at room temperature under a nitrogen atmosphere. Thereto, 3.0 g of thioacetic acid was added dropwise. After dropwise addition, the mixture was stirred at room temperature for 1 hour. Thereafter, 40 ml of MeOH was added to the reaction solution, and the mixture was further stirred for 1 hour. The reaction mixture was neutralized by dropwise addition of 3 N aqueous hydrochloric acid solution and extracted with ethyl acetate. Further, the organic layer was washed with water and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure to obtain 6.4 g of compound (ex-27).
화합물(ex-7) 5.5 g, 화합물(ex-27) 5.8 g, 및 탄산 칼륨 4.0 g을, N,N-디메틸포름아미드(DMF) 55 ml에 가하고, 질소 분위기 하 60℃에서 가열하면서 4시간 교반하였다. 거기에, 수산화 칼륨 1.6 g을 첨가하고, 100℃에서 1시간 교반하였다. 반응액에 물을 주입하고, 석출물을 여과하고, 물 및 메탄올로 세정하였다. 얻어진 결정을, 톨루엔 및 메탄올의 혼합 용액으로 재결정함으로써, 화합물(ex-28) 2.4 g을 얻었다.5.5 g of the compound (ex-7), 5.8 g of the compound (ex-27) and 4.0 g of potassium carbonate were added to 55 ml of N, N-dimethylformamide (DMF) Lt; / RTI > Thereto was added 1.6 g of potassium hydroxide, and the mixture was stirred at 100 占 폚 for 1 hour. Water was poured into the reaction solution, the precipitate was filtered, and washed with water and methanol. The obtained crystals were recrystallized from a mixed solution of toluene and methanol to obtain 2.4 g of the compound (ex-28).
화합물(ex-28) 2.0 g을 아세토니트릴(MeCN) 60 mL에 가하고, 질소 분위기 하, 실온에서 교반하였다. 거기에, 헥사니트토세륨(IV)산 암모늄(CAN) 6.2 g의 수용액 35 mL를 적하하였다. 적하 후, 실온에서 2시간 교반하였다. 디클로로메탄 및 물을 가하여 추출하고, 또한 유기층을 물로 세정하고, 무수 황산 마그네슘으로 건조하였다. 감압 하에서 용제를 증류 제거함으로써, 화합물(ex-29) 1.3 g을 얻었다.2.0 g of the compound (ex-28) was added to 60 mL of acetonitrile (MeCN), and the mixture was stirred at room temperature under a nitrogen atmosphere. Then, 35 mL of an aqueous solution of 6.2 g of ammonium hexanoate (IV) (CAN) (CAN) was added dropwise thereto. After dropwise addition, the mixture was stirred at room temperature for 2 hours. Dichloromethane and water were added to extract, and the organic layer was washed with water and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure to obtain 1.3 g of compound (ex-29).
화합물(ex-29) 1.3 g을, 에탄올 13 mL에 가하고, 질소 분위기 하, 10℃ 이하에서 교반하였다. 거기에, 수소화 붕소 나트륨 0.3 g을 첨가하였다. 그 후, 10℃ 이하에서 3시간 교반하였다. 반응액에 1 N 염산수를 13 mL 가하고, 이어서, 물을 13 mL 부가하였다. 석출물을 여과하고, 대량의 물로 세정함으로써, 화합물(ex-30) 1.3 g을 얻었다.1.3 g of the compound (ex-29) was added to 13 mL of ethanol, and the mixture was stirred at 10 DEG C or lower under a nitrogen atmosphere. To this, 0.3 g of sodium borohydride was added. Thereafter, the mixture was stirred at 10 DEG C or lower for 3 hours. To the reaction solution was added 13 mL of 1N hydrochloric acid water, and then 13 mL of water was added. The precipitate was filtered and washed with a large amount of water to obtain 1.3 g of Compound (ex-30).
화합물(ex-23) 3.7 g, 화합물(ex-30) 1.3 g, 및 N,N-디메틸-4-아미노피리딘(DMAP) 0.2 g을, 디클로로메탄 37 mL에 가하고, 질소 분위기 하에서 냉각하면서 교반하였다. 거기에, N,N'-디시클로헥실카르보디이미드(DCC) 1.8 g의 디클로로메탄 용액 4 mL를 적하하였다. 적하 후, 실온에서 16시간 교반하였다. 석출한 침전물을 여과하고, 유기층을 물로 세정하고, 무수 황산 마그네슘으로 건조하였다. 감압 하에서 디클로로메탄을 증류 제거하고, 잔사를 컬럼 크로마토그래피(실리카겔, 용리액: 톨루엔-아세트산 에틸 혼합물(용량비: 톨루엔/아세트산 에틸=10/1))로 정제하고, 메탄올로 재결정함으로써, 화합물(1-1-20-1) 1.6 g을 얻었다.3.7 g of the compound (ex-23), 1.3 g of the compound (ex-30) and 0.2 g of N, N-dimethyl-4-aminopyridine (DMAP) were added to 37 mL of dichloromethane and stirred under cooling in a nitrogen atmosphere . Then, 4 mL of a dichloromethane solution containing 1.8 g of N, N'-dicyclohexylcarbodiimide (DCC) was added dropwise thereto. After dropwise addition, the mixture was stirred at room temperature for 16 hours. The precipitated precipitate was filtered, and the organic layer was washed with water and dried over anhydrous magnesium sulfate. Dichloromethane was distilled off under reduced pressure and the residue was purified by column chromatography (silica gel, eluant: toluene-ethyl acetate mixture (volume ratio: toluene / ethyl acetate = 10/1)) and recrystallized from methanol to obtain 1- 1-20-1) was obtained.
얻어진 화합물(1-1-20-1)의 상전이 온도 및 NMR 분석값은 하기와 같다.The phase transition temperature and NMR analysis values of the obtained compound (1-1-20-1) are as follows.
상전이 온도(℃): C 103 IPhase transition temperature (캜): C 103 I
1H-NMR(CDCl3; δppm): 7.75(d, 2H), 7.69-7.62(m, 4H), 7.48(t, 2H), 7.41-7.36(m, 2H), 7.15-7.09(m, 6H), 6.83(d, 4H), 6.40(d, 2H), 6.16-6.08(m, 2H), 5.82(d, 2H), 4.85-4.77(m, 2H), 4.17(t, 4H), 3.94(t, 4H), 2.91(t, 4H), 2.74-2.57(m, 6H), 2.33-2.25(m, 4H), 2.16-2.08(m, 4H), 1.87-1.66(m, 12H), 1.55-1.41(m, 12H). 1 H-NMR (CDCl 3; δppm): 7.75 (d, 2H), 7.69-7.62 (m, 4H), 7.48 (t, 2H), 7.41-7.36 (m, 2H), 7.15-7.09 (m, 6H ), 6.83 (d, 4H), 6.40 (d, 2H), 6.16-6.08 (m, 2H), 5.82 (d, 2H), 4.85-4.77 (m, 4H), 2.91 (t, 4H), 2.74-2.57 1.41 (m, 12 H).
[실시예 9][Example 9]
하기 화합물(1-1-6-3)을 실시예 8에 기재된 합성법에 있어서 4-브로모메틸비페닐을 4-시아노벤질브로마이드로 변경한 점 이외에는 동일한 방법으로 합성하였다.The following compound (1-1-6-3) was synthesized in the same manner as in Example 8, except that 4-bromomethylbiphenyl was changed to 4-cyanobenzyl bromide.
[화학식 46](46)
얻어진 화합물(1-1-6-3)의 상전이 온도 및 NMR 분석값은 하기와 같다.The phase transition temperature and NMR analysis value of the obtained compound (1-1-6-3) are as follows.
상전이 온도(℃): C 109 IPhase transition temperature (캜): C 109 I
1H-NMR(CDCl3; δppm): 7.78(d, 2H), 7.73(m, 2H), 7.44(s, 1H), 7.19-7.08(m, 6H), 6.93(d, 4H), 6.40(d, 2H), 6.16-6.08(m, 2H), 5.82(d, 2H), 4.85-4.77(m, 2H), 4.17(t, 4H), 3.94(t, 4H), 2.91(t, 4H), 2.74-2.57(m, 6H), 2.33-2.23(m, 4H), 2.16-2.07(m, 4H), 1.87-1.66(m, 12H), 1.55-1.41(m, 12H). 1 H-NMR (CDCl 3; δppm): 7.78 (d, 2H), 7.73 (m, 2H), 7.44 (s, 1H), 7.19-7.08 (m, 6H), 6.93 (d, 4H), 6.40 ( 4H), 3.94 (t, 4H), 2.91 (t, 4H), 4.91 (d, 2H), 6.16-6.08 (m, 2H) , 2.74-2.57 (m, 6H), 2.33-2.23 (m, 4H), 2.16-2.07 (m, 4H), 1.87-1.66 (m, 12H), 1.55-1.41 (m, 12H).
[실시예 10][Example 10]
하기 화합물(1-1-6-4)을 실시예 8에 기재된 합성법에 있어서 4-브로모메틸비페닐을 4-트리플루오로메틸벤질브로마이드로 변경한 점 이외에는 동일한 방법으로 합성하였다.The following compound (1-1-6-4) was synthesized in the same manner as in Example 8, except that 4-bromomethylbiphenyl was changed to 4-trifluoromethylbenzyl bromide.
[화학식 47](47)
얻어진 화합물(1-1-6-4)의 상전이 온도 및 NMR 분석값은 하기와 같다.The phase transition temperature and NMR analysis value of the obtained compound (1-1-6-4) are as follows.
상전이 온도(℃): C 119 (N 35) IPhase transition temperature (캜): C 119 (N 35) I
1H-NMR(CDCl3; δppm): 7.78(d, 2H), 7.70(m, 2H), 7.41(s, 1H), 7.18-7.10(m, 6H), 6.83(d, 4H), 6.40(d, 2H), 6.16-6.08(m, 2H), 5.82(d, 2H), 4.85-4.77(m, 2H), 4.17(t, 4H), 3.94(t, 4H), 2.91(t, 4H), 2.74-2.57(m, 6H), 2.33-2.23(m, 4H), 2.16-2.07(m, 4H), 1.87-1.66(m, 12H), 1.55-1.41(m, 12H). 1 H-NMR (CDCl 3; δppm): 7.78 (d, 2H), 7.70 (m, 2H), 7.41 (s, 1H), 7.18-7.10 (m, 6H), 6.83 (d, 4H), 6.40 ( 4H), 3.94 (t, 4H), 2.91 (t, 4H), 4.91 (d, 2H), 6.16-6.08 (m, 2H) , 2.74-2.57 (m, 6H), 2.33-2.23 (m, 4H), 2.16-2.07 (m, 4H), 1.87-1.66 (m, 12H), 1.55-1.41 (m, 12H).
[실시예 11][Example 11]
하기 화합물(1-1-21-1)을 다음과 같이 하여 합성하였다.The following compound (1-1-21-1) was synthesized as follows.
[화학식 48](48)
화합물(ex-3) 5.0 g, 벤조일히드라진 2.9 g, 및 N,N-디메틸-4-아미노피리딘(DMAP) 0.5 g을, 디클로로메탄 100 mL에 가하고, 질소 분위기 하, 냉각하면서 교반하였다. 거기에, 염산 1-에틸-3-(3-디메틸아미노프로필)카르보디이미드(EDC·HCl) 4.4 g의 디클로로메탄 용액 8 mL를 적하하였다. 적하 후, 실온에서 16시간 교반하였다. 반응액에 물을 첨가하고, 결정을 여과하고, 얻어진 결정을 물, 디클로로메탄으로 세정함으로써, 화합물(ex-31) 5.4 g을 얻었다.5.0 g of the compound (ex-3), 2.9 g of benzoyl hydrazine and 0.5 g of N, N-dimethyl-4-aminopyridine (DMAP) were added to 100 mL of dichloromethane and stirred under cooling in a nitrogen atmosphere. Then, 8 mL of a dichloromethane solution of 4.4 g of 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (EDC.HCl) was added dropwise thereto. After dropwise addition, the mixture was stirred at room temperature for 16 hours. Water was added to the reaction solution, and the crystals were filtered, and the obtained crystals were washed with water and dichloromethane to obtain 5.4 g of Compound (ex-31).
화합물(ex-31) 5.3 g, 및 디이소프로필에틸아민(DIPEA) 5.8 g을, 아세토니트릴 265 ml에 가하고, 질소 분위기 하 실온에서 교반하였다. 거기에, 토실클로라이드(TsCl)수산화 칼륨 11.3 g을 첨가하고, 실온에서 16시간 더 교반하였다. 결정을 여과하고, 얻어진 결정을 물, 메탄올로 세정함으로써, 화합물(ex-32) 4.8 g을 얻었다.5.3 g of the compound (ex-31) and 5.8 g of diisopropylethylamine (DIPEA) were added to 265 ml of acetonitrile, and the mixture was stirred at room temperature under a nitrogen atmosphere. Thereto, 11.3 g of tosyl chloride (TsCl) potassium hydroxide was added, and the mixture was further stirred at room temperature for 16 hours. The crystals were filtered, and the obtained crystals were washed with water and methanol to obtain 4.8 g of the compound (ex-32).
화합물(ex-32) 3.8 g을 디클로로메탄 76 mL에 가하고, 질소 분위기 하 -70℃ 이하에서 교반하였다. 거기에, 삼브롬화 붕소 6.2 g을 적하하였다. 적하 후, -70℃ 이하에서 2시간 교반하고, 이어서, 실온에서 8시간 교반했다. 반응액을 물에 가하고, 석출한 결정을 물, 메탄올로 세정함으로써, 화합물(ex-33) 3.2 g을 얻었다.3.8 g of the compound (ex-32) was added to 76 mL of dichloromethane, and the mixture was stirred at -70 占 폚 or lower in a nitrogen atmosphere. Then, 6.2 g of boron tribromide was added dropwise thereto. After the dropwise addition, the mixture was stirred at -70 DEG C or lower for 2 hours, and then stirred at room temperature for 8 hours. The reaction solution was added to water, and the precipitated crystals were washed with water and methanol to obtain 3.2 g of Compound (ex-33).
화합물(ex-23) 5.0 g, 화합물(ex-33) 1.7 g, 및 N,N-디메틸-4-아미노피리딘(DMAP) 0.3 g을, 디클로로메탄 50 mL에 가하고, 질소 분위기 하, 냉각하면서 교반하였다. 거기에, N,N'-디시클로헥실카르보디이미드(DCC) 2.4 g의 디클로로메탄 용액 5 mL를 적하하였다. 적하 후, 실온에서 16시간 교반하였다. 석출한 침전물을 여과하고, 유기층을 물로 세정하고, 무수 황산 마그네슘으로 건조하였다. 감압 하에서 디클로로메탄을 증류 제거하고, 잔사를 컬럼 크로마토그래피(실리카겔, 용리액: 톨루엔-아세트산 에틸 혼합물(용량비: 톨루엔/아세트산 에틸=10/1))로 정제하고, 메탄올로 재결정함으로써, 화합물(1-1-21-1) 3.2 g을 얻었다.5.0 g of the compound (ex-23), 1.7 g of the compound (ex-33) and 0.3 g of N, N-dimethyl-4-aminopyridine (DMAP) were added to 50 mL of dichloromethane, Respectively. Then, 5 mL of a dichloromethane solution containing 2.4 g of N, N'-dicyclohexylcarbodiimide (DCC) was added dropwise thereto. After dropwise addition, the mixture was stirred at room temperature for 16 hours. The precipitated precipitate was filtered, and the organic layer was washed with water and dried over anhydrous magnesium sulfate. Dichloromethane was distilled off under reduced pressure and the residue was purified by column chromatography (silica gel, eluant: toluene-ethyl acetate mixture (volume ratio: toluene / ethyl acetate = 10/1)) and recrystallized from methanol to obtain 1- 1-21-1) was obtained.
얻어진 화합물(1-1-21-1)의 상전이 온도 및 NMR 분석값은 하기와 같다.The phase transition temperature and NMR analysis value of the obtained compound (1-1-21-1) are as follows.
상전이 온도(℃): C 122 (N 99) IPhase transition temperature (캜): C 122 (N 99) I
1H-NMR(CDCl3; δppm): 8.17(d, 2H), 7.90(s, 1H), 7.63-7.55(m, 3H), 7.30(d, 1H), 7.21(d, 1H), 7.13(d, 4H), 6.84(d, 4H), 6.40(d, 2H), 6.16-6.08(m, 2H), 5.82(d, 2H), 4.85-4.77(m, 2H), 4.17(t, 4H), 3.94(t, 4H), 2.91(t, 4H), 2.74-2.57(m, 6H), 2.33-2.25(m, 4H), 2.16-2.08(m, 4H), 1.87-1.66(m, 12H), 1.55-1.41(m, 12H). 1 H-NMR (CDCl 3; δppm): 8.17 (d, 2H), 7.90 (s, 1H), 7.63-7.55 (m, 3H), 7.30 (d, 1H), 7.21 (d, 1H), 7.13 ( 2H), 4.17 (t, 4H), 6.84 (d, 2H), 6.84 (d, 2H) , 3.94 (t, 4H), 2.91 (t, 4H), 2.74-2.57 (m, 6H), 2.33-2.25 (m, 4H), 2.16-2.08 , 1.55-1.41 (m, 12H).
<액정 조성물의 제작>≪ Preparation of liquid crystal composition &
[실시예 12][Example 12]
상기 합성한 본 발명 화합물과 이하에 나타내는 화합물(M2-7-1), (M1-15-1), (M1-16-1) 및 (M1-17-1)을 사용하여 액정 조성물(S-1∼S-12)을 제작하였다.Using the thus synthesized compound of the present invention and the following compounds (M2-7-1), (M1-15-1), (M1-16-1) and (M1-17-1) 1 to S-12).
[화학식 49](49)
액정 조성물에서의 본 발명 화합물의 종류와 함유량, 그 외의 중합성 액정 화합물의 종류와 함유량, 중합 개시제의 함유량, 계면활성제의 함유량, 및 용제의 함유량을 표 1에 나타내었다. 여기서 표 1 중, %는 액정 조성물의 총중량을 100 중량%로 했을 때의 각각의 재료의 함유 중량%를 나타낸다. 중합 개시제는 이르가큐어 907(BASF 재팬(주) 제조)를 사용하였고, 계면활성제는 프타젠트 FTX-218((주)네오스 제조)을 사용하였고, 용제는 시클로펜타논과 톨루엔의 혼합 용액(시클로펜타논톨루엔의 혼합 비율은 중량비로 1/1)을 사용하였다.Table 1 shows the kind and content of the compound of the present invention in the liquid crystal composition, the kind and content of the other polymerizable liquid crystal compound, the content of the polymerization initiator, the content of the surfactant, and the content of the solvent. In Table 1,% represents the content by weight of each material when the total weight of the liquid crystal composition is 100 wt%. Irgacure 907 (BASF Japan Co., Ltd.) was used as the polymerization initiator, Phtagent FTX-218 (manufactured by Neos Corporation) as the surfactant, and the solvent was a mixed solution of cyclopentanone and toluene The mixing ratio of non-toluene was 1/1 by weight.
[표 1][Table 1]
[실시예 13][Example 13]
<액정 조성물의 작성>≪ Preparation of liquid crystal composition &
실시예 12와 동일한 방법으로 액정 조성물을 작성하였다. 단, 중합 개시제는 아데카크루즈 NCI-930((주)ADEKA 제조)을, 용제는 시클로헥사논을 사용하였다.A liquid crystal composition was prepared in the same manner as in Example 12. The polymerization initiator was Adeka Cruz NCI-930 (manufactured by ADEKA Corporation), and cyclohexanone was used as the solvent.
[표 2][Table 2]
[비교예 1][Comparative Example 1]
실시예 12에 기재된 방법과 동일한 방법으로 상기 화합물(M2-7-1), (M1-15-1) 및 (M1-16-1)과 하기 화합물(C-1)을 사용하여 액정 조성물(SC-1∼SC-3)을 제작하였다.The liquid crystal composition (SC) was prepared by using the above-mentioned compounds (M2-7-1), (M1-15-1) and (M1-16-1) and the following compound (C- -1 to SC-3).
[화학식 50](50)
[표 3][Table 3]
<광학 이방성 필름의 제작>≪ Fabrication of optically anisotropic film &
[실시예 14][Example 14]
실시예 12 및 실시예 13에서 제작한 액정 조성물(S-1)∼(S-12)을, 러빙 처리된 배향막이 형성된 유리 기판 상에 스핀 코팅에 의해 도포했다. 이 기판을 80℃에서 2분간 가열하고, 실온에서 1분간 냉각시키고, 용제가 제거된 중합성 액정층을 공기 중에서 자외선에 의해 중합시켜, 액정의 배향 상태를 고정시킨 광학 이방성 필름을 얻었다. 이들 얻어진 광학 이방 필름을 편광 현미경 관찰 및 편광 해석 장치에서 확인한 바, 배향 결함이 없고 균일한 호모지니어스 배향을 가지고 있었다.The liquid crystal compositions (S-1) to (S-12) prepared in Example 12 and Example 13 were applied to a glass substrate on which a rubbed alignment film was formed by spin coating. The substrate was heated at 80 DEG C for 2 minutes, cooled at room temperature for 1 minute, and the polymerizable liquid crystal layer from which the solvent had been removed was polymerized by ultraviolet light in air to obtain an optically anisotropic film in which the alignment state of the liquid crystal was fixed. These obtained optical anisotropic films were confirmed by a polarization microscope observation and a polarization analyzer, and homogeneous homogeneous orientation was observed without alignment defects.
[비교예 2][Comparative Example 2]
실시예 14에 기재된 방법과 마찬가지로, 비교예 1에서 제작한 액정 조성물(SC-1)∼(SC-3)로부터 광학 이방성 필름을 얻었다. 이들 얻어진 광학 이방 필름을 편광 현미경 관찰 및 편광 해석 장치에서 확인한 바, (SC-1) 및 (SC-2)은 배향 결함이 없고 균일한 호모지니어스 배향을 가지고 있는 것을 확인할 수 있었다. (SC-3)은 결정이 석출하고 배향 결함이 생기고 균일한 호모지니어스 배향을 가지는 막은 얻을 수 없었다.An optically anisotropic film was obtained from the liquid crystal compositions (SC-1) to (SC-3) prepared in Comparative Example 1 in the same manner as in the method described in Example 14. When these obtained optical anisotropic films were confirmed by a polarizing microscope observation and a polarization analyzer, it was confirmed that (SC-1) and (SC-2) had homogeneous homogeneous orientation without alignment defects. (SC-3) crystals precipitated, alignment defects occurred, and a film having homogeneous homogeneous orientation could not be obtained.
(SC-3)과 (S-6)을 대비하면, 화합물(C-1)을 사용하는 것만으로는 형성하기 곤란한 균일한 호모지니어스 배향을 가지는 막이, 본 발명의 액정 화합물(1)을 사용하면, 형성 가능하게 되는 것을 알 수 있다.(SC-3) and (S-6), the film having homogeneous homogeneous orientation, which is difficult to be formed only by using the compound (C-1) Can be formed.
<광학 이방성 필름의 광학 특성>≪ Optical properties of optically anisotropic film >
[실시예 15∼26, 비교예 3∼4][Examples 15 to 26, Comparative Examples 3 to 4]
실시예 14 및 비교예 2에서 제작한 광학 이방성 필름의 필름면에 대하여 90°의 리타데이션의 파장 450 ㎚의 측정값(Re450) 및 파장 550 ㎚의 측정값(Re550), 막 두께, 파장 550 ㎚에서의 Δn, 및 파장 분산 특성을 표 4 및 표 5에 나타내었다.(Re 450 ) at a wavelength of 450 nm and a measured value (Re 550 ) at a wavelength of 550 nm with respect to the film surface of the optically anisotropic film produced in Example 14 and Comparative Example 2, ? N at 550 nm, and wavelength dispersion characteristics are shown in Tables 4 and 5.
[표 4][Table 4]
[표 5][Table 5]
실시예 15∼26의 광학 이방성 필름은 비교예 3과 비교하여 파장 분산 특성이 낮은 값을 나타낸다. 이는 본 발명의 화합물을 액정 조성물에 포함시킴으로써 보다 파장 분산 특성을 저하시키는 효과가 있는 것을 지지하는 것이며, 본 발명 화합물을 사용함으로써 얻어지는 광학 이방성 필름의 파장 분산 특성을 제어 가능한 것이 밝혀졌다. 또한, 실시예 20의 광학 이방성 필름에 있어서는 파장 분산 특성이 1 이하의 값을 나타내고, 역파장 분산 특성을 가지는 것을 확인할 수 있었다.The optically anisotropic films of Examples 15 to 26 exhibited lower values of wavelength dispersion characteristics than those of Comparative Example 3. This supports the fact that the compound of the present invention is contained in the liquid crystal composition to lower the wavelength dispersion characteristics, and it has been found that the wavelength dispersion characteristics of the optically anisotropic film obtained by using the compound of the present invention can be controlled. In addition, it was confirmed that the optically anisotropic film of Example 20 had a wavelength dispersion characteristic of 1 or less and had an inverse wavelength dispersion characteristic.
<광학 이방성 필름의 광학 특성의 내열성>≪ Heat resistance of optical properties of optically anisotropic film >
실시예 14 및 비교예 2에서 제작한 광학 이방성 필름을 200℃30분 소성(燒成) 후의 필름면에 대하여 90°의 파장 550 ㎚의 리타데이션을 측정한 결과를 표 6 및 7에 나타내었다. 여기서 표 6 및 7 중, 잔존 Re는 초기의 Re값을 100으로 했을 때의 200℃30분 소성 후의 Re의 값을 나타낸다.The retardation of the optically anisotropic film produced in Example 14 and Comparative Example 2 was measured at a wavelength of 550 nm at 90 DEG with respect to the film surface after firing at 200 DEG C for 30 minutes, and the results are shown in Tables 6 and 7. [ In Tables 6 and 7, the residual Re indicates the value of Re after the firing at 200 占 폚 for 30 minutes at an initial Re value of 100.
[표 6][Table 6]
[표 7][Table 7]
실시예 17∼26의 광학 이방성 필름은 비교예 3 및 4와 비교하여 200℃30분 소성 후의 리타데이션의 잔존율이 크다. 즉 열에 의한 광학 특성의 변화가 작은 것을 알 수 있다.Compared with Comparative Examples 3 and 4, the optically anisotropic films of Examples 17 to 26 had a large residual ratio of retardation after baking at 200 DEG C for 30 minutes. That is, the change in optical characteristics due to heat is small.
<광학 이방성 필름의 기계적 특성>≪ Mechanical properties of optically anisotropic film &
실시예 14 및 비교예 2에서 제작한 광학 이방성 필름의 막 표면의 기계적 강도를 연필 경도 시험에 의해 측정한 결과를 표 8 및 7에 나타내었다. 여기서 표 8 및 7 중, 경도(평행)는 광학 이방성 필름의 배향 방향과 평행한 방향으로 긁은 경우에 흠이 생길 때의 연필심의 형을 나타내고, 경도(수직)는 광학 이방성 필름의 배향 방향과 수직인 방향으로 긁은 경우에 흠이 생길 때 연필심의 경도를 나타낸다.The mechanical strength of the film surface of the optically anisotropic film produced in Example 14 and Comparative Example 2 was measured by pencil hardness test, and the results are shown in Tables 8 and 7. In Tables 8 and 7, the hardness (parallel) represents the shape of the pencil lead when scratches occur in the direction parallel to the alignment direction of the optically anisotropic film, and the hardness (vertical) This indicates the hardness of the pencil lead when scratches are made in the inward direction.
[표 8][Table 8]
[표 9][Table 9]
<액정 조성물의 제작>≪ Preparation of liquid crystal composition &
[실시예 27][Example 27]
본 발명 화합물과 이하에 나타내는 화합물(M2-1-1) 및 (M1-12-1)을 사용하여 액정 조성물(S-13)을 제작하였다.A liquid crystal composition (S-13) was prepared using the compound of the present invention and the following compounds (M2-1-1) and (M1-12-1).
[화학식 51](51)
화합물(1-1-6-1): 화합물(M2-1-1): 화합물(M1-12-1)=33: 33: 34의 중량비로, 이들 화합물을 혼합하였다. 이 조성물을 MIX1이라고 한다. 이 MIX1에 대하여, 중량비 0.10의 GA-1000(오사카 가스케미컬(주) 제조) 및 중량비 0.06의 중합 개시제 이르가큐어 907(BASF 재팬(주) 제조)을 첨가하고, 또한 시클로헥사논을 가하여, 용제의 비율이 75 중량%인 액정 조성물(S-13)로 만들었다.These compounds were mixed at a weight ratio of compound (1-1-6-1): compound (M2-1-1): compound (M1-12-1) = 33: 33: 34. This composition is referred to as MIX1. To this MIX 1, GA-1000 (manufactured by Osaka Gas Chemical Co., Ltd.) having a weight ratio of 0.10 and Irgacure 907 (BASF Japan Co., Ltd.) with a weight ratio of 0.06 were added, and cyclohexanone was further added thereto, Of the liquid crystal composition (S-13) was 75% by weight.
<광학 이방성 필름의 제작>≪ Fabrication of optically anisotropic film &
[실시예 28][Example 28]
실시예 27에서 제작한 액정 조성물(S-13)을, 유리 기판(마쓰나미슬라이드글라스: S-1112) 상에 스핀 코팅에 의해 도포했다. 이 기판을 80℃에서 2분간 가열하고, 실온에서 1분간 냉각시키고, 용제가 제거된 도막을 자외선에 의해 질소 기류 하에서 중합시켜, 균일한 호메오트로픽 배향을 가지는 액정 필름을 얻었다.The liquid crystal composition (S-13) prepared in Example 27 was applied onto a glass substrate (Matsunami Slide Glass: S-1112) by spin coating. This substrate was heated at 80 DEG C for 2 minutes, cooled at room temperature for 1 minute, and the solvent-removed coating film was polymerized under ultraviolet light in a stream of nitrogen to obtain a liquid crystal film having homogeneous homeotropic orientation.
<광학 이방성 필름의 광학 특성>≪ Optical properties of optically anisotropic film >
[실시예 29][Example 29]
실시예 28에서 작성한 광학 이방성 필름의 필름면에 대하여 지상축(遲相軸) 방향으로 45°의 리타데이션의 파장 450 ㎚의 측정값(Re450) 및 파장 550 ㎚의 측정값(Re550)으로부터 산출한 파장 분산 특성은 1.0439였다.(Re 450 ) at a wavelength of 450 nm and a measured value (Re 550 ) at a wavelength of 550 nm with respect to the film surface of the optically anisotropic film prepared in Example 28 at a retardation of 45 degrees in the slow axis direction The calculated wavelength dispersion characteristic was 1.0439.
본 발명의 화합물은 저파장 분산 특성 또는 역파장 분산 특성을 가지고, 또한 비교적 낮은 온도에서 액정상을 나타내고, 상기 화합물을 사용한 액정 조성물은, 파장 분산 특성의 제어가 용이하며, 상용성, 용해성이 뛰어나기 때문에 용이하게 광학 이방성 필름을 얻을 수 있다. 또한, 얻어진 광학 이방성 필름은 높은 기계적 강도나 내열성을 가진다. 그러므로, 이 중합체를 포함하는 필름은, 예를 들면, 위상차막, 광학 보상막, 반사막, 선택 반사막, 반사 방지막, 시야각 보상막, 액정 배향막, 편광 소자, 원편광 소자, 및 타원 편광 소자 등, 및 이들 막 또는 소자를 가지는 표시 소자에 바람직하다.The compound of the present invention has a low-wavelength dispersion property or an inverse wavelength dispersion property and shows a liquid crystal phase at a relatively low temperature. The liquid crystal composition using the compound can easily control the wavelength dispersion characteristics and is excellent in compatibility and dissolution An optically anisotropic film can be easily obtained. Further, the obtained optically anisotropic film has high mechanical strength and heat resistance. Therefore, the film containing the polymer can be used for various applications such as a retardation film, an optical compensating film, a reflective film, a selective reflective film, an antireflection film, a viewing angle compensating film, a liquid crystal alignment film, a polarizing element, a circularly polarizing element, And is preferable for a display element having such a film or element.
Claims (20)
[화학식 1]
(상기 식(1) 중에서,
A1 및 A2는 각각 독립적으로 1,4-페닐렌, 1,4-시클로헥실렌, 1,4-시클로헥세닐렌, 피리딘-2,5-디일, 또는 나프탈렌-2,6-디일이며, 이들에 있어서, 적어도 1개의 수소가, 불소, 염소, 시아노, 하이드록시, 포르밀, 트리플루오로아세틸, 디플루오로메틸, 트리플루오로메틸, 탄소수 1∼5의 알킬, 탄소수 1∼5의 알콕시, 탄소수 1∼5의 알킬에스테르 또는 탄소수 1∼5의 알카노일로 치환될 수도 있고;
Z1 및 Z2는 각각 독립적으로 단결합, -OCH2-, -CH2O-, -COO-, -OCO-, -COS-, -SCO-, -OCOO-, -CONH-, -NHCO-, -CF2O-, -OCF2-, -CH2CH2-, -CF2CF2-, -OCH2CH2O-, -CH=CHCOO-, -OCOCH=CH-, -CH2CH2COO-, -OCOCH2CH2-, -CH2CH2OCO-, -COOCH2CH2-, -CH=CH-, -N=CH-, -CH=N-, -N=CCH3-, -CCH3=N-, -N=N- 또는 -C≡C-이며;
m 및 n은, 각각 독립적으로 0∼3의 정수이며, 또한 1≤m+n≤4이며;
X1은 -O-, -S- 또는 -NR3-이며, R3는 수소, 탄소수 1∼5의 알킬, 또는 탄소수 1∼5의 알카노일이며;
Q1은 수소, 할로겐 또는 1가의 유기기이며;
R1 및 R2는 각각 독립적으로, 수소, 불소, 염소, 트리플루오로메틸, 트리플루오로메톡시, 시아노, 탄소수 1∼20의 알킬, 탄소수 2∼20의 알케닐, 탄소수 1∼20의 알콕시, 탄소수 1∼20의 알킬에스테르 또는 하기 식(2)으로 표시되는 기이고;
[화학식 2]
상기 식(2) 중에서, Y1은 단결합, -O-, -COO-, -OCO- 또는 -OCOO-이며; Y2는 단결합 또는 탄소수 1∼20을 가지는 알킬렌이며, 상기 알킬렌에 있어서 적어도 1개의 -CH2-는 -O-, -COO-, -OCO-, -CH=CH- 또는 -C≡C-로 치환될 수도 있고; PG는 하기 식(PG-1)∼식(PG-8) 중 어느 하나로 표시되는 중합성 기이고;
[화학식 3]
상기 식(PG-1)∼식(PG-8) 중에서, R4는 각각 독립적으로 수소, 할로겐, 메틸, 에틸 또는 트리플루오로메틸임).A compound represented by the following formula (1):
[Chemical Formula 1]
(In the above formula (1)
A 1 and A 2 are each independently 1,4-phenylene, 1,4-cyclohexylene, 1,4-cyclohexenylene, pyridine-2,5-diyl or naphthalene-2,6-diyl , Wherein at least one of the hydrogens is fluorine, chlorine, cyano, hydroxy, formyl, trifluoroacetyl, difluoromethyl, trifluoromethyl, alkyl of 1 to 5 carbon atoms, Alkoxy of 1 to 5 carbon atoms, alkyl ester of 1 to 5 carbon atoms, or alkanoyl of 1 to 5 carbon atoms;
Z 1 and Z 2 are each independently a single bond, -OCH 2 -, -CH 2 O-, -COO-, -OCO-, -COS-, -SCO-, -OCOO-, -CONH-, -NHCO- , -CF 2 O-, -OCF 2 - , -CH 2 CH 2 -, -CF 2 CF 2 -, -OCH 2 CH 2 O-, -CH = CHCOO-, -OCOCH = CH-, -CH 2 CH 2 COO-, -OCOCH 2 CH 2 - , -CH 2 CH 2 OCO-, -COOCH 2 CH 2 -, -CH = CH-, -N = CH-, -CH = N-, -N = CCH 3 - , -CCH 3 = N-, -N = N- , or -C≡C-, and;
m and n are each independently an integer of 0 to 3, and 1? m + n? 4;
X 1 is -O-, -S- or -NR 3 -, and R 3 is hydrogen, alkyl of 1 to 5 carbon atoms, or alkanoyl of 1 to 5 carbon atoms;
Q 1 is hydrogen, halogen or a monovalent organic group;
R 1 and R 2 are each independently hydrogen, fluorine, chlorine, trifluoromethyl, trifluoromethoxy, cyano, alkyl of 1 to 20 carbon atoms, alkenyl of 2 to 20 carbon atoms, alkoxy of 1 to 20 carbon atoms , An alkyl ester having 1 to 20 carbon atoms, or a group represented by the following formula (2);
(2)
In the formula (2), Y 1 is a single bond, -O-, -COO-, -OCO- or -OCOO-; Y 2 is a single bond or alkylene having 1 to 20 carbon atoms, and at least one -CH 2 - in the alkylene is -O-, -COO-, -OCO-, -CH = CH- or -C≡ C-; PG is a polymerizable group represented by any one of the following formulas (PG-1) to (PG-8);
(3)
In the formulas (PG-1) to (PG-8), R 4 is each independently hydrogen, halogen, methyl, ethyl or trifluoromethyl.
상기 식(1) 중에서, Q1이 하기 식(3) 또는 식(4)으로 표시되는 기인, 화합물:
[화학식 4]
(상기 식(3) 및 식(4) 중에서,
Z3는 각각 독립적으로, 단결합, -COO- 또는 -COS-이며;
Z4는 각각 독립적으로, 단결합, -CH=CH-, -N=CH-, -CH=N-, -N=CCH3-, -CCH3=N-, -N=N- 또는 -C≡C-이며;
R5는 수소, 불소, 염소, 시아노, 탄소수 1∼20의 알킬이며, 상기 알킬에 있어서 -CH2- 는 -O-, -S-, -CO-, -COO-, -OCO-, -OCOO-로 치환될 수도 있고, 상기 알킬에 있어서 수소는 할로겐으로 치환될 수도 있고;
A3는 각각 독립적으로, 2가의, 5원환 또는 6원환의 방향환, 또는 이들의 축합환이며, A4는 1가의, 5원환 또는 6원환의 방향환, 또는 이들의 축합환이며, A3 및 A4에서의 방향환 또는 이들의 축합환중 적어도 1개의 수소는 불소, 염소, 시아노, 니트로, 트리플루오로메틸, 트리플루오로메톡시, 탄소수 1∼5의 알킬, 탄소수 1∼5의 알콕시, 탄소수 1∼5의 알킬에스테르, 탄소수 1∼5의 알카노일 또는 탄소수 1∼5의 티오알킬로 치환될 수도 있고;
p는 0∼2의 정수임).The method according to claim 1,
In the above formula (1), Q 1 is a group represented by the following formula (3) or (4)
[Chemical Formula 4]
(In the above formulas (3) and (4)
Z 3 each independently represents a single bond, -COO- or -COS-;
Z 4 each independently represents a single bond, -CH = CH-, -N = CH-, -CH = N-, -N = CCH 3 -, -CCH 3 = N-, -N = N- or -C ≡C-;
R 5 is hydrogen, fluorine, chlorine, cyano or alkyl having 1 to 20 carbon atoms, and -CH 2 - in the alkyl is -O-, -S-, -CO-, -COO-, -OCO-, OCOO-, in which hydrogen may be substituted with halogen;
A 3 is independently an aromatic ring of a divalent, a 5-membered or a 6-membered ring, or a condensed ring thereof, A 4 is an aromatic ring of a monovalent, 5-membered or 6-membered ring, or a condensed ring thereof, and A 3 And at least one hydrogen in the aromatic ring or the condensed ring thereof in A 4 is fluorine, chlorine, cyano, nitro, trifluoromethyl, trifluoromethoxy, alkyl of 1 to 5 carbon atoms, alkoxy of 1 to 5 carbon atoms , An alkyl ester having 1 to 5 carbon atoms, an alkanoyl having 1 to 5 carbon atoms, or a thioalkyl having 1 to 5 carbon atoms;
p is an integer of 0 to 2).
상기 식(1) 중에서, R1 및 R2 중 적어도 1개가 상기 식(2)으로 표시되는 기인, 화합물.The method according to claim 1,
Wherein, in the formula (1), at least one of R 1 and R 2 is a group represented by the formula (2).
상기 식(1) 중에서, X1이 -S-인, 화합물.The method according to claim 1,
In the above formula (1), X 1 is -S-.
상기 식(1) 중에서, A1 및 A2가 각각 독립적으로 1,4-페닐렌 또는 1,4-시클로헥실렌이며, 이들에 있어서, 적어도 1개의 수소가, 불소, 트리플루오로메틸, 탄소수 1∼5의 알킬, 탄소수 1∼5의 알콕시, 탄소수 1∼5의 알킬에스테르 또는 탄소수 1∼5의 알카노일로 치환될 수도 있고;
Z1 및 Z2가 각각 독립적으로 단결합, -OCH2-, -CH2O-, -COO-, -OCO-, -CH=CHCOO-, -OCOCH=CH-, -CH2CH2COO-, -OCOCH2CH2-, -CH2CH2OCO- 또는 -COOCH2CH2-인, 화합물.The method according to claim 1,
In the formula (1), A 1 and A 2 each independently represent 1,4-phenylene or 1,4-cyclohexylene, wherein at least one hydrogen is fluorine, trifluoromethyl, An alkyl group having 1 to 5 carbon atoms, an alkoxy group having 1 to 5 carbon atoms, an alkyl ester having 1 to 5 carbon atoms, or an alkanoyl group having 1 to 5 carbon atoms;
Z 1 and Z 2 are each independently a single bond, -OCH 2 -, -CH 2 O-, -COO-, -OCO-, -CH═CHCOO-, -OCOCH═CH-, -CH 2 CH 2 COO- , -OCOCH 2 CH 2 -, -CH 2 CH 2 OCO- or -COOCH 2 CH 2 - in the compounds.
상기 식(1) 중에서, Q1이 하기 식(4)으로 표시되는 기이며,
[화학식 5]
상기 식(4) 중에서, Z3는, 단결합, -COO- 또는 -COS-이며; Z4는 단결합이며, A3는 각각 독립적으로, 2가의, 5원환 또는 6원환의 방향환, 또는 이들의 축합환이며, A4는 1가의, 5원환 또는 6원환의 방향환, 또는 이들의 축합환이며, A3 및 A4에서의 방향환 또는 이들의 축합환중 적어도 1개의 수소는 불소, 염소, 시아노, 니트로, 트리플루오로메틸, 트리플루오로메톡시, 탄소수 1∼5의 알킬, 탄소수 1∼5의 알콕시, 탄소수 1∼5의 알킬에스테르, 탄소수 1∼5의 알카노일 또는 탄소수 1∼5의티오알킬로 치환될 수도 있고, p는 0 또는 1의 정수인, 화합물.The method according to claim 1,
In the above formula (1), Q 1 is a group represented by the following formula (4)
[Chemical Formula 5]
In the above formula (4), Z 3 is a single bond, -COO- or -COS-; Z 4 is a single bond, A 3 is each independently an aromatic ring of a divalent, five-membered or six-membered ring, or a condensed ring thereof, A 4 is an aromatic ring of a monovalent, And at least one hydrogen of the aromatic rings or condensed rings thereof in A 3 and A 4 is a condensed ring of fluorine, chlorine, cyano, nitro, trifluoromethyl, trifluoromethoxy, alkyl of 1 to 5 carbon atoms , Alkoxy of 1 to 5 carbon atoms, alkyl ester of 1 to 5 carbon atoms, alkanoyl of 1 to 5 carbon atoms or thioalkyl of 1 to 5 carbon atoms, and p is an integer of 0 or 1.
상기 식(1) 중에서, A1 및 A2 중 적어도 1개가 1,4-시클로헥실렌인, 화합물.The method according to claim 1,
In the above formula (1), at least one of A 1 and A 2 is 1,4-cyclohexylene.
상기 식(1) 중에서, Z1 및 Z2 중 적어도 1개가 -CH2CH2COO-, -OCOCH2CH2-, -CH2CH2OCO- 또는 -COOCH2CH2-인, 화합물.The method according to claim 1,
In the above formula (1), at least one of Z 1 and Z 2 is -CH 2 CH 2 COO-, -OCOCH 2 CH 2 -, -CH 2 CH 2 OCO- or -COOCH 2 CH 2 -.
상기 식(1) 중에서, R1 및 R2가 하기 식(2-1)으로 표시되는 기인, 화합물:
[화학식 6]
(상기 식(2-1) 중에서, Y1은 단결합, -O-, -COO-, -OCO- 또는 -OCOO-이며, Y2는 단결합 또는 탄소수 1∼20을 가지는 알킬렌이며, 상기 알킬렌에 있어서 적어도 1개의 -CH2-는 -O-, -COO-, -OCO-, -CH=CH- 또는 -C≡C-로 치환될 수도 있고, R4는 수소 또는 메틸임).The method according to claim 1,
In the above formula (1), R 1 and R 2 are groups represented by the following formula (2-1): Compound:
[Chemical Formula 6]
(2-1), Y 1 is a single bond, -O-, -COO-, -OCO- or -OCOO-, Y 2 is a single bond or alkylene having 1 to 20 carbon atoms, In alkylene, at least one -CH 2 - may be replaced by -O-, -COO-, -OCO-, -CH = CH- or -C≡C-, and R 4 is hydrogen or methyl.
상기 식(1) 중에서, Q1이 하기 식(4-1)∼식(4-9) 중 어느 하나로 표시되는 기인, 화합물:
[화학식 7]
(상기 식(4-1)∼식(4-9) 중에서, X2는 -O- 또는 -S-이며, 적어도 1개의 -CH=는 -N=으로 치환될 수도 있고, 적어도 1개의 수소는 불소, 염소, 시아노, 트리플루오로아세틸, 트리플루오로메틸, 탄소수 1∼5의 알킬, 탄소수 1∼5의 알콕시, 탄소수 1∼5의 알킬에스테르 또는 탄소수 1∼5의 알카노일로 치환될 수도 있고, *는 결합 부위를 나타냄).The method according to claim 1,
In the above formula (1), Q 1 is a group represented by any one of formulas (4-1) to (4-9)
(7)
(In the formulas (4-1) to (4-9), X 2 is -O- or -S-, at least one -CH = may be substituted with -N =, and at least one hydrogen is Which may be substituted with fluorine, chlorine, cyano, trifluoroacetyl, trifluoromethyl, alkyl of 1 to 5 carbon atoms, alkoxy of 1 to 5 carbon atoms, alkyl ester of 1 to 5 carbon atoms or alkanoyl of 1 to 5 carbon atoms And * indicates the binding site).
하기 식(M1) 및 식(M2)으로 표시되는 화합물군으로부터 선택되는 적어도 1개를
함유하는 액정 조성물:
[화학식 8]
(상기 식(M1) 및 (M2) 중에서,
AM은 각각 독립적으로 1,4-페닐렌, 1,4-시클로헥실렌, 1,4-시클로헥세닐렌, 피리딘-2,5-디일, 플루오레논-2,7-디일 또는 나프탈렌-2,6-디일이며, 이들에 있어서, 적어도 1개의 수소가, 불소, 염소, 시아노, 하이드록시, 포르밀, 트리플루오로아세틸, 디플루오로메틸, 트리플루오로메틸, 탄소수 1∼5의 알킬, 탄소수 1∼5의 알콕시, 탄소수 1∼5의 알킬에스테르 또는 탄소수 1∼5의 알카노일로 치환될 수도 있고;
ZM은 각각 독립적으로 단결합, -OCH2-, -CH2O-, -COO-, -OCO-, -COS-, -SCO-, -OCOO-, -CONH-, -NHCO-, -CF2O-, -OCF2-, -CH2CH2-, -CF2CF2-, -CH=CHCOO-, -OCOCH=CH-, -CH2CH2COO-, -OCOCH2CH2-, -CH=CH-, -N=CH-, -CH=N-, -N=CCH3-, -CCH3=N-, -N=N- 또는 -C≡C-이며;
XM은 수소, 불소, 염소, 트리플루오로메틸, 트리플루오로메톡시, 시아노, 탄소수 1∼20의 알킬, 탄소수 2∼20의 알케닐, 탄소수 1∼20의 알콕시 또는 탄소수 1∼20의 알킬에스테르이며;
q는 1∼4의 정수이며;
a는 0∼20의 정수이며;
RM은 수소 또는 메틸이며;
YM은 단결합, -O-, -COO-, -OCO- 또는 -OCOO-임).At least one of the compounds according to claim 1; And
At least one compound selected from the group of compounds represented by the following formulas (M1) and (M2)
Containing liquid crystal composition:
[Chemical Formula 8]
(In the formulas (M1) and (M2)
A M is each independently selected from the group consisting of 1,4-phenylene, 1,4-cyclohexylene, 1,4-cyclohexenylene, pyridine-2,5-diyl, fluorenone- Diyl wherein at least one of the hydrogens is fluorine, chlorine, cyano, hydroxy, formyl, trifluoroacetyl, difluoromethyl, trifluoromethyl, alkyl of 1 to 5 carbon atoms , Alkoxy of 1 to 5 carbon atoms, alkyl ester of 1 to 5 carbon atoms, or alkanoyl of 1 to 5 carbon atoms;
Z M each independently represents a single bond, -OCH 2 -, -CH 2 O-, -COO-, -OCO-, -COS-, -SCO-, -OCOO-, -CONH-, -NHCO-, -CF 2 O-, -OCF 2 -, -CH 2 CH 2 -, -CF 2 CF 2 -, -CH = CHCOO-, -OCOCH = CH-, -CH 2 CH 2 COO-, -OCOCH 2 CH 2 -, -CH = CH-, -N = CH-, -CH = N-, -N = CCH 3 -, -CCH 3 = N-, -N = N- , or -C≡C-, and;
X M is hydrogen, fluorine, chlorine, trifluoromethyl, trifluoromethoxy, cyano, alkyl of 1 to 20 carbon atoms, alkenyl of 2 to 20 carbon atoms, alkoxy of 1 to 20 carbon atoms or alkyl of 1 to 20 carbon atoms Ester;
q is an integer of 1 to 4;
a is an integer from 0 to 20;
R M is hydrogen or methyl;
Y M is a single bond, -O-, -COO-, -OCO- or -OCOO-.
하기 식(M1)으로 표시되는 화합물 중 적어도 1개
를 함유하는 액정 조성물:
[화학식 9]
(상기 식(M1) 중에서,
AM은 독립적으로, 1,4-페닐렌 또는 1,4-시클로헥실렌이지만, AM 중 적어도 1개는 1,4-시클로헥실렌이며, 이들에 있어서, 적어도 1개의 수소가, 불소, 염소, 트리플루오로아세틸, 디플루오로메틸, 트리플루오로메틸, 탄소수 1∼5의 알킬, 탄소수 1∼5의 알콕시, 탄소수 1∼5의 알킬에스테르 또는 탄소수 1∼5의 알카노일로 치환될 수도 있고;
ZM은 각각 독립적으로 단결합, -OCH2-, -CH2O-, -COO-, -OCO-, -CH2CH2-, -CH2CH2COO- 또는 -OCOCH2CH2-이며;
q는 1 또는 2의 정수이며;
XM은 수소, 불소, 염소, 트리플루오로메틸, 트리플루오로메톡시, 시아노, 탄소수 1∼20의 알킬, 탄소수 1∼20의 알케닐, 탄소수 1∼20의 알콕시 또는 탄소수 1∼20의 알킬에스테르이며;
a는 0∼20의 정수이며;
RM은 수소 또는 메틸이며;
YM은 단결합, -O-, -COO-, -OCO- 또는 -OCOO-임).At least one of the compounds according to claim 1; And
At least one of the compounds represented by the following formula (M1)
: ≪ / RTI >
[Chemical Formula 9]
(In the above formula (M1)
A M is independently 1,4-phenylene or 1,4-cyclohexylene, but at least one of A M is 1,4-cyclohexylene, wherein at least one hydrogen is fluorine, Chlorine, trifluoroacetyl, difluoromethyl, trifluoromethyl, alkyl of 1 to 5 carbon atoms, alkoxy of 1 to 5 carbon atoms, alkyl ester of 1 to 5 carbon atoms, or alkanoyl of 1 to 5 carbon atoms Have;
Z M each independently represents a single bond, -OCH 2 -, -CH 2 O-, -COO-, -OCO-, -CH 2 CH 2 -, -CH 2 CH 2 COO- or -OCOCH 2 CH 2 - ;
q is an integer of 1 or 2;
X M is hydrogen, fluorine, chlorine, trifluoromethyl, trifluoromethoxy, cyano, alkyl of 1 to 20 carbon atoms, alkenyl of 1 to 20 carbon atoms, alkoxy of 1 to 20 carbon atoms or alkyl of 1 to 20 carbon atoms Ester;
a is an integer from 0 to 20;
R M is hydrogen or methyl;
Y M is a single bond, -O-, -COO-, -OCO- or -OCOO-.
키랄인 화합물을 적어도 1개 더 함유하는 액정 조성물.12. The method of claim 11,
And at least one chiral phosphorus compound.
2색성 색소 화합물을 적어도 1개 더 함유하는 액정 조성물.12. The method of claim 11,
A liquid crystal composition comprising at least one dichroic dye compound.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JPJP-P-2014-172479 | 2014-08-27 | ||
| JP2014172479 | 2014-08-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20160025475A true KR20160025475A (en) | 2016-03-08 |
Family
ID=55417548
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020150119701A Withdrawn KR20160025475A (en) | 2014-08-27 | 2015-08-25 | Liquid crystal compound, liquid crystal composition and polymer thereof |
Country Status (4)
| Country | Link |
|---|---|
| JP (1) | JP6648438B2 (en) |
| KR (1) | KR20160025475A (en) |
| CN (1) | CN105384723B (en) |
| TW (1) | TWI659090B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20230073781A (en) * | 2021-11-19 | 2023-05-26 | 금오공과대학교 산학협력단 | T-Shaped reactive mesogenic compounds having negative wagelength dippersion, Compensation film composition and Compensation film using the same |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6597244B2 (en) * | 2014-12-02 | 2019-10-30 | Jnc株式会社 | Liquid crystal compound, liquid crystal composition and polymer thereof |
| EP3272836B1 (en) * | 2015-03-19 | 2020-05-06 | Zeon Corporation | Liquid crystal composition, method for producing retardation layer, and circularly polarizing plate |
| EP3306364A4 (en) | 2015-05-28 | 2019-01-23 | Zeon Corporation | Circularly polarized light separating film and method for producing same |
| JPWO2017110638A1 (en) * | 2015-12-22 | 2018-10-11 | 日本ゼオン株式会社 | Liquid crystalline composition, liquid crystal cured layer and method for producing the same, and optical film |
| KR102167466B1 (en) * | 2016-03-29 | 2020-10-19 | 스미또모 가가꾸 가부시끼가이샤 | Liquid crystal composition |
| WO2017179359A1 (en) * | 2016-04-12 | 2017-10-19 | 三菱瓦斯化学株式会社 | Epoxy resin curing agent, epoxy resin composition, and carbon fiber-reinforced composite material |
| US20210284766A1 (en) * | 2016-07-15 | 2021-09-16 | Dic Corporation | Retardation film, elliptically polarizing plate, and display device including the same |
| US10961455B2 (en) * | 2016-08-09 | 2021-03-30 | Jnc Corporation | Polymerizable liquid crystal composition and liquid crystal polymer |
| CN107814783B (en) * | 2016-09-14 | 2021-03-16 | 江苏和成显示科技有限公司 | Polymerizable compound and preparation method and application thereof |
| US10703969B2 (en) | 2016-09-27 | 2020-07-07 | Kaohsiung Medical University | Detection method for quaternary ammonium compound having γ-carboxyl group |
| TWI630387B (en) * | 2016-09-27 | 2018-07-21 | 高雄醫學大學 | METHOD FOR DETECTING A QUATERNARY AMMONIUM COMPOUND HAVING A γ-ACID GROUP, DIAGNOSIS OF CARNITINE DEFICIENCY AND KIT FOR DETECTING THE QUATERNARY AMMONIUM COMPOUND HAVING THE γ-ACID GROUP |
| US10494571B2 (en) * | 2016-10-28 | 2019-12-03 | Jnc Corporation | Polymerizable liquid crystal compound, polymerizable liquid crystal composition, and liquid crystal polymerized films |
| JP2018077464A (en) * | 2016-11-01 | 2018-05-17 | 住友化学株式会社 | Compound, liquid crystal composition, optical film, polarizing plate, and optical display |
| JP2018077465A (en) | 2016-11-01 | 2018-05-17 | 住友化学株式会社 | Compound, liquid crystal composition, optical film, polarizing plate and optical display |
| KR102210179B1 (en) | 2016-11-29 | 2021-01-29 | 후지필름 가부시키가이샤 | Polymerizable liquid crystal composition, optically anisotropic film, optical film, polarizing plate, image display device, and organic electroluminescence display device |
| JP6465255B2 (en) * | 2016-12-26 | 2019-02-06 | Dic株式会社 | Liquid crystal composition and liquid crystal display device |
| CN110325525B (en) * | 2017-02-21 | 2022-11-11 | 富士胶片株式会社 | Polymerizable liquid crystal compound, method for producing polymerizable liquid crystal compound, polymerizable liquid crystal composition, optically anisotropic film, optical film, polarizing plate, and image display device |
| KR20190005800A (en) * | 2017-07-07 | 2019-01-16 | 제이엔씨 주식회사 | Polymerizable liquid crystal composition and a liquid crystal polymer film |
| JP7225736B2 (en) * | 2018-05-15 | 2023-02-21 | Jnc株式会社 | Compound, liquid crystal composition, and liquid crystal display element |
| TW202035380A (en) * | 2018-12-11 | 2020-10-01 | 日商Dic股份有限公司 | Liquid crystal composition, display element and compound |
| JP2023155605A (en) * | 2022-04-11 | 2023-10-23 | 住友化学株式会社 | Polymerizable compounds, mixed compositions |
Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH1068816A (en) | 1996-08-29 | 1998-03-10 | Sharp Corp | Phase difference plate and circularly polarizing plate |
| JP2001004837A (en) | 1999-06-22 | 2001-01-12 | Fuji Photo Film Co Ltd | Phase difference plate and circular polarization plate |
| JP2002372623A (en) | 2001-06-14 | 2002-12-26 | Nitto Denko Corp | Composite retardation plate, circular polarizing plate, liquid crystal display device, organic EL display device |
| WO2005038517A1 (en) | 2003-10-22 | 2005-04-28 | Lg Chem, Ltd. | In-plane switching liquid crystal display comprising compensation film for angular field of view using +a-plate and +c-plate |
| JP2005289980A (en) | 2004-03-08 | 2005-10-20 | Fuji Photo Film Co Ltd | Liquid crystal compound, liquid crystyal composition, polymer, retardation plate, and elliptical polarization plate |
| US20060182900A1 (en) | 2005-02-16 | 2006-08-17 | Lg Chem, Ltd. | Retardation film having a homeotropic alignment liquid crystal film and method for preparing the same |
| JP2009179563A (en) | 2008-01-29 | 2009-08-13 | Fujifilm Corp | Compound, liquid crystal composition and anisotropic material |
| JP2010031223A (en) | 2007-12-28 | 2010-02-12 | Sumitomo Chemical Co Ltd | Compound, optical film, and method for producing optical film |
| JP2010522893A (en) | 2007-03-30 | 2010-07-08 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング | Birefringent polymer film with negative optical dispersion |
| WO2012169424A1 (en) | 2011-06-10 | 2012-12-13 | 日本ゼオン株式会社 | Polymerizable compound, polymerizable composition, polymer, and optically anisotropic body |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3207241A1 (en) * | 1982-02-24 | 1983-09-01 | Schering AG, 1000 Berlin und 4709 Bergkamen | Novel indole derivatives, process for their preparation and pharmaceutical preparations which contain these compounds |
| FR2558158B1 (en) * | 1984-01-13 | 1986-05-16 | Roussel Uclaf | ETHENYL PHENOL INDOLE DERIVATIVES, SALTS THEREOF, PROCESS FOR THEIR PREPARATION, APPLICATION AS MEDICAMENTS, COMPOSITIONS CONTAINING THEM AND INTERMEDIATES |
| FR2584713B1 (en) * | 1985-07-11 | 1988-09-09 | Roussel Uclaf | NOVEL CARBOXAMIDE INDOLE DERIVATIVES, SALTS THEREOF, PROCESS AND INTERMEDIATES FOR THEIR PREPARATION, APPLICATION AS MEDICAMENTS AND COMPOSITIONS CONTAINING THEM |
| CN101470212B (en) * | 2007-12-28 | 2014-10-22 | 住友化学株式会社 | Optical film |
| JP5453956B2 (en) * | 2009-06-26 | 2014-03-26 | 住友化学株式会社 | Compound, optical film and method for producing optical film |
| US9206355B2 (en) * | 2012-04-20 | 2015-12-08 | Lg Chem, Ltd. | Polymerizable liquid crystal compound, polymerizable liquid crystal composition, and optically anisotropic body |
-
2015
- 2015-07-31 JP JP2015152078A patent/JP6648438B2/en active Active
- 2015-08-25 KR KR1020150119701A patent/KR20160025475A/en not_active Withdrawn
- 2015-08-26 TW TW104127799A patent/TWI659090B/en not_active IP Right Cessation
- 2015-08-26 CN CN201510530850.7A patent/CN105384723B/en not_active Expired - Fee Related
Patent Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH1068816A (en) | 1996-08-29 | 1998-03-10 | Sharp Corp | Phase difference plate and circularly polarizing plate |
| JP2001004837A (en) | 1999-06-22 | 2001-01-12 | Fuji Photo Film Co Ltd | Phase difference plate and circular polarization plate |
| JP2002372623A (en) | 2001-06-14 | 2002-12-26 | Nitto Denko Corp | Composite retardation plate, circular polarizing plate, liquid crystal display device, organic EL display device |
| WO2005038517A1 (en) | 2003-10-22 | 2005-04-28 | Lg Chem, Ltd. | In-plane switching liquid crystal display comprising compensation film for angular field of view using +a-plate and +c-plate |
| JP2005289980A (en) | 2004-03-08 | 2005-10-20 | Fuji Photo Film Co Ltd | Liquid crystal compound, liquid crystyal composition, polymer, retardation plate, and elliptical polarization plate |
| US20060182900A1 (en) | 2005-02-16 | 2006-08-17 | Lg Chem, Ltd. | Retardation film having a homeotropic alignment liquid crystal film and method for preparing the same |
| JP2010522893A (en) | 2007-03-30 | 2010-07-08 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング | Birefringent polymer film with negative optical dispersion |
| JP2010031223A (en) | 2007-12-28 | 2010-02-12 | Sumitomo Chemical Co Ltd | Compound, optical film, and method for producing optical film |
| JP2009179563A (en) | 2008-01-29 | 2009-08-13 | Fujifilm Corp | Compound, liquid crystal composition and anisotropic material |
| WO2012169424A1 (en) | 2011-06-10 | 2012-12-13 | 日本ゼオン株式会社 | Polymerizable compound, polymerizable composition, polymer, and optically anisotropic body |
Non-Patent Citations (3)
| Title |
|---|
| K. J. Kim et al, SID '06 Digest p.1158-1161 |
| M. Nakata et al, SID '06 P-58 |
| M. S. Park et al, IDW '04 FMC8-4 |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20230073781A (en) * | 2021-11-19 | 2023-05-26 | 금오공과대학교 산학협력단 | T-Shaped reactive mesogenic compounds having negative wagelength dippersion, Compensation film composition and Compensation film using the same |
| KR20240058814A (en) * | 2021-11-19 | 2024-05-07 | 국립금오공과대학교 산학협력단 | T-Shaped reactive mesogenic compounds having negative wagelength dippersion, Compensation film composition and Compensation film using the same |
Also Published As
| Publication number | Publication date |
|---|---|
| CN105384723B (en) | 2019-07-16 |
| CN105384723A (en) | 2016-03-09 |
| JP6648438B2 (en) | 2020-02-14 |
| TWI659090B (en) | 2019-05-11 |
| TW201608010A (en) | 2016-03-01 |
| JP2016047813A (en) | 2016-04-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6648438B2 (en) | Liquid crystal compound, liquid crystal composition and polymer thereof | |
| JP6787110B2 (en) | A polymerizable liquid crystal compound, a polymerizable liquid crystal composition, a liquid crystal polymer thereof, and a method for producing the liquid crystal polymer. | |
| JP6665581B2 (en) | Polymerizable liquid crystal composition and optically anisotropic film | |
| JP6597244B2 (en) | Liquid crystal compound, liquid crystal composition and polymer thereof | |
| KR101076669B1 (en) | Polymerizable liquid crystal composition and liquid crystal film having homogeneous alignment | |
| JP5987623B2 (en) | Polymerizable liquid crystal composition and optically anisotropic film | |
| JP6497241B2 (en) | Polymerizable liquid crystal compound, composition and polymer thereof | |
| JP6015988B2 (en) | Polymerizable liquid crystal composition and optical anisotropic body | |
| JP5321298B2 (en) | Polymerizable liquid crystal composition and optically anisotropic film using the same | |
| KR20160118131A (en) | Production method for optical compensation film | |
| JP6729106B2 (en) | Polymerizable liquid crystal compound, composition and polymer thereof | |
| US9540567B2 (en) | Polymerizable liquid crystal composition and optically anisotropic body | |
| JP2016056106A (en) | Liquid crystal compound having pyrrole or thiophene skeleton, liquid crystal composition and polymer of the same | |
| JP6107441B2 (en) | Liquid crystal compound, liquid crystal composition and polymer thereof | |
| JP6733328B2 (en) | Polymerizable liquid crystal composition and optically anisotropic substance | |
| KR101855525B1 (en) | Polymerizable liquid crystal composition and optical anisotropic body | |
| JP2017222808A (en) | Polymerizable liquid crystal composition and optical anisotropic body | |
| JP2019206677A (en) | Polymerizable liquid crystal compound, composition and polymer thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20150825 |
|
| PG1501 | Laying open of application | ||
| PC1203 | Withdrawal of no request for examination |